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List of abbreviations 
 
Ac  acetyl 
AIBN 2,2′-azobis(2-
methylpropionitrile) 
aq aqueous 
Ar aryl 
Bn  benzyl 
Boc  tert-butoxycarbonyl 
bs  broad singlet (NMR) 
CI  chemical ionization 
CM  cross-metathesis 
COSY correlation 
spectroscopy 
CSA  camphorsulfonic acid 
Cy  cyclohexyl 
d  doublet (NMR) 
dba  dibenzylidene acetone 
dd  double doublet (NMR) 
dt  double triplet (NMR) 
DBU 1,8-diazabicylco-
[5.4.0]-undec-7-ene 
DHA  dehydroalanine 
DIBALH diisobutylaluminium 
hydride 
DIPEA  diisopropylethylamine 
DMF N,N-dimethyl-
formamide 
DMSO  dimethylsulfoxide 
dppp 1,3-
diphenylphosphino-
propane 
e.g. exempli gratioa (for 
the sake of clarity) 
ee  enantiomeric excess 
et al.  et aliae (and others) 
EI  electron impact 
ESI  electrospray 
HPLC high performance 
liquid chromatography 
HRMS high resolution mass 
spectrometry 
i.e.  id est (that is) 
IR  infrared 
LC  liquid chromatography 
LCMS liquid chromatography 
mass spectrometry 
LDA lithium 
diisopropylamide 
m  meta 
m  multiplet (NMR) 
Mes  mesityl 
MOM  methoxymethyl 
Ms  methanesulfonyl 
n.d.  not determined 
NIS  N-iodosuccinimide 
NMO   
NMR nuclear magnetic 
resonance 
o ortho 
p para 
PG  protecting group 
phen  1,10-phenanthroline 
PTSA  p-toluenesulfonic acid 
q  quartet (NMR) 
RCM  ring-closing metathesis 
ROMP ring-opening 
metathesis 
polymerization 
rt room temperature 
s  singlet (NMR) 
t  triplet (NMR) 
TBAI tetrabutyl ammonium 
fluoride 
TBS  tert-butyldimethylsilyl 
TCCA trichloroisocyanuric 
acid 
TEMPO   
Tf trifluoromethane-
sulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC thin layer 
chromatography 
TMS  trimethylsilyl 
Ts  p-toluenesulfonyl 
TPAP   
  2
 
Contents 
 
List of abbreviations 1 
Contents 2 
 
Chapter 1. Olefin metathesis: An introduction 5 
1.1 Olefin metathesis 5 
1.2 Mechanism of olefin metathesis 6 
1.3 Well-defined catalytic systems 7 
1.4 Ring-closing metathesis (RCM) in organic synthesis 10 
1.5 Scope of RCM: heterosubstituted double bonds 12 
1.6 Purpose and outline of this investigation 16 
1.7 References and notes 17 
 
Chapter 2. Synthesis of allylic O,O-acetals via oxypalladation of alkoxyallenes 21 
2.1 Introduction 21 
2.2 Scope of the Pd-catalyzed O,O-acetal formation 23 
2.3 Oxypalladation with carboxylic acids 26 
2.4 Mechanistic considerations 28 
2.5 Ring-closing metathesis 29 
2.6 Conclusion 30 
2.7 Acknowledgements 30 
2.8 Experimental section 31 
2.9 References and notes 33 
 
Chapter 3. Ring-closing metathesis of α-alkoxyacrylates 35 
3.1 Introduction 35 
3.2 Preparation of aliphatic RCM-precursors 36 
3.3 Investigation of RCM behavior 37 
3.4 Inhibition of olefin isomerization by 1,4-benzoquinone 41 
3.5 A novel route to α-alkoxyacrylates and the synthesis of substituted benzofurans and 
-pyrans 42 
3.6 Conclusion 44 
3.7 Experimental section 44 
3.8 References and notes 48 
 
Chapter 4. RCM of carbohydrate-derived α-alkoxyacrylates 51 
4.1 Introduction 51 
4.2 Synthesis and RCM of a D-mannose-based α-alkoxyacrylate 52 
4.3 Synthesis of RCM-precursors from C5-carbohydrates 54 
4.4 Ring-closing metathesis of C5-carbohydrate-based α-alkoxyacrylates 54 
4.5 One-carbon homologation during ring-closing metathesis 55 
4.6 Towards a synthesis of KDN 58 
4.7 Conclusion 61 
4.8 Acknowledgements 61 
4.9 Experimental section 61 
3 
4.10 References and notes 67 
 
Chapter 5. Total syntheses of DAH, KDO and 2-deoxy-β-KDO 69 
5.1 Introduction 69 
5.2 Unsuccessful approaches to functionalize the glycal intermediates 72 
5.3 Completion of the synthesis of DAH 74 
5.4 Investigation of the Michael acceptor ability of the substituted glycals 75 
5.5 Completion of the syntheses of KDO and 2-deoxy-β-KDO 76 
5.6 Conclusion 77 
5.7 Experimental section 77 
5.8 References and notes 80 
 
Chapter 6. Ring-closing metathesis of dehydroamino acids 83 
6.1 Introduction 83 
6.2 Precursor synthesis 84 
6.3 Ring-closing metathesis of dehydroamino acids 87 
6.4 Introduction of allylic substituents 88 
6.5 Introduction of oxygen substituents 90 
6.6 Conclusion 94 
6.7 Acknowledgements 94 
6.8 Experimental section 94 
6.9 References and notes 102 
 
Chapter 7. Synthesis of optically active 4-substituted cyclic dehydroamino acids 103 
7.1 Introduction 103 
7.2 Synthesis of itaconic acid mono-esters 105 
7.3 Asymmetric hydrogenation: initial tests 107 
7.4 Asymmetric hydrogenation: library experiment 110 
7.5 Asymmetric hydrogenation: autoclave experiments 113 
7.6 Conversion to iodide scaffolds 114 
7.7 Alkylation of protected dehydroalanine and subsequent RCM 116 
7.8 Conclusions and future prospects 117 
7.9 Acknowledgements 118 
7.10 Experimental section 118 
7.11 References and notes 126 
 
Summary 129 
Samenvatting 135 
 
Dankwoord 141 
Curriculum Vitea 145 
List of publications and presentations 146 
 
 
 
 
 
  4
 
 
 
 
 
 
 
5 
 
 
 
Olefin metathesis: An introduction 
 
 
 
 
 
1.1 Olefin metathesis 
 
The term “olefin metathesis” was first introduced in 1967 by Calderon to describe 
the catalytic disproportionation of two double bonds (Figure 1.1).1 This reaction was 
initially observed in the 1950s during research on Ziegler-Natta polymerization processes.2 
Industrial chemists at DuPont found that alumina-supported molybdenum species catalyzed 
the transformation of propene into 2-butenes and ethylene and, additionally, the 
polymerization of cyclopentene and norbornene, forming thus far unprecedented polymers.3 
These observations were followed by several reports describing improved catalytic systems 
based on molybdenum and tungsten, that catalyzed either the polymerization of 
cycloolefins or the disproportionation of linear olefins.4  
 
R1
R2
R3
R4
R1 R3
R2 R4
catalyst
 
Figure 1.1. Metathesis of two olefinic bonds. 
 
 It was not until 1967 that it was recognized by Calderon and co-workers that both 
of the aforementioned transformations were essentially the result of the same reaction, i.e. 
olefin metathesis.1 This conclusion was based on their work on a catalytic system, derived 
from WCl3, EtOH and EtAlCl2, that was found to effect both the ring-opening 
polymerization of cycloolefins5a and the disproportionation of acyclic olefins.5b,c 
 
 
1 
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1.2 Mechanism of olefin metathesis 
 
 The discovery of the metathesis of olefins raised questions concerning the exact 
mechanism of this new type of reaction. Initially, a number of ideas were postulated, none 
of which fully matched experimental observations.4–6 In 1971, nonetheless, those early 
studies allowed Chauvin to propose a mechanism that appeared to be most consistent with 
experimental evidence7 and that was shortly thereafter supported by other groups.8 
Generally, this mechanism consists of a sequence of alternating [2+2]-cycloadditions and 
cycloreversions (Figure 1.2). Coordination of an olefin to a metal alkylidene species (I → 
II), formation of a metallacyclobutane complex (III) and subsequent release of a different 
olefin, results in the formation of a new metal alkylidene (IV). This species can then 
undergo the same sequence of transformations, eventually completing the 
disproportionation of two double bonds, as shown in Figure 1.1. 
 
[M] CH2
[M]
R1
[M]
R1
[M]
R1 R2
R1 R2
R1
[M] CH2
[2+2]
R1
[2+2]
[2+2]
[M]
R1 R
2
[2+2]
catalyst
precursor
R2
I
II
III
IV
V
VI
 
Figure 1.2. Mechanism of transition metal-catalyzed olefin metathesis, as proposed by Chauvin,7 illustrated using 
terminal olefinic bonds. 
 
Nowadays, this mechanism is generally accepted and new theoretical9 as well as 
experimental10 evidence for the involvement of different intermediates in the catalytic cycle 
is continuously being reported. 
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1.3 Well-defined catalytic systems 
 
 The “Chauvin mechanism” was of great influence to metathesis research, since the 
suggested involvement of metal alkylidenes provided an important lead for catalyst 
development. Until the mid-1970s, olefin metathesis was performed using ill-defined 
homogeneous or heterogeneous catalyst systems. In 1976, Katz reported the first well-
defined metal carbene that underwent olefin metathesis. The [W(CO)5(=CPh2)] complex (1, 
Figure 1.3) initiated metathesis – albeit at a low rate – of a variety of di- and trisubstituted 
cycloalkenes and E- and Z-2-pentenes.11,12 Around the same time, Schrock and co-workers 
had commenced their work on high-oxidation state metal alkylidene complexes, which 
were investigated for their behavior in the presence of olefins.13 In 1980 this resulted in the 
development of Nb/Ta-complexes (2) that catalyzed the metathesis of cis-2-pentene. 
Particularly the formation of new alkylidene complexes upon reaction of 2 with styrene 
presented solid proof for Chauvin’s proposed metathesis mechanism.14 
 
M
4
Osborn
1983
W
Cl
ArO
OEt2
O
5
Bassett
1985
W
Br
Br
O
O
+ GaBr3PEt3
W
PEt3
Cl
Cl
O
3
Schrock
1980
PMe3
Cl
tBuO
tBuO
2 (M = Nb, Ta)
Schrock
1980
(CO)5W
Ph
Ph
1
Katz
1975  
Figure 1.3. Early olefin metathesis catalysts. 
 
Early results with poorly defined high-oxidation state W-based systems (see: 
Section 1.1) suggested that alkylidene complexes of group 6 transition metals (i.e. W and 
Mo) might give active catalysts for olefin metathesis.15 Based on this assumption and on the 
encouraging results with high-oxidation state complexes 2, Schrock and co-workers, as well 
as other groups, set out to prepare a range of W- and Mo-alkylidene complexes and 
evaluate them as metathesis catalysts. The first stable, catalytically active W-alkylidene 
complexes were reported throughout the 1980s by the groups of Schrock,16 Osborn17 and 
Bassett18 (3–5, respectively, Figure 1.3). Finally, in 1990, Schrock reported a range of 
single-component imido alkylidene species, in which two bulky alkoxide ligands 
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contributed to the relative stability of the complexes (Figure 1.4). These compounds are still 
among the most active catalysts known to date and one version (6) is commercially 
available. For these reasons, it is not surprising that these complexes have found numerous 
applications in organic synthesis.15 
 
6
iPriPr
N
MoO
O
Me
Me
Ph
F3C CF3
Me
Me
F3C
F3C
M
NAr
Me
Ph
Me
RO
RO
M = W, Mo
Schrock
1990  
Figure 1.4. General structure of Schrock catalysts and the currently commercially available version (6). 
 
 The main disadvantages of the Schrock catalysts are (a) the fact that they are 
incompatible with a number of polar functional groups and (b) their high sensitivity to air, 
requiring handling under an inert atmosphere. In 1992, an important breakthrough in terms 
of catalyst stability was achieved by the group of Grubbs.19 Focusing on ruthenium instead 
of tungsten and molybdenum, initially led to the discovery of complex 7 as a metathesis 
catalyst20 (Figure 1.5). Although 7 is not as active as the molybdenum-based catalysts, it is 
significantly more versatile due to its remarkable functional group tolerance. In addition, it 
is air-stable as a solid and fairly resistant to water, alcohols and acids.20b An additional 
improvement was achieved when a range of alkyl- and aryldiazoalkane compounds were 
used for the preparation of new Ru-carbene complexes. The best result was obtained with 
benzylidene complex 8: not only was the catalyst readily available via this synthetic 
method, the initiation rate of 8 was also considerably higher than that of the 
diphenylvinylcarbene analogue 7.21 
 
Ru
PCy3
PCy3
Cl
Cl
MesN NMes
Ru
PCy3
Cl
Cl
MesN NMes
Ru
Cl
Cl
iPrO
Ru
PR3
PR3
Cl
Cl
Ph
Ph
Ph
7 (R = Ph, Cy)
Grubbs
1992, 1993
8a
Grubbs
1995
9a
Grubbs
1999
10a
Hoveyda
2000
Ph
MesN NMes
Ru
PCy3
Cl
Cl
9'
Nolan/Herrmann
1999
Ph
 
Figure 1.5. Different ruthenium-based olefin metathesis catalysts; a commercially available in 2006. 
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 Despite the remarkable stability and functional group-tolerance, the “first 
generation” Grubbs catalysts 7 and 8 were still an order of magnitude less active than the 
molybdenum-based Schrock catalysts. An important step in narrowing this gap was made in 
1999 by Grubbs and others by substituting one phosphine by a more strongly electron-
donating N-heterocyclic carbene (NHC) ligand, resulting in the “second generation” 
catalysts 9 and 9′ (Figure 1.5). The use of NHC ligands resulted in a dramatic increase in 
activity,22,23 which is analogous to the increased metathesis activity of PCy3-substituted 
catalysts compared to those substituted with the less donating PPh3.20a In addition, catalyst 9 
broadened the scope of ruthenium-catalyzed olefin metathesis to a degree that had thus far 
only been observed for the most active early transition-metal catalysts.22,24,25 
 The development of catalyst 9 with its impressive activity, stability and scope has 
led to a dramatic increase in research activities involving the design of novel olefin 
metathesis catalysts.26 One of the first and most important adaptations of 9 was reported in 
2000 by the group of Hoveyda. The introduction of a chelating styrenyl ether moiety 
resulted in the formation of phosphine-free catalyst 10 (Figure 1.5), which was found to be 
particularly stable and reactive.27 An additional advantage of the styrenyl “handle” of this 
catalyst is its suitability for extensive modification. Over the recent years, variations on this 
catalyst have been reported, most of which are based on steric and electronic alterations as 
well as attachment of the complex to various solid supports.28  
In addition, many modifications of 9 are based on the principle of faster initiation. 
Two noteworthy examples of this approach are shown in Figure 1.6: the phosphine-free 
complex 11 by Grubbs29 and the 14 electron complex 12 by Piers.30 
 
MesN NMes
Ru
Ph
Cl
N
N
Br
Br
Cl
11
Grubbs
2002
MesN NMes
Ru
Cl
Cl PCy3
12
Piers
2004
[B(C6F5)4] -+
 
Figure 1.6. Two recent examples of fast-initiating metathesis catalysts. 
 
 The evolvement into versatile, commercially available catalysts has over the past 
decade resulted in an explosion of applications of olefin metathesis in research areas, 
ranging from synthetic organic chemistry to materials science. In 2005, the revolutions in 
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these fields caused by the use of metathesis catalysts were recognized by the Royal 
Swedish Academy of Sciences, jointly awarding the Nobel prize in chemistry to Chauvin, 
Schrock and Grubbs.31 
 
1.4 Ring-closing metathesis (RCM) in organic synthesis 
 
 A number of synthetic transformations can be envisioned, based on the metathesis 
of two olefinic bonds according to the Chauvin mechanism. The reversible nature of the 
metathesis process, however, would in principle cause the formation of equilibrium 
mixtures of starting materials and products. Nevertheless, useful synthetic processes have 
been developed by taking advantage of either the release of ring strain or the formation of 
volatile co-products (Figure 1.7).32 The former is the driving force behind ring-opening 
metathesis (ROM) and ring-opening metathesis polymerization (ROMP).33 Conversely, 
ring-closing metathesis (RCM) and cross-metathesis (CM) are entropically driven if one of 
the products is volatile, such as ethene or propene. 
 
m
acyclic diene-
metathesis
polymerization
(ADMET)
ring-opening
metathesis
polymerization
(ROMP)
ring-closing metathesis
(RCM)
ring-opening metathesis
(ROM)
R1
R2
R3
R4+
R1
R4
R3
R2+
cross-
metathesis
(CM)
R3R1
R4R2
R1
R2
R3
R4
R3R2 R2
R1R
1
R3
enyne
metathesis
alkyne
metathesis
 
Figure 1.7. Different metathetic transformations. 
 
Finally, olefin metathesis is not restricted to alkenes, as alkyne bonds are known to 
undergo similar transformations (Figure 1.7). Both intermolecular and intramolecular 
reactions between one double and one triple bond (enyne metathesis) are catalyzed by most 
ruthenium-based catalysts (e.g. 8–10).34 On the other hand, the metathesis of two triple 
bonds (alkyne metathesis) is commonly carried out using Mo[N(tBu)(Ar)]3/CH2Cl2 systems 
or the tungsten alkylidene (tBuO)3W≡CCMe3.35 
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 While ROMP and ADMET have had significant implications on polymer 
chemistry – by facilitating the formation of functionalized (co-)polymers32,33 – CM and 
particularly RCM have revolutionized the area of organic synthesis over the past 15 years.36 
In this relatively short period of time, olefin metathesis has developed into one of the most 
widely employed methods for C-C bond formation and RCM is nowadays the most 
powerful tool for ring formation. Particularly, the enormous selection of heterocyclic ring 
systems of different ring-size that can be generated by RCM has reshaped the area of total 
synthesis of complex molecules.36a–c,37  
Two illustrations of the significance of RCM in total synthesis are shown in Figure 
1.8. Early examples of the use of RCM in macrocyclizations are the synthetic investigations 
of epothilones, which comprise a class of potent anticancer agents.38 For example, the total 
synthesis of epothilone C has been a popular subject of research, with many approaches 
relying on formation of the C12-C13 connection by RCM.39  
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O
H
MeH
H
H
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O H
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O
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H H
HH
H H
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Figure 1.8. Structures of epothilone C38,39 and ciguatoxin CTX3C40 including the connections that were realized 
by RCM. 
 
Finally, an impressive illustration of the power of RCM was given by Hirama and 
co-workers with their total synthesis of the marine polyether ciguatoxin CTX3C (Figure 
1.8). This complex neurotoxin, containing thirteen fused heterocyclic rings, was 
synthesized using six RCM-steps, with the nine-membered ring F being closed at the final 
stage of the synthesis.40 
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1.5 Scope of RCM: heterosubstituted double bonds 
 
 During the past decade, the scope of olefin metathesis and specifically RCM has 
continuously widened, particularly in terms of functional group tolerance. Nevertheless, 
direct functionalization of the double bond has in several cases proven to complicate RCM. 
Although many of such olefins have recently been cyclized, the grounds for (un)reactivity 
of specific substrates are still somewhat unclear and the use of functionalized olefins often 
remains a matter of trial-and-error. 
 
1.5.1 Electron-poor double bonds 
 
Olefin metathesis of electron-poor double bonds is challenging, because of lower 
reactivities compared to neutral olefins41 and the relative instability of electron-deficient 
metal carbene bonds.42 In the case of RCM between α,β-unsaturated carbonyl compounds 
and neutral terminal olefins it has been reported that the catalyst reacts preferentially with 
the neutral double bond, before metathesizing the electron-poor olefin to form the cyclized 
product.41b On the other hand, after metathesis of the unhindered olefin, the carbonyl 
function in the resulting carbene complexes (e.g. 13a/b) can chelate to the metal center, 
thereby lowering the rate of catalysis.43  
O O
( )n
[M]
O
OR
( )n
[M]
13a 13b  
This effect can sometimes be circumvented by the addition of a Lewis-acid, such 
as Ti(OiPr)4.43c The second generation ruthenium catalyst 9, with its more electron-rich 
ruthenium center, is generally less prone to such chelation and was found to be capable of 
cyclizing unsaturated esters and ketones in excellent yields.41b 
An illustration of the potential of RCM of electron-deficient olefins is given in 
Scheme 1.1. The generation of unsaturated lactones 15 via RCM of homoallylic acrylates 
14 has been applied in the total synthesis of a number of biologically relevant natural 
products,37a such as boronolide,44a fostriecin44b,c and malyngolide.44d 
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O O
O
R R
O
8 or 9
CH2Cl2
O
O
MeOH
HO MeOH
fostriecin
14 15
O
O
Me
C9H19
OH
malyngolide
O
O
OAc
OAc
Me
OAc
boronolide  
Scheme 1.1. RCM of allyl acrylates and several examples of biologically active natural products. 
 
Vinyl halides had initially been observed by Grubbs to be inactive in CM.41b A 
short time later, however, the same group reported the first example of metathesis of a 
directly halogenated olefin, namely 1,1-difluoroethene, employing a well defined catalyst 
(9).41a In 2003 this report was followed by a paper by Weinreb, describing the first 
examples of RCM of halide-substituted olefins, namely vinyl chlorides.45 By employing 
catalyst 9, five-, six- and seven-membered carbo- and heterocycles were prepared, 
containing a vinyl chloride moiety (e.g. 16, 17, Figure 1.9).  
 
Cl
MeO2C CO2Me
16 (n = 0,1,2)
(  )n
N
Cl
O Ph
17
N
Boc
N
Boc NBn
(  )n
F
O
20 (n = 1,2)
S NBnBocN
F
O O
18 19 21
Ar
CF3F
MeO2C
 
Figure 1.9. Examples of cyclic products, formed by RCM of halide- or CF3-substituted olefins.45–47 
 
Shortly hereafter, it was demonstrated by the groups of Brown,46a Rutjes46b,c and 
Haufe,46d that vinyl fluorides could also undergo RCM with 9, resulting in synthetically 
useful, fluoride-containing building blocks (e.g. 18–20). In addition, trifluoromethyl-
substituted olefins were reported by the group of Rutjes to be suitable substrates for RCM, 
resulting in a range of pharmaceutically relevant N-heterocycles (e.g. 21).46b,47 
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1.5.2 Enol ethers and enamides 
 
Early reports suggested that enol ethers were poor substrates for the first 
generation Grubbs catalyst 8. Only a few examples exist in which 8 successfully cyclizes 
enol ethers48 and generally they could only be cyclized utilizing the Schrock catalyst 6,49 or 
the Tebbe reagent [Cp2Ti(CH2)(ClAlMe2)].50 A reason for this could be the formation of a 
Ru carbene resulting from metathesis of the vinyl ether moiety and 8. The relatively fast 
reaction of the electron-rich double bond results in exclusive formation of a so-called 
Fisher-type carbene (i.e. 22), thereby deactivating the catalyst.41b,51 
Nonetheless, with the development of the more active catalyst 9, the 
metathesis of enol ethers has over the past few years evolved into a useful 
synthetic transformation. Rainier and co-workers were the first to show that 9 
worked just as well as the less robust Mo-catalyst 6 in the RCM of enol ethers.52a 
Moreover, they demonstrated the potential of enol ether-olefin RCM for natural product 
synthesis by applying this approach in their syntheses of the A–D and F–H subunits of the 
marine toxin gambierol (Scheme 1.2a).52b–c,53 
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O
Me
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O
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O
H
H
O
Me
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23 24
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O OMe
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BnO
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BnO O
O
OMe
O
O
BnO
BnO
BnO
O
BnO
BnO
BnO
BH3·THF
NaOOH
9
PhMe
90 °C
β−C-
trisaccharide
25 26  
Scheme 1.2. (a) Enol ether RCM in the synthesis of the F–H subunit of gambierol by Rainier.52c (b) RCM-based 
synthesis of a β-C-trisaccharide by Postema.56a 
 
 Noteworthy applications of enol ether metathesis in carbohydrate chemistry have 
been developed by several groups.36e,f For instance, Overhand, Overkleeft et al. have used 
this reaction as a key step in syntheses of cis- and trans-fused pyranopyran sugar amino 
acids.54 Furthermore, the group of Postema has applied enol ether metathesis in synthetic 
Ru
L
L
Cl
Cl OEt
22
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pathways towards several classes of carbohydrates. Their esterification-RCM protocol has 
resulted in flexible routes to a variety of biologically relevant β-C-glycosides55 and 
β-C-di/tri/tetra-saccharides (Scheme 1.2b).56 
 As a result of the problematic metathesis of enol ethers, enamides were long 
thought to be unsuitable substrates for olefin metathesis. In the past years, however, these 
fragments have also been shown to be versatile substrates for RCM (Scheme 1.3).57 
 
RN
PG
(  )n
27
R = H, Me
PG = Ts, Bz, CO2Et
n = 1, 2
N
PG
(  )n
R
 9', C2H4Cl2
84 °C
57−93%
N
TsNTs
R1
R2
R3
R1
R2
R3
(a) (b)
29
R1, R2, R3 = H, OMe
9, PhMe
110 °C
79−99% 3028
 
Scheme 1.3. (a) Enamide-olefin RCM by Kinderman et al.57a (b) Formation of indoles through RCM of enamides 
by Arisawa et al.57b 
 
The formation of five- and six-membered cyclic enamides 28 via RCM, using 9′ 
as catalyst, was first reported by the groups of Rutjes and Hiemstra. Remarkably, RCM of 
enamides 27 was also found to proceed using the first generation Grubbs catalyst 8, in most 
cases with only slightly lower yields.57a A short time later, the same RCM-based 
methodology was applied by Nishida and co-workers for the preparation of substituted 
indoles 30.57b 
 
1.5.3 Other substituents 
 
 Besides olefin metathesis on traditional electron-rich and -poor olefins, as 
discussed in the previous two sections, RCM of an additional number of heteroatom-
substituted olefins is worth mentioning. Several S- and P-substituted double bond have 
been applied in RCM, resulting in a range of heterocyclic products (Figure 1.10).58 Both 
vinylic sulfonates59 and sulfonamides60 have been cyclized, employing catalysts 8 or 9, 
resulting in five-, six- and seven-membered S-heterocycles (e.g. 31, 32). In addition, a 
number of different phosphorus-substituted olefins have been employed in RCM, resulting 
in the formation of cyclic vinyl phosphonates (33),61a,b phoshonamides (34)61b,c and 
phosphonamidates (35).61a 
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Figure 1.10. Examples of cyclic products, formed by RCM of S- or P-substituted olefins.59–61 
 
 Finally, other examples of successful olefin metathesis with heteroatom-
substituted double bonds include the use of B- and Si-substituted olefins.62 
 
1.6 Purpose and outline of this investigation 
 
 This chapter is intended to give a brief historical overview of the discovery of 
olefin metathesis and the development of synthetically useful catalysts for different types of 
metathetic transformations. In addition, the scope of ring-closing metathesis (RCM) in 
terms of directly functionalized double bonds is discussed as well as some illustrative 
examples of applications of RCM in natural product synthesis. Chapter 2 describes a 
comprehensive study of the scope of a combined oxypalladation/ring-closing metathesis 
route to oxygen heterocycles, which may serve as versatile building blocks for different 
classes of natural products. 
 Considering the examples of the ring-closing metathesis of electron-rich and -poor 
olefins discussed in this chapter, we set out to investigate the metathesis behavior of olefins 
that are substituted with both an electron-withdrawing and -donating group. Chapter 3 of 
this thesis describes the investigation of RCM of α-alkoxyacrylate-containing precursors, 
leading to a range of oxygen heterocyclic compounds. The application of this methodology 
to highly functionalized carbohydrate-derived substrates is discussed in Chapter 4, finally 
leading to useful glycal building blocks for a number of natural products and derivatives 
thereof. Further functionalization of two of these glycals resulted in efficient total syntheses 
of the natural products DAH and KDO and the potent enzyme inhibitor 2-deoxy-β-KDO, 
which are discussed in Chapter 5. 
 Inspired by the results obtained with the RCM of α-alkoxyacrylate precursors, we 
decided to extend this research to the nitrogen analogues, i.e. α,β-dehydroamino acids. The 
synthesis and subsequent RCM of a range of unsubstituted model systems are discussed in 
Chapter 6, as well as the investigation of several allylically substituted variants. As an 
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addition to the latter systems, Chapter 7 describes a combined asymmetric 
hydrogenation/ring-closing metathesis approach to optically active 4-substituted cyclic 
dehydroamino acids.63 
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Synthesis of allylic O,O-acetals via 
oxypalladation of alkoxyallenes 
 
 
 
2.1 Introduction 
 
Allylic O,O-acetals (1) represent a rather sensitive, but versatile compound class in 
synthetic organic chemistry. The possibility of rearrangement to the corresponding enol 
ether fragments, but also formation of oxycarbenium ions render these compounds useful 
intermediates in the synthesis of more elaborate synthetic targets. (Scheme 2.1). 
 
OR2R1O R1O
+
OR2
R1O
O OR2
R
1 2
(  )n
 
Scheme 2.1. Potential transformations of allylic O,O-acetals. 
 
In addition, the presence of a double bond makes these compounds potential 
precursors for ring-closing metathesis (RCM), which may result in the generation of cyclic 
O,O-acetals of type 2. These functionalized heterocyclic products represent useful building 
blocks for the synthesis of natural products and other biologically relevant compounds.1,2 
Scheme 2.2 shows a transition-metal catalyzed route developed in our group, in 
which we identified alkoxy-1,2-propadienes (”alkoxyallenes”, 4) as versatile building 
blocks for the preparation of such unsaturated oxygen heterocycles. A combination of 
palladium catalysis and ring-closing metathesis (RCM) was used to form cyclic acetals 6, 
which could be further functionalized via oxycarbenium ion chemistry.3,4 
A key element in this pathway is the formation of allylic O,O-acetals 5 via a 
palladium-catalyzed procedure. The fact that such acetals can be generated under mildly 
2 
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basic conditions, rather than via traditional, in this case, unreliable acid-catalyzed methods, 
makes this a useful synthetic procedure. 
 
OHR1
+
OR1 OR2
OR1 OR2
[Pd]
OR1
+
OR1
Nu(cleophile)
3
(n = 1,2) (  )n
(  )n(  )n
(  )n (  )n
4
(R2 = Me, Bn)
7
6
BF3·OEt2
Nu
R2O •
(RCM)5
[Ru]=CHPh
 
Scheme 2.2. Preparation of functionalized oxygen heterocycles via a Pd/Ru-catalyzed pathway. 
 
The viability of the palladium-catalyzed method for the successful construction of 
both O,O- and N,O-acetals and subsequent application in total synthesis has been illustrated 
in publications by our group5 and by others.6 For instance, Scheme 2.3 shows the 
application of the amidopalladation of benzyloxyallene with an unnatural amino acid 
resulting in a formal synthesis of the enantiomerically pure frog alkaloid quinolizidine 
233A.7 
 
MeO2C NH
Ns
4a
Pd(OAc)2/dppp
 Et3N
MeCN, rt
80%
BnO •Me3Si
MeO2C N
Ns
Me3Si
OBn
N
quinolizidine 233A8 9
 
Scheme 2.3. Formal synthesis of a 1-ethylquinolizidine frog alkaloid by Kinderman et al.7 
 
 In the area of O,O-acetal formation we previously demonstrated that the secondary 
alcohol 10 and the tertiary alcohol 13 could be efficiently transformed in the corresponding 
allylic acetals 11 and 14. Subsequent ring-closing metathesis of these acetals, by use of the 
first generation Grubbs catalyst, resulted in the efficient formation of heterocycles 12 and 
15 (Scheme 2.4).3,5a  
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OH
4b (5 equiv)
Pd(OAc)2/dppp, Et3N
MeCN, reflux, 3 h
98%
O OBnMeO2C
OH
4a (5 equiv)
Pd(OAc)2/dppp, Et3N
MeCN, rt, 92 h
97%
O OBnMeO2C
MeO2C
MeO2C
O OBnMeO2C
O OBnMeO2C
CH2Cl2, rt
74%
CH2Cl2, rt
77%
10
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11
14
12
15
BnO •
MeO •
MesN NMes
Ru
PhPCy3
Cl
Cl
Ru
Ph
PCy3
PCy3
Cl
Cl
 
Scheme 2.4. Oxypalladation of a secondary and tertiary alcohol followed by RCM.3,5a 
 
 In order to explore the scope of this mild palladium-catalyzed O,O-acetal 
formation and to obtain information on the precise mechanism of the transformation, we 
started a comprehensive investigation, using different substrates and catalysts. This chapter 
describes the results obtained with alcohols, phenols and carboxylic acids, as well as a 
discussion of the mechanism for this catalytic reaction. 
 
2.2 Scope of the Pd-catalyzed O,O-acetal formation 
 
 During these investigations, we decided to focus our attention on two different 
alkoxyallenes, namely benzyloxy- and phenethyloxyallene (4a and 4c, respectively). 
Syntheses of these allenes was carried out using procedures developed by Brandsma et al.8 
Thus, alkynes 16a and c9 were converted into the corresponding allenes 4a and c through 
reaction with KOtBu in refluxing toluene (Scheme 2.5). 
 
4a (R = Bn): 58%
4c (R = (CH2)2Ph): 52%
RO •RO
KOtBu (10 mol %)
PhMe
reflux16a (R = Bn)
16c (R = (CH2)2Ph)  
Scheme 2.5. Synthesis of benzyloxyallene (4a) and phenethyloxyallene (4c). 
 
 A range of primary and secondary alcohols was selected for evaluation in the 
palladium-catalyzed O,O-acetal formation with allenes 4a or c (Table 2.1). First of all, 
3-buten-1-ol (17) was transformed into the corresponding allylic acetal (22), using 4a and 
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Pd(OAc)2/dppp, in a yield of 55% (entry 1). Interestingly, use of a Pd(0) source, i.e. 
Pd(dba)2 instead of Pd(II), resulted in the formation of 22 as well, in an even slightly 
improved yield of 65% (entry 2). Carrying out the reaction under neutral conditions, by 
omitting Et3N, did not significantly influence the results either and yielded 22 in 59% (entry 
3). 
 
Table 2.1. Oxypalladation with primary and secondary alcohols.a 
[Pd]/dppp, Et3N
MeCN
R1O OR2
R1OH
R2O •
4a (R2 = Bn)
4c (R2 = (CH2)2Ph)
 
entry alcohol catalyst allene product yield
b 
(%) 
1 
OH  
17 Pd(OAc)2 4a 
O OBn  
22 55 
2 17  Pd(dba)2 4a 22  65 
 3c 17  Pd(dba)2 4a 22  59 
4 
OH  
18 Pd(dba)2 4a 
BnO OBn  
23 77 
5 18  Pd(dba)2 4c 
BnO O(CH2)2Ph  
24 80 
6 OH
 
19 Pd(OAc)2 4a 
Ph(CH2)O OBn  
24 73 
7 19  Pd(OAc)2 4c 
Ph(CH2)O O(CH2)2Ph  
25 98 
8 
OH  
20 Pd(dba)2 4a 
O OBn  
26 – 
9 20  Pd(OAc)2 4a 26  – 
10 
OH  
21 Pd(dba)2 4a 
O OBn  
27 – 
11 21  Pd(OAc)2 4a 27  – 
a Conditions: 0.2 M solution in MeCN, alkoxyallene (3 equiv), [Pd]/dppp (5 mol %), Et3N (1.5 equiv), room 
temperature, 24–48 h. b Isolated yield. c Et3N was omitted. 
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 Subjection of a different primary alcohol (i.e. benzyl alcohol 8) to the Pd(0)-
catalyzed conditions, employing either 4a or c, resulted in the formation of acetals 23 and 
24 in yields of 77% and 80%, respectively (entries 4 and 5). Additionally, phenethyl 
alcohol (19) also underwent oxypalladation and allylic acetals 24 and 25 were isolated in 
yields of 73% and 98% (entries 6 and 7). Surprisingly, no conversions were observed when 
secondary alcohols 20 or 21 were used. Reactions under either Pd(0)- or Pd(II)-catalyzed 
conditions showed no product formation after prolonged reaction times. Instead, complete 
decomposition of the allene was observed after 72 h. These observations are particularly 
striking in view of the readily proceeding reactions of the more sterically hindered 
secondary (10) and tertiary alcohol (13) that were reported earlier by us (see: Scheme 
2.4).3,5a Possibly, a slight variation in acidity between the hydroxyl groups in 10 and 13 and 
those in 20 and 21 is the cause for the dramatic difference in reactivity. Hence, it is not 
inconceivable that the use of different bases might cause the latter alcohols to react, 
although we actually never proved this. 
 The oxypalladation of phenols under the Pd(II)-catalyzed conditions described in 
this chapter has been briefly investigated before in our group, albeit with mixed results.1c,10 
The encouraging results obtained with Pd(0)-catalysts described in Table 2.1, however, 
prompted us to reinvestigate the oxypalladation of the three (substituted) phenols 28a–c 
under Pd(0)- or Pd(II)-catalyzed conditions (Table 2.2). 
 
Table 2.2. Oxypalladation of benzyloxyallene with phenols. 
 
OH O OBn
4a (3 equiv)
[Pd]/dppp (5 mol %)
base (1.5 equiv)
MeCN, rt, 1 h
R R
28a-c 29a-c
BnO •
 
entry substrate R [Pd] base product yield (%) 
1 28a H Pd(OAc)2 Et3N 29a 99 
2 28a H Pd(dba)2 Et3N 29a 99 
3 28a H Pd(dba)2 – 29a 95 
4 28b NO2 Pd(dba)2 Et3N 29b 80 
5 28c OMe Pd(dba)2 Et3N 29c 97 
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First of all, phenol (28a) was reacted with 4a under the influence of Pd(OAc)2. A 
surprisingly fast reaction was observed, resulting in the formation of acetal 29a in an 
excellent yield of 99% within 1 h (entry 1). Introduction of Pd(dba)2 instead of Pd(OAc)2 
produced the same result, again yielding the product in 99% in a reaction time of 1 h (entry 
2). Finally, omitting the base did not significantly influence the outcome of the reaction, 
and resulted in the formation of 29a in an isolated yield of 95% (entry 3). 
The excellent results obtained with phenol led us to investigate the behavior of the 
electron-poor p-nitrophenol (28b) and the electron-rich p-methoxyphenol (28c). 
Gratifyingly, both were found to react readily with 4a under the described conditions, 
resulting in the isolation of 29b and c in yields of 80% and 97%, respectively (entries 4 and 
5). 
 
2.3 Oxypalladation with carboxylic acids 
 
 The use of carboxylic acids instead of alcohols in the oxypalladation of 
alkoxyallenes has not been investigated before. Nevertheless, this transformation could in 
principle lead to synthetically useful allylic esters and, in case of unsaturated carboxylic 
acids, via RCM to functionalized lactones and derivatives. Consequently, we set out to 
investigate the reaction of olefinic carboxylic acids 30a–c with benzyloxyallene (4a) using 
the conditions described above (Table 2.3). First of all, the reactions of acrylic acid (30a) 
with 4a using Pd(II) or Pd(0) successfully yielded the desired allylic ester 31a in 68 and 
49%, respectively (entries 1 and 2). In sharp contrast, the reaction of vinylacetic acid (30b) 
with either Pd(OAc)2 or Pd(dba)2 resulted in complicated mixtures of products, which could 
not be separated by column chromatography (entries 3 and 4). A likely explanation for this 
observation might be that the terminal double bond partially isomerizes to the more stable 
internal one, resulting in the formation of an E/Z-mixture of the conjugated acrylate. 
 On the other hand, subjection of homologous 4-pentenoic acid (30c) to the 
appropriate conditions resulted in the formation of the desired product 31c. Both the use of 
Pd(OAc)2 and Pd(dba)2 led to clean conversion into 31c in isolated yields of 69% and 71% 
(entries 5 and 6). In addition, the reaction proceeded in the absence of base, albeit in a 
somewhat lower yield of 59% (entry 7). The use of Pd(PPh3)4 also afforded 31c, this time 
in a moderate yield of 50% (entry 8). 
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Table 2.3. Oxypalladation of benzyloxyallene with unsaturated carboxylic acids. 
OH catalyst (5 mol %)base (1.5 equiv)
MeCN, rt, 3 h
O
(  )n
BnO •
4a (3 equiv)
O OBnO
(  )n
30a-c 31a-c  
entry substrate n catalyst base product yield (%) 
1 30a 0 Pd(OAc)2/dppp Et3N 31a 68 
2 30a 0 Pd(dba)2/dppp Et3N 31a 49 
3 30b 1 Pd(OAc)2/dppp Et3N 31b – 
4 30b 1 Pd(dba)2/dppp Et3N 31b – 
5 30c 2 Pd(OAc)2/dppp Et3N 31c 69 
6 30c 2 Pd(dba)2/dppp Et3N 31c 71 
7 30c 2 Pd(dba)2/dppp – 31c 59 
8 30c 2 Pd(PPh3)4 Et3N 31c 50 
 
 Finally, we decided to test the reaction of a benzoic acid derivative with 4a under 
similar conditions. As depicted in Scheme 2.6, reaction of p-methoxybenzoic acid (32) 
under standard conditions resulted in the formation of the desired allylic ester 33 in 4 h at 
room temperature in a yield of 61%. 
 
OH
O
MeO
OO OBn
33
Pd(dba)2/dppp, Et3N
MeCN, rt, 4 h
61%
BnO •
4a (3 equiv)
32
 
Scheme 2.6. Oxypalladation of benzyloxyallene with a benzoic acid derivative. 
 
These observations are remarkable, since oxypalladation involving carboxylic 
acids has been reported to be extremely dependent on the palladium source.11 Moreover, 
these reactions generally require an excess of base in order to proceed.12 We herewith, 
however, clearly show that this is not the case in oxypalladation of alkoxyallenes with 
carboxylic acids, thereby making this a relatively robust procedure. 
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2.4 Mechanistic considerations 
 
 In principle, two mechanistic pathways can be envisioned for the palladium-
catalyzed C-O bond formation discussed in the previous sections (Scheme 2.7). The 
catalytic cycle that has so far been assumed to be operative in this transformation3 is based 
on a Pd(II)-driven Wacker-type mechanism (cycle A). Coordination of a Pd(II) species to 
the most electron-rich double bond would result in electrophilic activation of the allene 
(complex I). This can then undergo nucleophilic attack by the (deprotonated) alcohol, 
resulting in a vinylpalladium complex (II), which upon protonolysis gives the allylic acetal 
or ester and recovery of the Pd(II) catalyst. The oxidation state of Pd does not change in 
this process. 
 In a different mechanism, one can envisage a Pd(0)-catalyzed pathway for this 
reaction (cycle B). Initially, a Pd(0) species, which can also be generated in situ from a 
Pd(II) source, oxidatively adds to an O-H bond, thereby generating a Pd-hydride species 
(III). Insertion of the allene into the Pd-H bond would then result in a π-allylpalladium 
complex (IV) in which the hydrogen is transferred to the center C-atom of the allene. 
Reductive elimination finally results in release of the O,O-acetal and regeneration of Pd(0).  
Pd2+
R'O
H
R OH
Pd2+
OR
OR'RO
OR
H
[Pd0]
[PdII]
Pd2+
OR'RO
[PdII]
R OH
L
LPd
OR'RO
·
OR'
·
·
OR'
·
OR'
cycle A cycle B
III
III
IV
 
Scheme 2.7. Possible catalytic cycles for palladium-catalyzed O,O-acetal formation. 
 
 In principle, both catalytic cycles can occur in the presence of a Pd(II)-based 
catalyst(-precursor), but only cycle B can be catalyzed by a Pd(0)-source. Thus, the 
observation that Pd(0)-species catalyze the oxypalladation process as readily as a Pd(II)-
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species, is an important indication that catalytic cycle B is occurring. In addition, the fact 
that most reactions proceed equally well in the absence of a base suggests that the 
nucleophilicity of the substrate is not of great importance. This would, however, be the case 
in cycle A, where nucleophilic attack of the substrate on the activated allene is the key step. 
The latter is also suggested by the observation of substantially higher reaction rates for 
phenols and, more importantly, carboxylic acids as compared to those of regular alcohols 
(Figure 2.1). Finally, oxidative insertion of Pd(0) into O-H bonds of carboxylic acids during 
various palladium-catalyzed transformations is known,11,13 thereby also pointing to cycle B 
as the operating mechanism. 
 
R
O
OH
R OHOH
R
> >
 
Figure 2.1. Relative reactivities of substrates in the palladium-catalyzed acetal formation. 
 
 In conclusion, the observed behavior of different substrates towards both Pd(II)- 
and Pd(0)-species leads us to propose the Pd(0)-driven catalytic cycle B (Scheme 2.7) as 
the most probable mechanism for the oxypalladation of alkoxyallenes. This is in line with a 
tentative mechanism that was previously proposed for the aminopalladation of 
alkoxyallenes.7,14 
 
2.5 Ring-closing metathesis 
 
 The ring-closing metathesis of allylic acetals and esters, formed via the transition 
metal catalyzed method discussed in this chapter, was beyond the initial scope of the 
current study. However, three potential RCM-precursors were prepared during this 
investigation and in order to further study the potential of these specific allylic O,O-acetals, 
we decided to test their reactivity in combination with RCM-catalysts (Scheme 2.8). 
 Subjection of acetal 22 to the 2nd generation Grubbs catalyst (B) in toluene at room 
temperature resulted in a clean conversion to heterocycle 34 in a yield of 89%. In contrast, 
allylic esters 31a and c did not react under these conditions. Reactions with catalysts A or B 
either in dichloromethane at room temperature or in toluene at 70 °C showed only starting 
material after 20 h. In addition, the Schrock catalyst C, which is more reactive than A and 
B, but less tolerant to functional groups, did not result in any conversion either. 
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O OBnO OBn
22
B (10 mol %)
PhMe, rt, 3 h
89% 34
O OBnO
(  )n
31a (n = 0)
31c (n = 2)
xA, B or  C
B
Ru
Ph
PCy3
PCy3
Cl
Cl
MesN NMes
Ru
PhPCy3
Cl
Cl
iPriPr
N
MoH3C(F3C)2CO MeMe
Ph
H3C(F3C)2CO
C
A
catalysts:
 
Scheme 2.8. Ring-closing metathesis of allylic acetals and esters. 
 
Coordination of the carbonyl functions of 31a and c to the metal center of the 
catalyst, is a possible explanation for the observed lack of reactivity.15 However, when 
carrying out the reaction in the presence of two equivalents Ti(OiPr)4 – a known method for 
circumventing such intramolecular chelation15a – merely decomposition of the starting 
material was observed. 
 
2.6 Conclusion 
 
 The synthesis of allylic O,O-acetals has been realized via a mild, Pd-catalyzed 
route involving a range of alcohols and phenols. Surprisingly, two secondary alcohols did 
not exhibit any reactivity, even though a secondary and a tertiary alcohol had already been 
shown to react in earlier work. In addition, carboxylic acids were found to be particularly 
suitable substrates for this catalytic reaction, thereby significantly expanding the scope of 
this reaction. Based on the behavior of the tested substrates under different reaction 
conditions, a Pd(0)-driven mechanistic pathway, which proceeds through a Pd-π-allyl 
intermediate, is proposed for the oxypalladation of alkoxyallenes. 
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2.8 Experimental section 
 
General information 
All reactions were performed under a nitrogen atmosphere, unless stated otherwise. Nitrogen and 
argon were dried over SICAPENT®, CaCl2 and KOH. CH2Cl2 was distilled over CaH2. THF and Et2O 
were distilled over Na. Acetonitrile was distilled and stored on molecular sieves (4Ǻ). Benzene was 
dried on molecular sieves (4Ǻ). Toluene was distilled and subsequently deoxygenated by the freeze-
pump-thaw method. Et3N was distilled and stored over KOH. All other chemicals were purchased and 
used without further purification, unless stated otherwise. Column chromatography was carried out 
using Acros silica gel (0.035–0.070 mm, 60 Ǻ) or Merck silica gel 60 (0.040–0.063 mm). 1H and 13C-
NMR spectra were recorded on a Bruker DPX 200, a Bruker DMX 300 or a Varian Inova 400 
spectrometer. Chemical shifts are reported in ppm, using TMS as an internal standard. Coupling 
constants are reported as J-values in Hz. IR measurements were performed on an ATI Mattison 
Genesis Series FTIR spectrometer. Mass spectra were measured on a Fisons (VG) Micromass 7070E 
apparatus or a Finnigan MAT 900S apparatus. Optical rotations were determined with a Perkin-Elmer 
241 polarimeter. Microwave reactions were carried out in a CEM Discover apparatus.  
 
((Propa-1,2-dienyloxy)methyl)benzene (4a) 
This compound was prepared from 16a9 following a procedure by Brandsma.8 The yield 
was 8.12 g (58%). Analytical data agreed with those reported in literature.16 1H-NMR 
(CDCl3, 200 MHz): δ 7.21–7.12 (m, 5H), 6.79 (t, J = 5.9 Hz, 1H), 5.32 (d, J = 5.9 Hz, 2H), 4.49 (s, 
2H). 13C-NMR (CDCl3, 50 MHz): δ 202.2, 138.1, 128.9, 128.3, 122.4, 91.5, 71.1. 
 
(2-(Propa-1,2-dienyloxy)ethyl)benzene (4c) 
This compound was prepared from 16c9 following a procedure by Brandsma.8 The 
yield was 2.20 g (52%). 1H-NMR (CDCl3, 300 MHz): δ 7.31–7.18 (m, 5H), 6.73 (t, 
J = 5.9 Hz, 1H), 5.43 (d, J = 6.0 Hz, 2H), 3.78 (t, J = 7.1 Hz, 2H), 2.96 (t, J = 7.1 Hz, 2H). 13C-NMR 
(CDCl3, 75 MHz): δ 202.1, 142.9, 128.5, 128.4, 126.9, 122.0, 90.9, 67.1, 36.5. 
 
General procedure A for the oxypalladation of alcohols, phenols and carboxylic acids 
The starting material was dissolved in MeCN (0.10–0.20 M) and Pd(OAc)2 or Pd(dba)2 (5 mol %), 
dppp (5 mol %) and Et3N (1.5 equiv) were added under an inert atmosphere. After stirring for 5 min, 
the appropriate allene (4a or c; 3 equiv) was added and the reaction was stirred at room temperature 
for the specified time. The solvent was removed in vacuo and the product was isolated by column 
chromatography. 
 
((1-(But-3-enyloxy)allyloxy)methyl)benzene (22) 
This compound was prepared from 17 and 4a following general procedure A, using 
Pd(dba)2. The reaction time was 48 h and the product was purified by column 
chromatography (EtOAc/heptane, 1:40). The yield was 135 mg (65%). 1H-NMR (CDCl3, 
300 MHz): δ 7.33 (m, 5H), 5.98–5.82 (m, 2H), 5.57–5.33 (m, 2H), 5.11 (m, 3H), 4.63 
(dAB, J = 11.8 Hz, 2H), 3.63 (m, 2H,), 2.39 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 138.1, 135.2, 
135.1, 128.4, 127.7, 127.5, 100.8, 67.1, 67.7, 27.7. IR (film): ν 3073, 2921, 1210 cm-1. HRMS (EI+): 
calculated for C14H19O2, [M+H]+: 219.1385, measured: 219.1385. 
 
(Prop-2-ene-1,1-diylbis(oxy))bis(methylene)dibenzene (23) 
This compound was prepared from 18 and 4a following general procedure A, using 
Pd(dba)2. The reaction time was 48 h and the product was purified by column 
chromatography (EtOAc/heptane, 1:50). The yield was 160 mg (77%).The analytical 
O OBn
BnO OBn
BnO •
Ph(H2C)2O •
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data agreed with those reported in literature.17 1H-NMR (CDCl3, 200 MHz): δ 7.36–7.23 (m, 10H), 
5.95 (ddd, J = 4.6, 10.5, 17.4 Hz, 1H), 5.55–5.31 (m, 2H), 5.13 (dt, J = 1.2, 4.6 Hz, 1H), 4.61 (dAB, J 
= 11.8 Hz, 4H). 13C-NMR (CDCl3, 50 MHz): δ 138.0, 134.9, 128.3, 127.7, 127.5, 118.9, 100.2, 67.0. 
 
(2-(1-(Benzyloxy)allyloxy)ethyl)benzene (24) 
This compound was prepared from 18 and 4c following general procedure A, using 
Pd(dba)2. The reaction time was 48 h and the product was purified by column 
chromatography (EtOAc/heptane, 1:30). The yield was 79 mg (80%). 1H-NMR 
(CDCl3, 200 MHz): δ 7.36–7.20 (m, 10H), 5.87 (ddd, J = 4.7, 10.5, 17.3 Hz, 1H), 5.47–5.28 (m, 2H), 
5.00 (d, J = 4.7 Hz, 1H), 4.48 (m, 2H), 3.76 (m, 2H), 2.90 (t, J = 7.1 Hz, 2H). 13C-NMR (CDCl3, 50 
MHz): δ 139.1, 137.9, 135.0, 129.0, 128.3 (2), 127.7, 127.4, 127.0, 118.9 100.7, 67.1, 65.9, 36.8. 
HRMS (EI+): calculated for C18H20O2, [M]+: 268,1463, found: 268.1455. 
 
(2,2'-(Prop-2-ene-1,1-diylbis(oxy))bis(ethane-2,1-diyl))dibenzene (25) 
This compound was prepared from 19 and 4c following general procedure A, 
using Pd(OAc)2. The reaction time was 48 h and the product was purified by 
column chromatography (EtOAc/heptane/Et3N, 2:100:1). The yield was 296 
mg (98%). 1H-NMR (CDCl3, 200 MHz): δ 7.30–7.16 (m, 10H), 5.79 (ddd, J = 4.7, 10.6, 17.4 Hz, 
1H), 5.38–5.23 (m, 2H), 4.88 (dt, J = 1.2, 4.7 Hz, 1H), 3.75–3.54 (m, 4H), 2.85 (t, J = 7.1 Hz, 4H). 
13C-NMR (CDCl3, 50 MHz): δ 139.1, 135.0, 129.0, 128.3, 127.0, 118.9 100.7, 65.8, 36.8. HRMS 
(EI+): calculated for C19H22O2, [M]+: 282,1620, found: 282.1613. 
 
(1-(Benzyloxy)allyloxy)benzene (29a) 
This compound was prepared from 28a and 4a following general procedure A, using 
Pd(OAc)2. The reaction time was 1 h and the product was purified by column 
chromatography (EtOAc/heptane, 1:50). The yield was 205 mg (99%). 1H-NMR 
(CDCl3,300 MHz): δ 7.36–6.98 (m, 10H), 6.05 (ddd, J = 4.5, 10.6, 17.3 Hz, 1H), 5.69 (dt, J = 1.3, 4.4 
Hz 1H), 5.58 (dt, J = 1.3, 17.3 Hz, 1H), 5.42 (dt, J = 1.3, 10.6 Hz, 1H), 4.69 (dAB, J = 11.6 Hz, 2H). 
13C-NMR (CDCl3, 50 MHz): δ 157.4, 138.1, 134.9, 130.1, 129.0, 128.5, 128.3, 122.7, 120.0, 118.0, 
100.7, 67.9. IR (film): ν 3068, 2947, 1217 cm-1. HRMS (EI+): calculated for C16H16O2, [M]+: 
240.1150, found: 240.1149. 
 
1-(1-(Benzyloxy)allyloxy)-4-nitrobenzene (29b) 
This compound was prepared from 28b and 4a following general procedure A, 
using Pd(dba)2. The reaction time was 1 h and the product was purified by 
column chromatography (EtOAc/heptane/Et3N, 5:100:1). The yield was 169 mg 
(80%). 1H-NMR (CDCl3,300 MHz): δ 8.17 (d, J = 4.8 Hz, 2H), 7.31 (m, 5H), 7.13 (d, J = 4.9 Hz, 
2H), 6.05 (m, 1H), 5.82 (dt, J = 1.3, 4.4 Hz, 1H), 5.68–5.48 (m, 2H), 4.69 (dAB, J = 11.8 Hz, 2H). 13C-
NMR (CDCl3, 75 MHz): δ 161.4, 142.2 136.7, 133.0, 128.5, 128.0, 127.9, 125.6, 120.5, 116.9, 99.8, 
67.6. HRMS (EI+): calculated for C16H15NO4, [M]+: 285.1001, found: 285.1002. 
 
1-(1-(Benzyloxy)allyloxy)-4-methoxybenzene (29c) 
This compound was prepared from 28c and 4a following general procedure A, 
using Pd(dba)2. The reaction time was 1 h and the product was purified by 
column chromatography (EtOAc/heptane/Et3N, 3:100:1). The yield was 218 mg 
(97%). 1H-NMR (CDCl3, 300 MHz): δ 7.34 (m, 5H), 7.03 (d, J = 9.0 Hz, 2H), 6.84 (d, J = 9.3 Hz, 
2H), 6.05 (m, 1H), 5.60 (m, 1H), 5.59–5.39 (m, 2H), 4.73 (dAB, J = 11.7 Hz, 2H), 3.80 (s, 3H). 13C-
NMR (CDCl3, 75 MHz): δ 154.4, 150.3, 137.4, 134.3, 128.2, 127.6, 127.5, 119.0, 118.8, 114.3, 101.1, 
67.4, 55.7. HRMS (EI+): calculated for C17H18O3, [M]+: 270.1256, found: 270.1258. 
 
O OBn
O OBn
O2N
O OBn
MeO
BnO O(CH2)Ph
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1-(Benzyloxy)allyl acrylate (31a) 
This compound was prepared from 30a and 4a following general procedure A, using 
Pd(OAc)2. The reaction time was 3 h and the product was purified by column 
chromatography (EtOAc/heptane/Et3N, 3:100:1). The yield was 73 mg (68%). 1H-
NMR (CDCl3, 300 MHz): δ 7.32 (m, 5H), 6.46 (dd, J = 1.4, 17.3 Hz, 1H), 6.37 (dt, J = 1.1 Hz, 1H), 
6.19–6.06 (m, 1H), 5.94 (m, 1H), 5.88 (dd, J = 1.4, 10.4 Hz, 1H), 5.49 (dt, J = 1.4, 17.3 Hz, 1H), 5.33 
(dt, J = 1.4, 10.4 Hz, 1H), 4.79–4.63 (dAB, J = 11.5 Hz, 2H). 13C-NMR (CDCl3, 50 MHz): δ 171.3, 
138.9, 135.5, 133.3, 129.0, 128.5, 128.3, 127.6, 119.7, 100.9, 67.8. HRMS (EI+): calculated for 
C13H14O3, [M]+: 218.0943, found: 218.0939. 
 
1-(Benzyloxy)allyl pent-4-enoate (31c) 
This compound was prepared from 30c and 4a following general procedure A, using 
Pd(OAc)2. The reaction time was 3 h and the product was purified by column 
chromatography (EtOAc/heptane/Et3N, 1:100:1). The yield was 78 mg (69%). 1H-
NMR (CDCl3, 300 MHz): δ 7.32 (m, 5H), 6.35 (dt, J = 1.1, 4.9 Hz, 1H), 5.78–6.03 
(m, 2H,), 5.49 (dt, 1H, J = 1.1, 17.3 Hz), 5.33 (dt, J = 1.1, 10.6 Hz, 1H), 5.09 (m, 2H), 4.79–4.58 
(dAB, J = 11.8 Hz, 2H), 2.44 (m, 4H). 13C-NMR (CDCl3, 50 MHz): δ 173.0, 138.1, 137.3, 134.3, 
129.1, 128.5, 128.3, 119.6, 116.4, 97.1, 71.5, 34.3, 29.5. HRMS (EI+): calculated for C15H18O3, [M]+: 
246.1256, found: 246.1253. 
 
1-(Benzyloxy)allyl 4-methoxybenzoate (33) 
This compound was prepared from 32 and 4a following general procedure A, using 
Pd(dba)2. The reaction time was 4 h and the product was purified by column 
chromatography (EtOAc/heptane/Et3N, 2:100:1). The yield was 123 mg (61%). 1H-
NMR (CDCl3, 200 MHz): δ 8.03 (d, J = 9.2 Hz, 2H), 7.40–7.26 (m, 5H), 6.92 (d, J = 
8.9 Hz, 2H), 6.53 (d, J = 5.1 Hz, 1H), 6.02 (m, 1H), 5.94–5.61 (m, 2H), 4.85–4.68 
(dAB, J = 11.8 Hz, 2H), 3.86 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 165.3, 163.3, 137.0, 133.4, 131.7, 
128.2, 127.7, 122.0, 118.9, 113.5, 96.6, 70.9, 55.5. HRMS (EI+): calculated for C18H18O4, [M]+: 
298.1205, found: 298.1203. 
 
2-Benzyloxy-5,6-dihydro-2H-pyran (34) 
To a solution of 22 (21.0 mg, 96 μmol) in toluene (2 mL) under an inert atmosphere was 
added catalyst B (8.2 mg, 10 mol %). The reaction mixture was stirred at room 
temperature for 3 h after which the solvent was evaporated. The product was isolated by 
column chromatography (EtOAc/heptane, 1:50). The yield was 16.3 mg (89%). The analytical data 
agreed with those reported in literature.18 1H NMR (CDC13, 300 MHz): δ 7.40–7.26 (m, 5H), 6.06 (m, 
1H), 5.76 (m, 1H). 5.01 (s, 1H), 4.69 (dAB, J = 11.8 Hz, 2H), 4.01 (dd, J = 3.7, 11.4 Hz, 1H), 3.76 (dd, 
J = 6.1, 11.4 Hz, 1H), 2.43–2.23 (m, 1H), 1.92 (dt, J = 5.2, 17.7 Hz, 1H). 13C-NMR (CDCl3, 300 
MHz): δ 138.2, 129.2, 128.2, 128.0, 127.5, 125.6, 92.8, 69.2, 57.4, 24.6. 
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Ring-closing metathesis of  
α-alkoxyacrylates 
 
 
 
3.1 Introduction 
 
Over the past decade ring-closing metathesis (RCM) has rapidly emerged as one 
of the most important and widely utilized techniques in organic synthesis.1 During this 
period, the scope of this type of reaction has been continuously increased starting from 
regular terminal olefins to olefins that are substituted with very different electron-
withdrawing or electron-donating substituents. Many examples nowadays exist where 
electron-poor olefins have been cyclized in high yields,2 including results from our own 
group.3 On the other hand, RCM of electron-rich olefins – substituted with heteroatoms 
such as oxygen or nitrogen – is also encountered, although this is occasionally found to be 
problematic. Early examples of electron-rich olefins involve Ti-mediated cyclization 
reactions of enol ethers,4 followed by other examples where either Mo-catalysts5 or Ru-
catalysts have been used.6 In addition, our group was the first to demonstrate that electron-
rich enamide double bonds could be efficiently cyclized into their cyclic counterparts,7 
which was later also shown by others in the synthesis of indoles.8  
Considering these reactions, we realized that virtually no RCM examples exist of 
olefins substituted with both electron-withdrawing and electron-donating substituents (e.g. 
olefin 2, Scheme 3.1). Notwithstanding, we anticipated that such a transformation would 
hold a considerable potential since cyclic ethers 1 are formed, which may be synthetically 
useful building blocks. We also envisaged that if such cyclizations are successful, more 
elaborated cyclic ethers 3 could be synthesized, which might eventually provide practical 
pathways to biologically relevant natural products, such as the family of 3-deoxy-2-
ulosonic acids.9 Examples from this class of compounds include DAH (4, 3-deoxy-D-
arabino-2-heptulosonic acid), KDO (5, 3-deoxy-D-manno-2-octulosonic acid), KDN (6, 
3 
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3-deoxy-D-glycero-D-galacto-2-nonulosonic acid) and N-acetylneuraminic acid (Neu5Ac 
(7), 5-acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid) (Scheme 3.1). 
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Scheme 3.1. Ring-closing metathesis of α-alkoxyacrylates and potential natural product targets. 
 
3.2 Preparation of aliphatic RCM-precursors 
 
Initially, we set out to investigate the potential of the ring-closing metathesis 
reaction for the generation of unsaturated oxygen heterocycles 1 as shown in Scheme 3.1. 
We thereby focused on the generation of small six- and seven-membered ring systems as 
well as on a larger twelve-membered ring oxacycle. 
 
OOH( )n ( )n
9a (n = 2): 83%
9b (n = 3): 78%
9c (n = 8): 84%
O
OLiO
tBuLi, THF
-78 °C to rt, 2 h
 
then CO2(g)
-78 °C, 30 min
then BnBr, DMF
50 °C, 18 h
O
OBnO
( )n ( )n
11a (n = 2): 32%
11b (n = 3): 29%
11c (n = 8): 30%
Pd(OAc)2/
1,10-phenanthroline (5 mol %) 
CH2Cl2, rt, 4-6 days
OEt
8a-c
10a-c
 
Scheme 3.2. Synthesis of RCM-precursors. 
 
The α-alkoxyacrylate precursors 11a–c for the formation of six-, seven- and 
twelve-membered rings, respectively, were initially prepared from the corresponding 
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unsaturated alcohols 8 as shown in Scheme 3.2. First, the alcohol functions were efficiently 
vinylated in good yields according to a recently reported, relatively mild procedure, using a 
Pd(OAc)2/phenanthroline catalyst and ethyl vinyl ether.10 Next, the resulting vinyl ethers 9 
were lithiated with tert-butyllithium, followed by reaction with CO2 at low temperature, 
resulting in the corresponding lithium carboxylate salts 10. Subsequent addition of an 
excess of benzyl bromide produced the desired benzyl esters 11 in moderate yields. 
Treatment of the lithiated vinyl ether directly with methyl chloroformate also resulted in the 
formation of the α-alkoxyacrylate moieties, however the yields were significantly lower 
and the reproducibility was poor. 
 
3.3 Investigation of RCM behavior 
 
With the availability of three model substrates, the stage was set for the first 
investigation of the metathesis behavior of the α-alkoxyacrylate double bonds. Subjection 
of compound 11a to the first generation Grubbs catalyst A at either 70 or 95 ºC in toluene 
did not result in any cyclization, but instead in slow formation of the homodimeric product 
13a (Table 3.1, entries 1 and 2). This is an indication that catalyst A is not sufficiently 
active to react with the highly functionalized double bond. Thus, the relatively unhindered, 
mono-substituted double bonds from two molecules of 11a undergo cross-metathesis (CM), 
resulting in the selective formation of 13a. 
The more active second generation Grubbs catalyst B, on the other hand, showed 
cyclic products with a conversion of 85% at 70 ºC within 2 h. Surprisingly, GC-MS 
analysis of the products showed the presence of an almost equal amount of the five-
membered heterocycle 12d together with the anticipated six-membered ring 12a (entry 3), 
which could not be separated by silica gel chromatography. Isomerization of the terminal 
double bond to the more stable internal one prior to the cyclization reaction must be the 
reason for this observation. This undesired side reaction has over the past years been 
reported in a number of other publications.7,11 
In most cases, isomerization has been attributed to the presence of a ruthenium-
hydride species.11d,12 Olefin isomerization would than proceed via the generally accepted 
insertion-elimination mechanism (Scheme 3.3).13 
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Table 3.1. RCM results of 11a using catalysts A–Da 
11a (n = 2) 12d12a 13a (n = 2)
OBnO2C
(  )n OBnO2C O
BnO2C O
O CO2Bn(  )n(  )nBnO2C
+ +
A C DB
Ru
Ph
PCy3
PCy3
Cl
Cl
MesN NMes
Ru
PhPCy3
Cl
Cl
MesN NMes
Ru
Cl
Cl
iPrO
iPriPr
N
MoO
O
Me
Me
Ph
F3C CF3
Me
Me
F3C
F3C
catalysts:
 
a Reactions were performed under a N2 atmosphere, in approximately 0.03 M solutions; b GC yields, unless noted 
otherwise; c Isolated yield; d Catalyst was purified by column chromatography directly before use. 
 
This mechanistic pathway requires a ruthenium hydride complex with a free site 
(I). Coordination of a double bond to ruthenium followed by insertion of the olefin into the 
Ru-H bond can lead to a primary or secondary alkylruthenium species (III and IV, 
respectively). While β-H elimination from complex III can only regenerate the original 
terminal double bond, elimination from IV can result in either the terminal or the internal 
olefin (complex II or V, respectively). Finally, release of the substrate from V would then 
liberate the isomerized RCM-precursor. 
 
Entry Catalyst (mol %)/ Additive (mol %) 
Temp 
(ºC) Solvent 
Time 
(h) 12a
b 12db 13ab 11ab 
1 A (20) 70 PhMe 40 – –  56c n.d. 
2 A (20) 95 PhMe 18 – –  65c n.d. 
3 B (10) 70 PhMe 2 45 40 – 15 
4 B (10)d 70 PhMe 2 51 28 – 21 
5 B (10)/Cy3PO (10) 60 PhMe 20 40 28 23 9 
6 B (10)/ (PhO)P(O)(OH)2 (100) 
70 PhMe 20 16 36 31 17 
7 B (10) 60 (ClCH2)2 48 32 29 – 39 
8 C (10) 50 PhMe 48 42 22 9 27 
9 C (10) 85 PhMe 3 40 56 – 4 
10 D (15) 50 PhMe 3 – –  59c n.d. 
11 D (15) 85 PhMe 2 12 2 47 39 
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Scheme 3.3. Hydride-based mechanism for olefin isomerization. 
 
The cause of formation of such a ruthenium-hydride species has long been a 
subject of discussion. Grubbs has reported that a Fischer-carbene complex, resulting from 
reaction of the Ru-catalyst with a vinyl ether moiety, could be converted into a Ru-H 
species upon prolonged heating.12b However, in the proposed mechanism it is the α-vinyl 
ether hydrogen, which is effectively transferred to the Ru.14 This can obviously not occur 
with compounds 11a–c, which all lack such a hydrogen atom. Recently, Grubbs and 
co-workers found, that prolonged heating of the ruthenium methylidene species, generated 
from the precatalyst, gives rise to a dinuclear ruthenium hydride complex (Scheme 3.4). 
Particularly the observation that this product was capable of efficiently isomerizing 
terminal olefins is a clear indication that metal hydride species are indeed the source of this 
side-reaction during olefin metathesis.15 
 
N N
Ru
MesN NMes
Ru CH2
Cl
Cl
CRu
Cl Cl
Cl
N 
Mes
MesN
HPCy3
C6H6
55 °C +   CH3PCy3
+Cl-
 
Scheme 3.4. Formation of a ruthenium hydride under metathesis conditions, reported by Grubbs.15 
 
Column chromatographic purification of catalyst B immediately before use, as 
suggested by Snapper and co-workers,12a significantly decreased the amount of 
isomerization (Table 3.1, entry 4). In contrast, the addition of tricyclohexylphosphine oxide 
was reported by Nolan and co-workers to slow down the catalysis and thereby inhibit 
isomerization.16 Unfortunately, we found this not to be the case for compound 11a. A 
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decrease in activity was indeed observed, but this only resulted in formation of a substantial 
amount of the homodimeric cross-metathesis product 13a (entry 5). Using 
phenylphosphoric acid17 as an additive did not improve the ratio either, instead it yielded 
mainly the isomerized product and the dimer (entry 6). 
The use of catalysts C and D did not improve the outcome of the reaction. The 
Hoveyda catalyst C produced results comparable to those obtained with B (entries 8 and 9), 
whereas the Schrock catalyst D hardly yielded any cyclized product (entries 10 and 11). In 
conclusion, only catalysts B and C were able to readily react in the desired fashion with the 
acrylic double bond of 11a. The optimal temperature for the RCM reaction was 
approximately 70 ºC, since higher temperatures appeared to promote isomerization and 
lower temperatures resulted in significant amounts of the cross-metathesis product. 
When the homologue 11b was reacted under the optimized conditions with 
catalyst B, a similar double bond migration prior to RCM was observed (Scheme 3.5). 
Besides the expected seven-membered ring 12b, the corresponding six- and five-membered 
ring systems 12a and 12d were encountered in comparable yields. Especially the formation 
of the latter product is remarkable, since the terminal double bond must have isomerized 
twice before cyclization to the five-membered ring can take place. 
 
12d (21%)12a (30%)
13b (5%)
12b (20%)
B (10 mol %)
PhMe
 70 °C, 16 h
11b (n = 3)
OBnO2C
(  )n
OBnO2C O
BnO2C O ( )3
OBnO2C
BnO2C
+ +
+ 11b (24%)
O CO2Bn( )3
 
Scheme 3.5. Single and double olefin isomerization prior to the cyclization of 11b. 
 
Finally, we were unsuccessful in generating a twelve-membered ring from 
precursor 11c. Reaction of 11c with catalyst B at 70 ºC in toluene gave exclusively the 
dimer 13c, resulting from cross-metathesis of the starting material, in 56% isolated yield 
(Scheme 3.6). 
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13c (56%)
B (10 mol %)
PhMe
70 °C, 5 h
11c
OBnO2C
( )8 BnO2C O ( )8
O CO2Bn( )8
 
Scheme 3.6. Homodimerization of 11b instead of ring-closing metathesis. 
 
3.4 Inhibition of olefin isomerization by 1,4-benzoquinone 
 
Recently, a significant improvement was reported in preventing isomerization as a 
side reaction during olefin metathesis. Grubbs and co-workers found that the addition of 
certain metal hydride scavengers can prevent isomerization, without hindering the 
metathesis process itself. For instance, catalytic amounts of benzoquinones or organic acids 
(e.g. acetic acid) were found to completely inhibit olefin isomerization during the RCM of 
diallyl ether in CD2Cl2 at 40 °C.18 Despite the fact that the RCM of α-alkoxyacrylates needs 
to be carried out in toluene and at elevated temperatures, we decided to study the influence 
of 1,4-benzoquinone on the isomerization of seven-membered ring precursor 11b. 
 
12a
12%
3%
12b
55%
36%
B (10 mol %)
PhMe
80 °C, 16 h
11b
OBnO2C OBnO2COBnO2C
+ +
+ 11b
33%
15%
13b
7%
46%
BnO2C O ( )3 2
+ 20 mol % 1,4 benzoquinone:
+ 100 mol % 1,4 benzoquinone:
( )3
 
Scheme 3.7. Influence of 1,4-benzoquinone on olefin isomerization; yields are based on 1H-NMR. 
 
 Indeed, a significant effect on the product distribution was observed, when using 
1,4-benzoquinone as an additive during RCM (Scheme 3.7). No trace of five-membered 
ring 12d and only minor amounts of six-membered ring 12a were observed, suggesting that 
the quinone does indeed inhibit olefin isomerization to a certain degree. The use of 20 
mol % of the additive resulted in the formation of 12% of 12a, however when adding 100 
mol %, only 3% of 12a was observed. Besides inhibiting isomerization, it also appears that 
1,4-benzoquinone lowers the activity of the catalyst to some extent. This is illustrated by 
the formation of a remarkably high amount of homodimer 13b (46%), when using 
100 mol % of quinone. The – less active – first generation Grubbs catalyst (A) was already 
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found to exclusively give homodimerization (see Table 3.1), also because it is not 
sufficiently active to react with the acrylic double bond. 
 
3.5 A novel route to α-alkoxyacrylates and the synthesis of 
substituted benzofurans and -pyrans 
 
As can be concluded from Section 3.2, preparation of the metathesis precursors, 
more specifically the required α-alkoxyacrylate fragments, appeared not to be 
straightforward. At the time that this research was initiated, only one suitable pathway had 
been reported. This method involves a laborious three-step procedure, based on a carbene 
insertion employing dimethyl diazomalonate, followed by alkylation with Eschenmoser’s 
salt and subsequent elimination/decarboxylation, with typical overall yields of 25–40%.19 
 
Br
Br
CO2R N
H
Br
N
CO2R
Et3N, 0 ºC
PhMe 15a (R = Me): 91%
15b (R = Et): 92%
ROH
15a/b
base CO2RRO
N
MeI
base CO2RRO
16 17
14a (R = Me)
14b (R = Et)
 
Scheme 3.8. Novel route from alcohols to α-alkoxyacrylates. 
 
During our search for shorter and more efficient pathways to these fragments, we 
developed a synthetic method based on bromides 15a–b. Treatment of an alcohol with 15 
under basic conditions would result in intermediate 16, which can then be converted into 
olefin 17 by N-methylation with MeI and base-induced elimination of the resulting 
quaternary ammonium salt (Scheme 3.8). Bromides 15a–b can easily be prepared from the 
corresponding commercially available 2,3-dibromides 14a–b through a reaction that 
presumably proceeds via an elimination/conjugate addition mechanism. Reacting 14a–b 
with pyrrolidine and Et3N in toluene at 0 ºC for 30 min resulted in the formation of 15a–b 
in good yields. Compounds 15a and b were directly used for the next step without further 
purification. 
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To test this methodology we decided to apply the sequence to phenol (18) and 
thiophenol (19). Gratifyingly, reaction of 18 and 19 with 15a or b followed by N-
methylation and subsequent elimination proceeded well, resulting in α-alkoxyacrylate 20 
and α-alkylthioacrylate 21 in overall yields of 55% and 53%, respectively (Scheme 3.9). In 
addition, we observed that isolation of the intermediate substitution products was 
unnecessary. Instead, a single extraction in between the substitution and the 
methylation/elimination steps was sufficient for the overall reaction sequence to proceed 
efficiently. 
 
XH X CO2R
20 (X = O, R = Me): 55%
21 (X = S, R = Et): 53%
NaH, 15a/b
Et2O/DMF, rt
18 (X = O)
19 (X = S)
MeI, Na2CO3 
ROH, refluxX CO2R
N
 
Scheme 3.9. Formation of functionalized acrylates from (thio)phenol. 
 
As expected, applying these conditions to ortho-substituted phenols 22 and 23 
resulted in the formation of RCM-precursors 24 and 25 in satisfactory yields of 61% and 
78%, respectively (Scheme 3.10). Subsequent ring-closing metathesis proceeded rapidly 
within 30 min, using the second generation Grubbs catalyst (B) in toluene at 70 ºC. The 
resulting benzofuran carboxylate (26) and benzopyran carboxylate (27) were isolated in 
excellent yields of 89% and 92%. 
 
OH O CO2Et
O CO2Et
27 (92%)
O
CO2Et
26 (89%)B (5 mol %)
PhMe, 70 °C
30 min
22 (n = 0)
23 (n = 1)
1) NaH, 15b
Et2O/DMF, rt, 4 h
2) MeI, Na2CO3
EtOH, reflux
( )n
24 (n = 0): 61%
25 (n = 1): 78%
( )n
 
Scheme 3.10. RCM-mediated synthesis of benzofuran- and benzopyrancarboxylates. 
 
Interestingly, no olefin isomerization was observed prior to the cyclization of 25. 
This is surprising in view of the readily occurring isomerization in precursors 11a–b and 
considering the fact that the double bond in 25 was expected to be particularly prone to 
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isomerization. An explanation may be found in the observation that RCM is considerably 
faster for 24 and 25, probably due to the presence of a cyclic backbone. As a result, 
cyclization might be complete before significant amounts of ruthenium hydride species are 
formed and in addition, a large rate difference between cyclization and isomerization might 
inhibit the latter process altogether.  
 
3.6 Conclusion 
 
Application of ring-closing metathesis on α-alkoxyacrylates showed that the 
unsubstituted six- and seven-membered oxygen heterocycles could be efficiently generated 
by this method. A drawback, however, was that isomerization of the unhindered terminal 
olefin occurred as an undesired side-reaction, which could be partially inhibited by the 
addition of 1,4-benzoquinone. Upon switching to phenol-based precursors, cyclization 
proceeded readily and in good yield without any isomerization. This resulted in the efficient 
formation of benzofuran and benzopyran derivatives. Finally, a novel two-step 
transformation was developed to efficiently convert alcohols, phenols and thiophenols into 
α-alkoxyacrylate/α-alkylthioacrylate functionalities. This makes these highly substituted 
RCM-precursors more easily accessible from the corresponding olefinic alcohols.20 
 
3.7 Experimental section 
 
General information 
For general experimental details, see Section 2.8. 
2-Vinylphenol21 was prepared by Wittig olefination of salicyl aldehyde using Ph3P=CH2. 
 
General procedure A for preparation of vinyl ethers 
To a solution of the alcohol in ethyl vinyl ether (0.3 M) was added a solution of Pd(OAc)2 (5 mol %) 
and 1,10-phenanthroline (5.5 mol %) in a small amount of CH2Cl2. The mixture was stirred in air for 
4–6 days, filtered over Celite and carefully concentrated in vacuo. The resulting crude product was 
filtered over a short silica gel column (100% pentane) to remove any starting alcohol. The vinyl 
ethers were filtered over a short path of silica gel (100% pentane) and directly used in the next steps. 
 
5-Vinyloxypent-1-ene (9a) 
This compound was prepared from 8a following general procedure A. The yield was 
2.37 g (83%). Analytical data agreed with those reported in literature.22 1H-NMR 
(CDCl3, 300 MHz): δ 6.45 (dd, J = 6.6, 14.3 Hz, 1H), 5.81 (m, 1H), 5.03 (m, 2H), 4.16 (dd, J = 1.8, 
14.3 Hz, 1H), 3.96 (dd, J = 1.8, 6.9 Hz, 1H), 3.68 (t, J = 6.4 Hz, 2H), 2.15 (m, 2H), 1.74 (m, 2H). 13C-
NMR (CDCl3, 75 MHz): δ 151.6, 137.6, 114.9, 86.2, 67.3, 30.3, 28.4. 
 
O( )2
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6-Vinyloxyhex-1-ene (9b) 
This compound was prepared from 8b following general procedure A. The yield was 
3.09 g (78%). 1H-NMR (CDCl3, 200 MHz): δ 6.46 (dd, J = 6.7, 14.5 Hz, 1H), 5.80 
(m, 1H), 4.99 (m, 2H), 4.15 (dd, J = 2.0, 14.3 Hz, 1H), 3.96 (dd, J = 2.0, 6.7 Hz, 1H), 3.67 (t, J = 6.3 
Hz, 2H), 2.08 (m, 2H), 1.70–1.43 (m, 4H). 13C-NMR (CDCl3, 75 MHz): δ 151.6, 138.2, 114.4, 86.1, 
67.9, 33.6, 28.7, 25.5. 
 
11-Vinyloxyundec-1-ene (9c) 
This compound was prepared from 8c following general procedure A. The yield was 
2.91 g (84%).1H-NMR (CDCl3, 300 MHz): δ 6.45 (dd, J = 6.9, 14.3 Hz, 1H), 5.80 (m, 
1H), 4.95 (m, 2H), 4.16 (dd, J = 1.9, 14.4 Hz, 1H), 3.95 (dd, J = 1.9, 6.8 Hz, 1H), 3.66 (t, J = 6.6 Hz, 
2H), 2.03 (m, 2H), 1.64 (m, 2H), 0.86 (m, 12H). 13C-NMR (CDCl3, 75 MHz): δ 151.7, 138.9, 114.0, 
86.1, 68.1, 34.0, 29.7, 29.6, 29.5, 29.3, 29.2. 29.1, 26.2. 
 
General procedure B for preparation of the α-alkoxyacrylates 
To a solution of the vinyl ether in THF (0.35 M) was added a 1.7 M pentane solution of tBuLi (1.7 
equiv) at –78 ºC. After stirring for 1 h, the cold bath was removed and the mixture was stirred for 1 h 
at room temperature. Next, the reaction was cooled again to –78 ºC and during 30 min a stream of 
CO2 was led through the solution, followed by stirring for another hour upon gradually warming to 
room temperature. Benzyl bromide (1.7 equiv) and DMF were then added and the reaction was stirred 
overnight at 50 ºC. After cooling to room temperature, H2O was added and the resulting mixture was 
extracted three times with pentane. The organic layers were concentrated and the product purified by 
column chromatography (EtOAc/hexane/Et3N 2:100:1). 
 
Benzyl 2-(4-pentenyloxy)acrylate (11a) 
This compound was prepared from 9a following general procedure B. The yield was 
335 mg (32%). 1H-NMR (C6D6, 200 MHz): δ 7.06 (m, 5H), 5.69–5.52 (m, 1H), 5.44 
(d, J = 2.2 Hz, 1H), 5.04 (s, 2H), 4.92 (m, 2H), 4.26 (d, J = 2.2 Hz, 1H), 3.30 (t, J = 6.4 
Hz, 2H), 1.99 (m, 2H), 1.54 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 162.7, 151.0, 137.4, 135.5, 
128.3, 128.0, 127.9, 115.1, 94.1, 67.8, 66.9, 30.2, 27.9. IR (film): ν 3066, 3034, 2946, 1734, 1618, 
1165 cm-1. HRMS (CI+): calculated for C15H18O3, [M]+: 246.1256, found: 246.1250. 
 
Benzyl 2-(5-hexenyloxy)acrylate (11b) 
This compound was prepared from 9b following general procedure B. The yield was 
260 mg (29%). 1H-NMR (C6D6, 300 MHz): δ 7.05 (m, 5H), 5.74–5.60 (m, 1H), 5.45 (d, 
J = 2.1 Hz, 1H), 5.05 (s, 2H), 4.97 (m, 2H), 4.29 (d, J = 2.3 Hz, 1H), 3.33 (t, J = 6.0 
Hz, 2H), 1.89 (m, 2H), 1.50 (m, 2H), 1.34 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 162.7, 151.0, 
138.1, 135.5, 128.3, 128.0, 127.9, 114.6, 93.9, 68.4, 66.8, 33.5, 28.1, 25.4. IR (film): ν 3066, 3033, 
2959, 1735, 1618, 1166 cm-1. HRMS (CI+): calculated for C16H20O3, [M]+: 260.1412, found: 
246.1414. 
 
Benzyl 2-(10-undecenyloxy)acrylate (11c) 
This compound was prepared from 9c following general procedure B. The yield was 98 
mg (30%). 1H-NMR (CDCl3, 200 MHz): δ 7.36 (m, 5H), 5.91–5.71 (m, 1H), 5.34 (d, J 
=  2.2 Hz, 1H), 5.24 (s, 2H), 4.96 (m, 2H), 4.60 (d, J = 2.3 Hz, 1H), 3.73 (t, J = 6.7 Hz, 
2H), 2.03 (m, 2H), 1.75 (m, 2H), 1.28 (m, 12H). 13C-NMR (CDCl3, 50 MHz): δ 160.8, 151.2, 139.2, 
128.6, 128.5, 128.2, 128.1, 114.1, 94.0, 68.6, 66.8, 33.8, 29.5, 29.4, 29.3, 29.1, 28.9, 28.5, 25.9. IR 
(film): ν 3066, 3033, 2924, 1734, 1617, 1166 cm-1. HRMS (EI+): calculated for C21H30O3, [M]+: 
330.2195, found: 330.2191. 
 
O
OBnO
( )2
O
OBnO
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General procedure C for the ring-closing metathesis reactions of compounds 11a-c 
A solution of the α-alkoxyacrylate (20–30 mg) and the catalyst in toluene (0.03 M) was stirred and 
monitored by TLC or GC. When no further conversion was observed, the mixture was concentrated 
and the products isolated by column chromatography. The different products could not be separated 
by this method, but GC-MS allowed us to determine the nature and ratio of the compounds. With this 
knowledge we were able to assign the 1H-NMR-signals of compounds 12a, b, d (data are shown 
below). 
 
Benzyl 3,4-dihydro-2H-6-pyrancarboxylate (12a) 
1H-NMR (C6D6, 200 MHz): δ 7.20–7.03 (m, 5H), 6.06 (t, J = 4.1 Hz, 1H), 5.03 (s, 2H), 
3.60 (dd, J = 4.8, 5.1 Hz, 2H), 1.56 (m, 2H), 1.21 (m, 2H). LRMS: m/z 218 (M+). 
 
 
Benzyl 4,5,6,7-tetrahydro-2-oxepinecarboxylate (12b) 
1H-NMR (C6D6, 300 MHz): δ 7.20–7.03 (m, 5H), 6.44 (t, J = 6.0 Hz, 1H), 5.06 (s, 2H), 
3.68 (m, 2H), 1.84 (m, 2H), 1.47 (m, 2H), 1.31 (m, 2H). LRMS: m/z 232 (M+). 
 
 
Benzyl 4,5-dihydro-2-furancarboxylate (12d) 
1H-NMR (C6D6, 200 MHz): δ 7.20–7.03 (m, 5H), 5.71 (t, J = 3.2 Hz, 1H), 5.08 (s, 2H), 
3.91 (t, J = 9.8 Hz, 2H), 1.98 (dt, J = 3.2, 9.8 Hz, 2H). LRMS: m/z 204 (M+). 
 
Benzyl 2-[(E)-8-(1-[(benzyloxy)carbonyl]-vinyloxy)-4-octenyl]oxyacrylate (13a) 
1H-NMR (C6D6, 300 MHz): δ 7.17–7.03 (m, 10H), 5.45 (t, J = 2.1 Hz, 2H), 5.26 
(m, 2H), 5.06 (m, 4H), 4.31 (t, J = 1.8 Hz, 2H), 3.36 (t, J = 6.3 Hz, 4H), 2.03 (m, 
4H), 1.58 (m, 4H). 
 
Benzyl 2-[(E)-20-(1-[(benzyloxy)carbonyl]-vinyloxy)-10-icosenyl]oxyacrylate (13c) 
1H-NMR (C6D6, 300 MHz): δ 7.18–7.07 (m, 10H), 5.61 (m, 2H), 5.54 (d, J = 2.2 
Hz, 2H), 5.13 (s, 4H), 4.40 (d, J = 2.2 Hz, 2H), 3.46 (t, J = 6.3 Hz, 4H), 2.16 (m, 
4H), 1.61 (m, 4H), 1.51–1.28 (m, 24H). 
 
Methyl 2-bromo-3-(pyrrolidin-1-yl)propanoate (15a) 
A solution of methyl 2,3-dibromopropanoate (2.01 g, 8.17 mmol) in toluene (130 
mL) was cooled to 0 ºC and pyrrolidine (0.68 mL, 8.05 mmol) and Et3N (1.15 mL, 
8.17 mmol) were added. After stirring at 0 ºC for 1 h, the resulting suspension was 
filtered over Celite, washed with H2O (25 mL), dried (MgSO4) and concentrated. The 
resulting crude product was >95% pure according to NMR and therefore directly used in the next 
step. The yield was 1.72 g (89%). 1H-NMR (CDCl3, 200 MHz): δ 4.33 (dd, J = 6.0, 9.2 Hz, 1H), 3.88 
(s, 3H), 3.30 (dd, J = 9.2, 12.9 Hz, 1H), 2.95 (dd, J = 6.0, 12.9 Hz, 1H), 2.72 (m, 4H), 1.84 (m, 4H). 
13C-NMR (CDCl3, 300 MHz): δ 169.5, 59.3, 58.2, 54.1, 43.0, 23.6. 
 
Ethyl 2-bromo-3-(pyrrolidin-1-yl)propanoate (15b) 
The same procedure was applied as for 15a, using ethyl 2,3-dibromopropanoate. The 
yield of the crude product was 1.77 g (92%). 1H-NMR (CDCl3, 200 MHz): δ 4.38–
4.26 (m, 3H), 3.28 (dd, J = 9.2, 12.7 Hz, 1H), 2.95 (dd, J = 6.0, 12.7 Hz, 1H), 2.62 (m, 
4H), 1.76 (m, 4H), 1.37 (t, J = 7.0 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 169.4, 
61.8, 59.3, 54.1, 43.0, 23.6, 13.9. 
 
 
OBnO2C
OBnO2C
BnO2C O (  )2 2
OBnO2C
BnO2C O (  )8 2
N
CO2MeBr
N
CO2EtBr
 
Ring-closing metathesis of α-alkoxyacrylates 
47 
General procedure D for preparation of the α-alkoxyacrylates 
To a cooled (0 ºC) solution of the alcohol (1 equiv) in diethyl ether/DMF (1:1, 0.05M) was added 
NaH (60% in mineral oil; 1.5 equiv) and the mixture was stirred at 40 ºC for 1 h. After cooling to 
room temperature, freshly prepared 15a or b (2 equiv) was added and the reaction was stirred for 18 
h. Next, H2O was added, the mixture was extracted with pentane (3 ×) and the combined organic 
layers were concentrated in vacuo. The residue was dissolved in (m)ethanol/MeCN (1:1, 0.1M), MeI 
(10 equiv) and Na2CO3 (5 equiv) were added and the reaction mixture was allowed to stir at reflux 
temperature for 48 h. Next, H2O was added and the mixture was extracted with CH2Cl2 (3 ×). The 
combined organic layers were dried with MgSO4, concentrated and the product was purified by 
column chromatography (EtOAc/heptane). 
 
Methyl 2-phenoxyacrylate (20) 
This compound was prepared from phenol following general procedure D. The 
yield was 62 mg (55%). The analytical data were in agreement with those reported 
in literature.23 1H-NMR (CDCl3, 300 MHz): δ 7.32–7.05 (m, 5H), 5.69 (d, J = 2.0 
Hz, 1H), 4.88 (d, J = 2.0 Hz, 1H), 3.83 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 162.9, 155.0, 150.4, 
129.6, 124.1, 119.1, 103.8, 52.6. 
 
Ethyl 2-(phenylsulfanyl)acrylate (21) 
This compound was prepared from thiophenol following general procedure D. The 
yield was 26 mg (53%). The analytical data were in agreement with those reported 
in literature.24 1H-NMR (CDCl3, 300 MHz): δ 7.45–7.27 (m, 5H), 6.31 (s, 1H), 5.24 
(s, 1H), 4.25 (q, J = 7.1 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 163.9, 
138.7, 133.9, 132.8, 129.4, 128.6, 122.3, 61.9, 14.3. 
 
Ethyl 2-(2-vinylphenoxy)acrylate (24) 
This compound was prepared from 2-vinylphenol following general procedure D. 
The yield was 35 mg (61%). 1H-NMR (CDCl3, 300 MHz): δ 7.57 (d, J = 7.5 Hz, 
1H), 7.27–7.12 (m, 2H), 6.98–6.83 (m, 2H), 5.77 (dd, J = 1.1, 17.7 Hz, 1H), 5.57 
(d, J = 2.1 Hz, 1H), 5.29 (dd, J = 1.1, 11.0 Hz, 1H), 4.63 (d, J = 2.1 Hz, 1H), 4.30 
(q, J = 7.2 Hz, 2H), 1.32 (t, J = 7.2 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ δ 162.3, 151.7, 150.8, 
130.4, 129.5, 128.8, 126.4, 124.8, 120.2, 115.5, 101.8, 61.7, 14.4. HRMS (EI+): calculated for 
C13H14O3, [M]+: 218.0943, found: 218.0943. 
 
Ethyl 2-(2-allylphenoxy)acrylate (25) 
This compound was prepared from 2-allylphenol following general procedure D. 
The yield was 7.13 g (78%). 1H-NMR (CDCl3, 300 MHz): δ 7.26–7.08 (m, 3H), 
6.95 (dd, J = 1.4, 7.8 Hz, 1H), 5.94 (m, 1H), 5.57 (d, J = 2.1 Hz, 1H), 5.07 (m, 2H), 
4.66 (d, J = 2.1 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.36 (d, J = 6.7 Hz, 2H), 1.32 (t, 
J = 7.1 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 162.3, 152.4, 150.7, 136.0, 131.5, 130.3, 127.4, 
124.7, 119.7, 116.0, 101.5, 61.6, 34.1, 14.4.HRMS (EI+): calculated for C14H16O3, [M]+: 232.1100, 
found: 232.1099. 
 
Ethyl benzofuran-2-carboxylate (26) 
To a solution of 24 (18.5 mg, 84.8 μmol) in toluene (3 mL) was added 5 mol % of 
(IMes)(PCy3)Cl2Ru=CHPh (B). The reaction was stirred under an inert atmosphere 
at 70 ºC for 30 min, followed by removal of the solvent in vacuo. The product was 
purified by column chromatography (EtOAc/heptane, 1:20). The yield was 14.3 mg (89%). The 
analytical data were in agreement with those reported earlier.25 1H-NMR (CDCl3, 300 MHz): δ 7.69–
O CO2Me
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7.27 (m, 5H), 4.44 (q, J = 6.9 Hz, 2H), 1.42 (t, J = 6.9 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 159.3, 
155.4, 145.5, 127.3, 126.8, 123.6, 122.6, 113.6, 112.2, 61.6, 14.6.  
 
Ethyl 4H-2-chromenecarboxylate (27) 
To a solution of 25 (29.7 mg, 128 μmol) in toluene (4 mL) was added 5 mol % of 
(IMes)(PCy3)Cl2Ru=CHPh (B). The reaction was stirred under an inert atmosphere 
at 70 ºC for 30 min, followed by removal of the solvent in vacuo. The product was 
purified by column chromatography (EtOAc/heptane, 1:20). The yield was 24.0 mg (92%). 1H-NMR 
(CDCl3, 300 MHz): δ 7.17–6.96 (m, 4H), 6.22 (t, J = 4.1 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.55 (d, J 
= 4.1 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 161.3, 150.8, 141.5, 128.7, 
127.7, 123.7, 118.0, 116.9, 110.0, 61.4, 24.7, 14.4. HRMS (EI+): calculated for C12H12O3, [M]+: 
204.0787, found: 204.0787. 
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RCM of carbohydrate-derived  
α-alkoxyacrylates 
 
 
 
4.1 Introduction 
 
As discussed in the previous chapter, we envisaged that application of ring-closing 
metathesis (RCM) of α-alkoxyacrylates to more elaborate substrates could result in a short 
and efficient pathway towards the family of 3-deoxy-2-ulosonic acids (e.g. 1–3).1 Scheme 
4.1 shows the retrosynthetic approach to this class of compounds, starting from naturally 
occurring sugars 7. Key challenges in the synthetic route are synthesis of the metathesis 
precursors 6, RCM of these precursors and further functionalization of the resulting 
heterocycles 5. 
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Scheme 4.1. Metathesis-based retrosynthetic route for 3-deoxy-2-ulosonic acids. 
 
 Although the undesired olefin isomerization described in the previous chapter can 
potentially cause problems during the course of these syntheses, we were hopeful that the 
substituents in the substrates might efficiently retard the isomerization as a result of steric 
hindrance.2 With these expectations and with the availability of a suitable procedure for the 
4 
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synthesis of α-alkoxyacrylate functionalities, the stage was set for application of this 
methodology to an RCM-based synthesis of the glycal precursors for DAH (1), KDO (2) 
and derivatives.3 
 
4.2 Synthesis and RCM of a D-mannose-based  
α-alkoxyacrylate 
 
 The RCM-based approach to the functionalized glycal precursor for KDO involves 
the retrosynthetic route discussed above (Scheme 4.1), starting from commercially 
available di-O-isopropylidene-protected D-mannose (8). Thus, compound 8 was reacted 
with the appropriate Wittig reagent under literature conditions to give the olefinic alcohol 9 
in 92%.4 As already discussed in Section 3.5, one suitable pathway towards 
α-alkoxyacrylate fragments has been reported by Ganem and co-workers.5 In order to 
compare this method to the newly developed 2-step procedure described in Section 3.5, we 
decided to prepare RCM-precursor 12 via both pathways (Scheme 4.2). 
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Scheme 4.2. Synthesis of D-mannose-based RCM-precursor 12. 
 
Following the procedure by Ganem, alcohol 9 was reacted with the rhodium 
carbenoid generated from dimethyl diazomalonate6 and Rh2(OAc)4, to give the insertion 
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product 10 in 63% yield. Alkylation of 10 with Eschenmoser’s salt under mildly basic 
conditions then gave compound 11 in 82%. Treatment with an excess of methyl iodide in 
refluxing acetonitrile led to the formation of the quaternary ammonium salt, followed by 
elimination and iodide-induced decarboxylation to produce the desired RCM-precursor 12 
in an overall yield of 38% from 9. 
 Next, compound 12 was synthesized according to the method based on the use of 
bromide 13a. Substitution of the bromide in 13a by the alkoxide derived from 9, followed 
by N-methylation with MeI and subsequent elimination, resulted in the formation of 12 in a 
yield of 70%. The differences in the number of reaction steps (2 compared to 3 steps) and 
the overall yield (70 compared to 38%) clearly render the latter route a more valuable 
method for the preparation of α-alkoxyacrylate-containing RCM-precursors. 
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Scheme 4.3. Synthesis of glycal intermediate for KDO via RCM. 
 
Ring-closing metathesis of 12, using the second generation Grubbs catalyst A gave 
heterocycle 14 in an excellent yield of 91% (Scheme 4.3). Interestingly, the use of first 
generation catalysts B and C also resulted in cyclization, albeit under more harsh conditions 
and with lower yields. This is particularly surprising, since catalyst B was not capable of 
cyclizing the model systems that were described in Section 3.3, but instead gave selective 
homodimerization of the substrates. 
Functionalized glycal 14 is a known intermediate in the synthesis of KDO,7 and 
more importantly, a crucial starting point for the synthesis of derivatives thereof.8 With the 
combined precursor synthesis/ring-closing metathesis sequence we are now able to prepare 
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this useful scaffold in only four steps from commercially available starting materials in an 
overall yield of 59%. 
 
4.3 Synthesis of RCM-precursors from C5-carbohydrates 
 
Encouraged by the previous results, we set out to apply the same approach in a 
synthetic route towards potential glycal intermediates for DAH (1) and a number of 
isomeric derivatives. Scheme 4.4 shows the preparation of the D-arabinose-based RCM-
precursors for 1 (i.e. 23a–b), as well as analogues with a ribo-, lyxo- and xylo-
configuration. Alcohols 19–22 were prepared from the protected C5-sugars 15–189 under 
standard Wittig conditions, following known procedures.10 The poor yield of 20 (28%) can 
be explained by readily occurring epimerization at C-2 – leading to the arabino-variant 19 
– which is an even more distinct problem at elevated temperatures. Both this observation as 
well as the yield of 20 are in accordance with those reported in literature.10c Next, the 
alcohol groups were converted into α-alkoxyacrylate moieties using the same two-step 
procedure that was used in the previous section, involving bromides 13a–b. RCM-
precursors 23–26 were isolated in satisfying yields of 49–67%.  
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Scheme 4.4. Synthesis of RCM-precursors from protected carbohydrates. 
 
 
4.4 Ring-closing metathesis of C5-carbohydrate-based  
α-alkoxyacrylates 
 
Gratifyingly, ring-closing metathesis of 23a–b and 24 proceeded readily with the 
second generation Grubbs catalyst (A) in toluene at 80 ºC (Scheme 4.5). Considering the 
 
RCM of carbohydrate-derived α-alkoxyacrylates 
55 
highly functionalized nature of the olefins, the heterocycles 27a–b and 28 were isolated in 
remarkably good yields of 82%, 80% and 85%, respectively. On the other hand, D-lyxose-
derived olefin 25 reacted significantly slower under these conditions. After portionwise 
addition of the catalyst and a prolonged reaction time, 29 could be isolated in a yield of 
51%.  
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Scheme 4.5. Ring-closing metathesis of carbohydrate-derived α-alkoxyacrylates; a Reaction time was 20 h, 
catalyst was added portionwise; b 20 mol % of catalyst was used and added portionwise 
 
Interestingly, an unexpected side reaction was observed in the cyclization of xylo-
derivative 26. Moreover, the reaction appeared to stop at a certain conversion, leaving a 
significant amount (43%) of unreacted starting material behind. Although the side product 
could not be separated from the major, expected product 30 by silica gel chromatography, 
both compounds were eventually obtained in analytically pure form through preparative 
HPLC. After extensive investigation of the analytical data the side-product was identified 
as the seven-membered ring 31 (Scheme 4.5). 
 
4.5 One-carbon homologation during ring-closing metathesis 
 
The generation of the seven-membered ring 31 from 26 implies that a methylene 
group is introduced during the RCM process, which is unprecedented in ring-closing olefin 
metathesis. The observation of such an “insertion mechanism” sharply contrasts with the 
frequently observed “deletion mechanism” where propylene is expelled, caused by olefin 
isomerization prior to cyclization.11,12 Interestingly, when a mixture of the two products was 
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resubjected to the metathesis conditions, the ratio did not change. This suggests that the 
one-carbon homologation takes place in the starting compound 26 prior to cyclization. 
Carrying out the reaction at different temperatures and/or concentrations did not 
significantly influence the ratio between 30 and 31, although lower concentrations clearly 
resulted in higher conversions of the starting material (Table 4.1, entries 1 and 2). On the 
other hand, in case one equivalent of A was used, the ratio 30:31 changed from 2.6:1 to 
1.2-1.5:1 (entries 3–5). Finally, the first generation catalysts B and C also produced 31 as a 
side product, albeit with lower conversions (entries 6 and 7). 
 
Table 4.1. Ring-closing metathesis and one-carbon homologation of 26. 
O
OBn
OBn
OBn
EtO2C
OEtO2C
OBn
OBn
H
OBn
OEtO2C
OBn
OBn
H
OBn
+
26 30 31
[Ru]
 
Entry Cat. (mol %) Conc. (M) 30 (%) 31 (%) 30:31 26 (%) 
1 A (20) 0.05 39 15 2.6:1 43 
2 A (20) 0.02 52 19 2.7:1 25 
3 A (100) 0.05 31 24 1.3:1 n.d. 
4 A (100) 0.02 47 40 1.2:1 n.d. 
5b A (100) 0.02 56 36 1.5:1 n.d. 
6 B (20) 0.02 15c 11c 1.4:1 74c 
7 C (20) 0.02 18c 13c 1.4:1 69c 
a Conditions: solution in toluene, inert atmosphere, 80 °C, 18 h. b At 60 °C. c Based on 1H NMR 
 
The possible occurrence of this unprecedented transformation including a tentative 
mechanism has recently been postulated by others based on DFT calculations on 
ruthenacyclobutane intermediates.13 This mechanistic pathway involves β-hydrogen 
elimination from the known metathesis intermediate II, resulting in π-allylruthenium(IV) 
complex III (Scheme 4.6). Reductive elimination to complex IV and subsequent 
dissociation of the olefin from the metal center would then generate the homologated 
product. 
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Scheme 4.6. Tentative homologation mechanism. 
 
In our case, this would imply that subjection of 26 to this pathway would lead to 
the homologated RCM-precursor 32, which then gives 31 upon cyclization (Scheme 4.7). 
Since a ruthenium carbene species is not regenerated through this sequence, it also 
represents a decomposition pathway for olefin metathesis catalysts. This is in agreement 
with (a) the observation of lower total conversions in cases of catalytic amounts of A and 
(b) the fact that the yield of homologated product never exceeds the amount of catalyst used 
(Table 4.1). 
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Scheme 4.7. Possible formation of 30 and 31 from 32. 
 
Unfortunately, we have not been able to observe compound 32 by NMR, 
presumably due to the high reactivity of the relatively unhindered mono-substituted double 
bond. In addition, we cannot exclude the occurrence of olefin isomerization in 32 under 
metathesis conditions, eventually resulting in formation of 30 (Scheme 4.7). Thus, the 
homologation might in fact be more efficient than the ratio between 30 and 31 initially 
suggests. In order to further investigate this assumption, we decided to synthesize 
compound 3314 and subject it to the previously discussed conditions to see whether it would 
be possible to isolate the corresponding homologated product. The lack of a second double 
bond in 33 eliminates the possibility of cyclization and we anticipated that the presence of 
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an allylic benzyloxy substituent would inhibit formation of a homodimeric cross-metathesis 
product,15 thereby preventing these two reactions to compete with the homologation. 
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Scheme 4.8. Cross-metathesis with catalyst-originating styrene. 
 
Indeed, no homodimerization took place, but instead, cross-metathesis (CM) of 33 
was observed with styrene that presumably originates from catalyst A (Scheme 4.8). The 
efficient nature of this reaction prevented us from detecting any homologated products. 
Nevertheless, this outcome is somewhat surprising, especially since the incorporation of 
styrene is generally not observed as a side reaction in olefin metathesis. 
 
4.6 Towards a synthesis of KDN 
 
 A noteworthy limitation of the scope of the described metathesis-based 
methodology is caused by the fact that it relies on naturally occurring carbohydrates. 
Somewhat more elaborate members of the 3-deoxy-2-ulosonic acid family, such as KDN 
(3a, 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid) and N-acetylneuraminic acid 
(Neu5Ac (3b), 5-acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid),3 have 
one additional carbon in the side chain, thereby complicating their synthesis via this route. 
For instance, the total synthesis of KDN (3a) via the same pathway would require the 
preparation of glycal 35. The corresponding RCM-precursor 36 would then have to be 
prepared from the protected, unnatural C7-carbohydrate 37 (Scheme 4.9). 
We envisaged that the reported lactone 3816 is a potential starting point for the 
synthesis of KDN. The key structural advantage of 38 is the fact the single hydroxyl that 
needs to remain unprotected during the synthesis is present as the lactone-carbonyl 
function. Consequently, if the OH-groups in 38 can be protected in a suitable fashion, 
subsequent reduction of the lactone would result in the desired protected, unnatural 
C7-carbohydrate 37 (Scheme 4.9). 
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Scheme 4.9. Retrosynthetic approach to KDN from an unnatural C7-sugar. 
 
 Hence, 38 was synthesized in two steps from D-arabinose (39) according to 
literature procedures16 (Scheme 4.10). A Wittig reaction of 39 with the stabilized 
phosphorane 40 produced compound 41 as a single (E)-geometrical isomer. Next, 
dihydroxylation of the allylic alcohol with OsO4/NMO was carried out, exhibiting a 
diastereoselectivity that obeys Kishi’s empirical rule. This rule predicts that in the 
dihydroxylation of acyclic allylic alcohols the relative stereochemistry between the resident 
hydroxyl and the adjacently introduced hydroxyl group is erythro (anti).17 The resulting 
dihydroxylation product underwent facile cyclization during acidic workup, which is a 
result of the acid-lability of the diphenylmethyl ester. Upon liberating diphenylmethanol, 
the resulting lactone 38 was isolated in an overall yield of 57% and with a diastereomeric 
ratio of 7:1, both of which are in agreement with the reported values.16 
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Scheme 4.10. Synthesis of lactone 38 following a procedure by Madsen et al.16 
 
Protection of lactones such as 38 is not particularly trivial, due to the high risk of 
epimerization at the base-sensitive α-position. In addition, the basic conditions needed at a 
later stage of the synthesis complicate the use of base-sensitive substituents, such as acetyl 
protecting groups or silyloxy groups. Thus, benzylation seems to be the most suitable 
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method, also because of the availability of several non-basic protection methods (Scheme 
4.11). Unfortunately, benzylation of 38 with Ag2O/BnBr in diethyl ether or dioxane did not 
result in any reaction after 2 days, according to TLC. On the other hand, reaction of 38 with 
benzyl 2,2,2-trichloroacetimidate and either triflic acid or TMSOTf in dioxane did show 
conversion. Crude 1H-NMR of the products, however, showed a complicated mixture 
where, on average, less than two benzyl groups had been incorporated. 
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Scheme 4.11. Attempted protection of lactone 38; conditions: (a) BnBr (7–10 equiv), Ag2O (8 equiv), Et2O or 
dioxane, rt, 2 d. (b) Cl3CC(=NH)OBn (10 equiv), CF3SO3H (cat.) or TMSOTf (cat), dioxane, rt, 18 h. 
 
 Since it is apparently difficult to benzylate the five hydroxyl groups in 38 under 
relatively mild, non-basic conditions, we decided to investigate the possibility of protecting 
two hydroxyl groups as a cyclic acetal. Treatment of 38 with 2,2-dimethoxypropane in 
acetone under acidic conditions resulted in the formation of O,O-isopropylidene protected 
lactone 42 in a yield of 71% (Scheme 4.11). Unfortunately, benzylation of 42 hardly 
offered any improvement compared to the protection of 38. In this case, both the 
Ag2O/BnBr and the benzyl 2,2,2-trichloroacetimidate method showed some conversion, 
however, the only clear product that could be observed was a mono-benzylated product. 
This leads to the suggestion that perhaps one or two hydroxyl groups are poorly accessible 
in the molecule, making protection with a sterically demanding benzyl group difficult, if 
not impossible. 
 After these unsatisfactory results, we decided to abandon our investigations into 
the synthesis of KDN. Nevertheless, if a suitable protection procedure for 38 can be 
developed, the described route may still prove to be a versatile synthetic pathway for the 
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preparation of this specific class of products, including KDN and unnatural derivatives 
thereof. 
 
4.7 Conclusion 
 
 The ring-closing metathesis of α-alkoxyacrylates was successfully applied to 
highly functionalized, carbohydrate-derived olefins. This resulted in a high-yielding 4-step 
procedure from protected natural sugars to substituted glycals, which can serve as versatile 
building blocks for biologically relevant derivatives, including KDO, DAH and a range of 
derivatives. 
In addition, the first example of a one-carbon homologation in a ring-closing 
metathesis reaction was observed. This result provides important new insights into catalyst 
decomposition during ruthenium-based olefin metathesis. Furthermore, it might open up 
new possibilities for versatile tandem reaction sequences.18 
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4.9 Experimental section 
 
General information 
For general experimental details, see Section 2.8. 
The syntheses of compounds 13a–b are described in Chapter 3. 
 
(R)[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl][(4S,5R)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-
yl]methanol (9) 
This compound was synthesized according to a literature procedure.4 The yield was 
1.88 g (92%). 1H-NMR (CDCl3, 300 MHz): δ 6.09 (m, 1H), 5.37 (m, 2H), 4.69 (t, J 
= 7.8 Hz, 1H), 4.38 (d, J = 7.5 Hz, 1H), 4.09–3.96 (m, 3H), 3.45 (t, J = 7.9 Hz, 1H), 
2.19 (d, J = 8.1 Hz, 1H), 1.52 (s, 3H), 1.40 (s, 3H), 1.38 (s, 3H), 1.34 (s, 3H). 13C-
NMR (CDCl3, 75 MHz): δ 134.0, 119.5, 109.2, 108.5, 79.1, 76.7, 76.0, 67.1, 27.0, 
26.8, 25.5, 24.7. 
 
 
O
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Dimethyl 2-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)((4R,5R)-2,2-dimethyl-5-vinyl-1,3-dioxolan-
4-yl)methoxy)malonate (10) 
To a solution of 9 (184 mg, 0.71 mmol) and Rh2(OAc)4 (6.5 mg, 2.1 mol %) in 
benzene (4 mL) was added dimethyl diazomalonate6 (213 mg, 1.35 mmol) over a 
period of 10 min. The mixture was stirred at 55 °C for 3 h, cooled to room 
temperature and an additional 10 mL of benzene was added. The organic layer 
was washed with saturated NaHCO3 (15 mL) and H2O (2 × 15 mL), dried 
(Na2SO4) and concentrated. The product was purified by column chromatography 
(EtOAc/heptane, 1:4). The yield was 173 mg (63%). 1H-NMR (CDCl3, 300 MHz): δ 5.85 (m, 1H), 
5.29 (m, 2H), 4.98 (s, 1H), 4.56 (dd, J = 5.9, 7.0 Hz, 1H), 4.20–4.07 (m, 4H), 3.78 (m, 7H), 1.50 (s, 
3H), 1.38 (s, 3H), 1.33 (s, 3H), 1.32 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 166.9, 166.7, 134.2, 
118.7, 109.2, 108.5, 79.8, 79.4, 79.3, 78.7, 75.8, 66.7, 52.8, 52.6, 27.8, 26.1, 25.8, 25.1. IR (film); ν 
2986, 1747, 1214, 1155, 1031 cm-1. [α]25D = +28.4 (c 0.40, CH2Cl2). HRMS (EI+): calculated for 
C18H28O9, [M]+: 388.1733, found: 388.1724. 
 
Dimethyl 2-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)((4R,5R)-2,2-dimethyl-5-vinyl-1,3-dioxolan-
4-yl)methoxy)-2-((dimethylamino)methyl)malonate (11) 
To a solution of 10 (75 mg, 0.19 mmol) and CH2=NMe2I (54 mg, 0.29 mmol) in 
CH2Cl2 (3 mL) was added Et3N (45 μL, 0.32 mmol). The mixture was stirred at 
reflux temperature for 48 h, cooled to room temperature and an additional 10 mL 
CH2Cl2 was added. The reaction mixture was washed with saturated aqueous 
NaHCO3 (10 mL) and the water layer was extracted with CH2Cl2 (2 × 10 mL). 
The combined organic layers were dried (MgSO4) and concentrated, after which 
the product was purified by column chromatography (EtOAc/heptane, 1:2). The 
yield was 70 mg (82%). 1H-NMR (CDCl3, 300 MHz): δ 5.97 (m, 1H), 5.28 (m, 2H), 4.62 (t, J = 5.9 
Hz, 1H), 4.41 (m, 1H), 4.32–4.20 (m, 3H), 4.05 (m, 1H), 3.75 (s, 3H), 3.72 (s, 3H), 3.10 (dAB, J = 
14.1 Hz, 2H), 2.25 (s, 6H), 1.48 (s, 3H), 1.40 (s, 3H), 1.35 (s, 3H), 1.33 (s, 3H). 13C-NMR (CDCl3, 75 
MHz): δ 168.8, 135.1, 117.6, 109.1, 107.7, 79.4, 78.3, 77.3, 74.9, 68.2, 62.1, 52.7, 52.4, 46.7, 28.1, 
26.2, 25.8, 25.3. IR (film): ν 2985, 2773, 1748, 1214, 1160, 1034 cm-1. [α]25D = +52.3 (c 0.30, 
CH2Cl2). HRMS (CI+): calculated for C21H36NO9, [M+H]+: 446.2390, found: 446.2386. 
 
General procedure A for the preparation of α-alkoxyacrylates 
To a cooled (0 ºC) solution of the alcohol (1 equiv) in diethyl ether/DMF (1:1, 0.05M) was added 
NaH (60% in mineral oil; 2.5 equiv) and the mixture was stirred at 40 ºC for 1 h. After cooling to 
room temperature, freshly prepared 13a or b (3.0 equiv) was added and the reaction was stirred for 18 
h. Next, H2O was added, the mixture was extracted with diethyl ether (3 ×) and the combined organic 
layers were concentrated in vacuo. The residue was dissolved in (m)ethanol/MeCN (1:1, 0.1M), MeI 
(10 equiv) and Na2CO3 (5 equiv) were added and the reaction mixture was allowed to stir at reflux 
temperature for 48 h. Next, H2O was added and the mixture was extracted with CH2Cl2 (3 ×). The 
combined organic layers were dried with MgSO4, concentrated and the product was isolated by 
column chromatography (EtOAc/heptane, 1:6). 
 
Methyl 2-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)((4R,5R)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-
yl)methoxy)acrylate (12) 
From 11: A solution of 11 (30 mg, 68 µmol) and MeI (48 µL, 0.77 mmol) in 
MeCN (4 mL) was stirred at reflux temperature. After 48 h, the reaction mixture 
was concentrated in vacuo and the product was isolated by column 
chromatography (EtOAc/heptane, 1:4). The yield was 17 mg (73%; 38% from 9). 
From 9: This compound was synthesized, following general procedure A for the 
preparation of α-alkoxyacrylates. The yield was 225 mg (70%). 1H-NMR 
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(CDCl3, 300 MHz): δ 5.79 (m, 1H), 5.50 (d, J = 3.0 Hz, 1H), 5.30 (m, 2H), 5.87 (d, J = 2.4 Hz, 1H), 
4.68 (dd, J = 6.9, 7.5 Hz, 1H), 4.34–4.19 (m, 3H), 4.03 (m, 2H), 3.78 (s, 3H), 1.61 (s, 3H), 1.39 (s, 
3H), 1.35 (s, 3H), 1.34 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 163.2, 150.3, 133.7, 119.4, 109.6, 
108.8, 96.8, 78.9, 78.5, 76.7, 75.4, 65.6, 52.3, 26.7, 26.5, 25.9, 25.6. IR (film): ν 2984, 2935, 1734, 
1623, 1199, 1165, 1057 cm-1. [α]25D = –44.7 (c 0.3, CH2Cl2). HRMS (EI+): calculated for C17H26O7, 
[M]+: 342.1679, found: 342.1675. 
 
(3aR,4R,7aR)-Methyl 4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-4,7a-dihydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6-carboxylate (14) 
To a solution of 12 (213 mg, 0.623 mmol) in toluene (12 mL) was added 10 
mol % of (IMes)(PCy3)Cl2Ru=CHPh (A) and the mixture was stirred under an 
inert atmosphere at 85 °C for 1 h. The reaction was ended by exposure to air 
and removal of the solvent in vacuo. The product was purified by column 
chromatography (EtOAc/heptane, 1:6). The yield was 178 mg (91%). 
Analytical data agreed with those reported in literature.7b 1H-NMR (CDCl3, 300 
MHz): δ 5.99 (dd, J = 1.5, 3.3 Hz, 1H), 4.78 (dd, J = 3.3, 6.0 Hz, 1H), 4.45 (m, 2H), 4.19 (m, 2H), 
3.82 (m, 1H), 3.79 (s, 3H), 1.46 (s, 1H), 1.41 (s, 9H). 13C-NMR (CDCl3, 75 MHz): δ 162.2, 143.7, 
110.9, 110.3, 109.5, 76.4, 73.8, 71.2, 68.8, 66.8, 52.4, 28.2, 27.1, 26.9, 25.5. [α]25D = +31.9 (c 0.3, 
CH2Cl2). 
 
(2R,3R,4R)-1,3,4-Tris(benzyloxy)hex-5-en-2-ol (19) 
This compound was synthesized according to known procedures, analytical data 
agreed with those reported in literature.10b The yield was 856 mg (86%). 1H-NMR 
(CDCl3, 300 MHz): δ 7.38–7.23 (m, 15H), 6.00–5.89 (m, 1H), 5.30 (m, 2H), 4.53 
(m, 4H), 4.40 (dAB, J = 12.0 Hz, 2H), 4.07 (dd, J = 3.9, 7.2 Hz, 1H), 4.00 (m, 1H), 
3.52 (m, 3H), 2.82 (d, J = 4.9 Hz, 1H). 13C-NMR (CDCl3, 75 MHz): δ 138.0, 137.9, 137.6, 134.9. 
128.2 (2), 128.1, 127.9 (2), 127.7, 127.5, 127.4, 118.8, 80.5, 80.2, 74.1, 73.4, 70.9, 70.7, 70.4. 
 
(2R,3R,4S)-1,3,4-Tris(benzyloxy)hex-5-en-2-ol (20) 
This compound was synthesized according to known procedures, analytical data 
agreed with those reported in literature.10c The yield was 180 mg (28%). 1H NMR 
(CDCl3, 300 MHz): δ 7.31–7.17 (m, 15H), 5.99–5.87 (m, 1H), 5.34 (m, 2H), 4.64–
4.48 (m, 4H), 4.57 (dAB, J = 11.7 Hz, 2H), 4.14 (dd, J = 3.9, 7.8 Hz, 1H), 3.83 (m, 
1H), 3.70 (m, 1H), 3.61 (m, 2H), 2.67 (d, J = 4.8 Hz, 1H). 13C NMR (CDCl3, 75 MHz): δ 138.2(2), 
137.8, 134.9, 128.2, 128.1(3), 127.9, 127.6, 127.5, 127.4(2), 127.3, 119.5, 82.0, 80.9, 74.1, 73.4, 70.8, 
70.4. 
 
(2R,3S,4R)-1,3,4-Tris(benzyloxy)hex-5-en-2-ol (21) 
This compound was synthesized according to known procedures, analytical data 
agreed with those reported in literature.10a The yield was 281 mg (46%). 1H NMR 
(CDCl3, 300 MHz): δ 7.35–7.18 (m, 15H), 5.96 (m, 1H), 5.36 (m, 2H), 4.70–4.52 
(m, 4H), 4.52 (dAB, J = 11.5 Hz, 2H), 4.09 (dd, J = 3.9, 7.8 Hz, 1H), 3.77–3.57 (m, 
4H), 2.83 (br d, J = 5.7 Hz). 13C NMR (CDCl3, 75 MHz): δ 138.2, 138.0(2), 135.4, 128.2(2), 
128.1(2), 127.8, 127.5(3), 127.4, 119.5, 81.4, 80.6, 79.6, 74.4, 73.2, 71.1, 70.3. 
 
(2R,3S,4S)-1,3,4-Tris(benzyloxy)hex-5-en-2-ol (22) 
This compound was synthesized according to known procedures, analytical data 
agreed with those reported in literature.10b The yield was 271 mg (75%). 1H NMR 
(CDCl3, 300 MHz): δ 7.31–7.16 (m, 15H), 5.85 (m, 1H), 5.35 (m, 2H), 4.63–4.39 
(m, 4H), 4.61 (dAB, J = 11.4 Hz,, 2H), 4.08 (dd, J = 6.6, 7.5 Hz, 1H), 3.91 (m, 1H), 
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3.60 (dd, J = 2.6, 6.6 Hz, 1H), 3.41 (dd, J = 3.3, 6.0 Hz, 2H), 2.42 (d, J = 6.8 Hz, 1H). 13C NMR 
(CDCl3, 75 MHz): δ 138.1(2), 137.8, 135.0, 128.2, 128.1, 128.0(2), 127.7(2), 127.6, 127.5, 127.3, 
119.2, 82.1, 80.2, 75.0, 73.3, 71.2, 70.7, 70.0. 
 
Methyl 2-((2R,3S,4R)-1,3,4-tris(benzyloxy)hex-5-en-2-yloxy)acrylate (23a) 
This compound was synthesized from 19 and 13a, following general procedure A. 
The yield was 708 mg (69%). 1H-NMR (CDCl3, 300 MHz): δ 7.32–7.24 (m, 
15H), 5.89 (m, 1H), 5.38 (d, J = 2.5 Hz, 1H), 5.32 (m, 2H), 4.72 (d, J = 2.5 Hz, 
1H), 4.67 (s, 2H), 4.50 (s, 2H), 4.46 (m, 1H), 4.43 (dAB, J = 11.7 Hz, 2H), 4.04 
(m, 1H), 3.91–3.72 (m, 3H), 3.77 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 163.7, 
149.8, 138.3, 138.2, 138.1, 135.4, 128.3, 128.2, 128.1 (2), 127.7, 127.6, 127.5 (2), 127.4, 119.0, 96.3, 
80.1, 80.0, 77.3, 74.9, 73.3, 70.6, 67.9, 52.2. IR (CH2Cl2): ν 3029, 2948, 2865, 1734, 1621 cm-1. 
[α]22D = –8.6 (c 1.3, CH2Cl2). HRMS (CI+): calculated for C31H35O6, [M+H]+: 503.2434, found: 
503.2434.  
 
Ethyl 2-((2R,3S,4R)-1,3,4-tris(benzyloxy)hex-5-en-2-yloxy)acrylate (23b) 
This compound was synthesized from 19 and 13b, following general procedure A. 
The yield was 380 mg (68%). 1H-NMR (CDCl3, 300 MHz): δ 7.31–7.24 (m, 15H), 
5.89 (m, 1H), 5.38 (d, J = 2.6 Hz, 1H), 5.31 (m, 2H), 4.72 (d, J = 2.6 Hz, 1H), 4.69 
(s, 2H), 4.51 (s, 2H), 4.45 (m, 1H), 4.44 (dAB, J = 11.8 Hz, 2H), 4.22 (q, J = 7.2 
Hz, 2H), 4.04 (m, 1H), 3.88 (m, 2H), 3.75 (dd, J = 5.1, 10.9 Hz), 1.29 (t, J = 7.2 
Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 162.9, 149.9, 138.1 (2), 138.0, 135.2, 128.1, 128.0, 127.9, 
127.8, 127.4, 127.3, 127.2, 118.8, 96.0, 80.3, 80.2, 77.4, 75.0, 73.3, 70.7, 68.1, 61.3, 14.4. IR 
(CH2Cl2): ν 3030, 2927, 2869, 1727, 1620 cm-1. [α]22D = –6.2 (c 0.5, CH2Cl2). HRMS (CI+): 
calculated for C32H37O6, [M+H]+: 517.2590, found: 517.2597. 
 
Ethyl 2-((2R,3S,4S)-1,3,4-tris(benzyloxy)hex-5-en-2-yloxy)acrylate (24) 
This compound was synthesized from 20 and 13b, following general procedure A. 
The yield was 27 mg (49%). 1H NMR (CDCl3, 300 MHz): δ 7.30–7.15 (m, 15H), 
5.89–5.75 (m, 1H), 5.40 (d, J = 2.7 Hz, 1H), 5.37–5.21 (m, 2H), 4.80 (d, J = 2.1 
Hz, 1H), 4.69 (s, 2H), 4.49 (s, 2H), 4.46 (m, 1H), 4.48 (dAB, J = 11.6 Hz, 2H), 4.24 
(q, J = 6.9 Hz, 2H), 4.00 (dd, J = 6.0, 7.5 Hz, 1H), 3.93 (dd, J = 4.5, 6.0 Hz, 1H), 
3.83–3.70 (m, 2H), 1.29 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 163.0, 150.0, 138.2, 
138.1, 135.3, 128.1 (2), 128.0, 127.4 (3), 127.3 (2), 119.5, 96.3, 80.7, 79.6, 78.1, 74.4, 73.3, 70.5, 
68.5, 61.3, 14.4. IR (CH2Cl2): ν 3023, 2920, 1722, 1623 cm-1. [α]25D = +20.3 (c 0.2, CH2Cl2). HRMS 
(CI+): calculated for C32H37O6, [M+H]+: 517.2590, found: 517.2593. 
 
Ethyl 2-((2R,3R,4R)-1,3,4-tris(benzyloxy)hex-5-en-2-yloxy)acrylate (25) 
This compound was synthesized from 21 and 13b, following general procedure A. 
The yield was 272 mg (55%). 1H NMR (CDCl3, 300 MHz): δ 7.32–7.17 (m, 15H), 
6.01–5.90 (m, 1H), 5.45–5.37 (m, 2H), 5.24 (d, J = 2.4 Hz, 1H), 4.71–4.44 (m, 
6H), 4.38 (d, J = 2.7 Hz, 1H), 4.26–4.11 (m, 4H), 3.72 (m, 3H), 1.30 (t, J = 7.2 Hz, 
3H). 13C NMR (CDCl3, 75 MHz): δ 162.6, 150.9, 138.3, 138.1, 137.9, 136.0, 
128.3, 128.1 (2), 128.0 (2), 127.5 (2), 127.4, 127.3, 127.0, 119.4, 94.0, 80.7, 80.0, 76.4, 74.3, 73.6, 
70.2, 69.2, 61.3, 14.4. IR (CH2Cl2): ν 3022, 2868, 1723, 1619 cm-1. [α]25D = –17.7 (c 1.5, CH2Cl2). 
HRMS (CI+): calculated for C32H37O6, [M+H]+: 517.2590, found: 517.2607. 
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Ethyl 2-((2R,3R,4S)-1,3,4-tris(benzyloxy)hex-5-en-2-yloxy)acrylate (26) 
This compound was synthesized from 22 and 13b, following general procedure A. 
The yield was 33 mg (49%). 1H NMR (CDCl3, 300 MHz): δ 7.35–7.19 (m, 15H), 
5.92–5.77 (m, 1H), 5.33 (d, J = 2.5 Hz, 1H), 5.24 (m, 2H), 4.73 (m, 2H), 4.71 (d, J 
= 2.7 Hz, 1H), 4.40 (dAB, J = 11.7 Hz, 2H), 4.41-4.13 (m, 5H), 4.08 (dd, J = 5.3, 
7.7 Hz, 1H), 3.78 (t, J = 5.1 Hz, 1H), 3.69-3.43 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
13C NMR (CDCl3, 75 MHz): δ 163.0, 150.6, 138.4, 138.0, 137.8, 135.1, 128.1(2), 128.0, 127.9, 
127.5(2), 127.3(2), 118.9, 96.1, 80.9, 80.4, 78.7, 75.0, 73.3, 70.6, 67.7, 61.3, 14.4. IR (CH2Cl2):  ν 
3023, 2863, 1722, 1619 cm-1. [α]25D = +1.3 (c 0.8, CH2Cl2). HRMS (CI+): calculated for C32H37O6, 
[M+H]+: 517.2590, found: 517.2588. 
 
General procedure B for ring-closing metathesis 
To a solution of the α-alkoxyacrylate in toluene (0.05 M) was added 10 mol % of 
(IMes)(PCy3)Cl2Ru=CHPh (A) and the mixture was stirred under an inert atmosphere at 80 °C for 
4 h. The reaction was ended by exposure to air and removal of the solvent in vacuo. The product was 
purified by column chromatography (EtOAc/heptane, 1:6). 
 
(4R,5S,6R)-Methyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-5,6-dihydro-4H-pyran-2-
carboxylate (27a) 
This compound was synthesized from 23a, following general procedure B. The 
yield was 529 mg (82%). The analytical data agreed with literature data.19 1H-
NMR (CDCl3, 300 MHz): δ 7.34–7.25 (m, 15H), 6.11 (d, J = 3.1 Hz, 1H), 4.82–
4.53 (m, 6H), 4.28 (dd, J = 3.1, 6.2 Hz, 1H), 4.19 (m, 1H), 3.95 (dd, J = 6.2, 8.6 
Hz, 1H), 3.84 (d, J = 3.8 Hz, 2H), 3.81 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 162.6, 144.3, 138.0, 
137.9, 137.8, 128.5, 128.4, 128.3, 127.9, 127.8 (3), 127.6, 108.3, 77.8, 75.4, 73.8, 73.5 (2), 70.9, 67.7, 
52.4. [α]22D = –9.6 (c 0.5, CH2Cl2). 
 
(4R,5S,6R)-Ethyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-5,6-dihydro-4H-pyran-2-carboxylate 
(27b) 
This compound was synthesized from 23b, following general procedure B. The 
yield was 77 mg (80%). 1H-NMR (CDCl3, 300 MHz): δ 7.34–7.24 (m, 15H), 
6.08 (d, J = 3.1 Hz, 1H), 4.82–4.55 (m, 6H), 4.30–4.16 (m, 2H), 4.26 (q, J = 7.2 
Hz, 2H), 3.94 (dd, J = 6.1, 8.4 Hz, 1H), 3.84 (d, J = 3.8 Hz, 2H), 1.32 (t, J = 7.2 
Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 161.8, 144.2, 137.8, 137.7, 137.6, 128.2 (2), 128.1, 127.7, 
127.6 (2), 127.5, 127.4, 107.8, 77.7, 75.5, 73.8, 73.5, 73.4, 71.0, 67.7, 61.5, 14.4. IR (CH2Cl2):  ν 
3029, 2866, 1733, 1652 cm-1. [α]22D = –5.9 (c 0.5, CH2Cl2). HRMS (CI+): calculated for C30H33O6, 
[M+H]+: 489.2277, found: 489.2277.  
 
(4S,5S,6R)-Ethyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-5,6-dihydro-4H-pyran-2-carboxylate 
(28) 
This compound was synthesized from 24, following general procedure B. The 
yield was 17 mg (85%). 1H NMR (CDCl3, 300 MHz): δ 7.34–7.24 (m, 15H), 
6.05 (d, J = 5.5 Hz, 1H), 4.72–4.50 (m, 6H), 4.35 (dt, J = 2.9, 10.0 Hz, 1H), 4.24 
(q, J = 7.1 Hz, 2H), 4.03 (dd, J = 3.8, 5.7 Hz, 1H), 3.88 (d, J = 3.1 Hz, 2H), 3.83 
(dd, J = 3.8, 10.0 Hz, 1H), 1.31 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 161.9, 145.5, 
138.0, 137.9, 137.5, 128.2, 127.8 (2), 127.5, 106.0, 74.4, 73.5, 72.9, 71.8, 71.2, 68.2, 65.9, 61.5, 14.4. 
IR (CH2Cl2): ν 3020, 2872, 1732, 1645 cm-1. [α]25D = +200.5 (c 0.2, CH2Cl2). HRMS (CI+): 
calculated for C30H32O6, [M]+: 488.2199, found: 488.2198. 
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(4R,5R,6R)-Ethyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-5,6-dihydro-4H-pyran-2-carboxylate 
(29) 
This compound was synthesized from 25, following general procedure B. The 
catalyst was added portionwise over 4 h, and the total reaction time was 20 h. 
The yield was 48 mg (51%) and 37 mg (42%) of starting material was recovered. 
1H NMR (CDCl3, 300 MHz): δ 7.30–7.18 (m, 15H), 6.25 (d, J = Hz, 1H), 4.59–
4.43 (m, 6H), 4.24 (q, J = 7.1 Hz, 2H), 4.42 (m, 2H), 4.15 (m, 1H), 3.85 (m, 2H), 1.30 (t, J = 7.1 Hz, 
3H). [α]25D = –58.9 (c 0.1, CH2Cl2). HRMS (CI+): calculated for C30H33O6, [M+H]+: 489.2277, found: 
489.2275.20 
 
(4S,5R,6R)-Ethyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-5,6-dihydro-4H-pyran-2-carboxylate 
(30) and (5S,6R,7R)-ethyl 5,6-bis(benzyloxy)-7-(benzyloxymethyl)-4,5,6,7-tetrahydrooxepine-2-
carboxylate (31) 
The reaction was carried out according to general 
procedure B, using 26 and 20 mol % of catalyst, which 
was added portionwise. 1H NMR showed a mixture of 
two products in a ratio of 1:0.45, which could not be 
separated by column chromatography. After separation 
by preparative HPLC, the isolated products were identified as 30 (major) and 31 (minor). The 
combined yield was 54%. 30: 1H NMR (CDCl3, 300 MHz): δ 7.36–7.21 (m, 15H), 6.12 (dd, J = 1.5, 
5.1 Hz, 1H), 4.59–4.43 (m, 6H), 4.23 (q, J = 7.2 Hz, 2H), 4.17 (m, 1H), 3.84 (m, 2H), 3.75 (m, 2H), 
1.30 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 162.3, 145.8, 138.0, 137.9, 137.6, 128.5, 
128.4 (2), 128.2, 128.0, 127.9, 127.7 (2), 106.5, 73.9, 73.4, 72.5, 71.8, 70.5, 67.8, 67.7, 61.4, 14.1. IR 
(CH2Cl2):  ν 3022, 2930, 1726, 1637 cm-1. [α]22D = +61.2 (c 0.24, CH2Cl2). HRMS (EI+): calculated 
for C30H32O6, [M]+: 488.2199, found: 488.2190. 31: 1H NMR (CDCl3, 400 MHz): δ 7.32–7.25 (m, 
15H), 6.17 (dd, J = 5.0, 7.0 Hz, 1H), 4.75–4.47 (m, 6H), 4.30 (dt, J = 1.9, 6.6 Hz, 1H), 4.18 (q, J = 
7.2 Hz, 2H), 3.89 (m, 2H), 3.79 (dd, J = 5.5, 10.0 Hz, 1H), 3.71 (dd, J = 6.6, 10.0 Hz, 1H), 2.60 (ddd, 
J = 2.3, 7.0, 17.1 Hz, 1H), 2.48 (ddd, J = 5.0, 8.9, 17.1 Hz), 1.25 (t, J = 7.2 Hz, 3H). 13C NMR 
(CDCl3, 75 MHz): δ 163.4, 149.3, 138.3, 138.2, 138.0, 128.4, 128.3 (2), 128.0, 127.8, 127.7 (2), 
127.6 (2), 115.8, 81.1, 80.1, 78.4, 73.9, 73.5, 71.6, 69.1, 61.1, 27.0, 14.2. IR (CH2Cl2): ν 3052, 2985, 
1717, 1649 cm-1. [α]22D = +4.5 (c 0.11, CH2Cl2). HRMS (EI+): calculated for C31H35O6, [M+H]+: 
503.2434, found: 503.2427. 
 
((2R,3R,4S,E)-2-Methoxy-6-phenylhex-5-ene-1,3,4-triyl)tris(oxy)tris(methylene)-tribenzene (34) 
To a solution of 3314 (4.4 mg, 10.2 μmol) in toluene (1 mL) was added 
(IMes)(PCy3)Cl2Ru=CHPh (A, 8.7 mg, 1.0 equiv) and the mixture was stirred 
under an inert atmosphere at 80 °C. After 18 h the reaction was exposed to air 
and the solvent was removed in vacuo. The product was purified by column 
chromatography (EtOAc/heptane, 1:10). The isolated yield of 34 was 74%. 1H-NMR (CDCl3, 300 
MHz): δ 7.40-7.23 (m, 20H), 6.61 (d, J = 16.2 Hz, 1H), 6.19 (dd, J = 8.2, 16.2 Hz), 4.88-4.61 (m, 
3H), 4.39 (m, 3H), 4.27 (m, 1H), 3.71 (d, J = 6.2 Hz, 1H), 3.53 (m, 3H), 3.38 (s, 3H). 13C-NMR 
(CDCl3, 75 MHz): δ 138.8, 138.5, 138.1, 136.5, 133.7, 128.6, 128.5, 128.3 (2), 128.2, 128.0, 127.9, 
127.8, 127.6, 127.5, 127.1, 126.6, 81.9, 81.5, 80.1, 75.3, 73.3, 70.7, 69.2. [α]22D = +10.3 (c 0.3, 
CHCl3). HRMS (CI+): calculated for C34H37O4, [M+H]+: 509.2692, found: 509.2708. 
 
(4R,5S,6R,E)-benzhydryl 4,5,6,7-tetrahydroxyhept-2-enoate (41) 
This compound was prepared from D-arabinose according to literature 
procedures.16 The yield was 5.78 g (81%). 1H-NMR (DMSO-d6/D2O 20:1, 
300 MHz): δ 7.40–7.23 (m, 10H), 7.08 (dd, J = 4.3, 15.6 Hz, 1H), 6.75 (s, 
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1H), 6.15 (dd, J = 2.2, 15.6 Hz, 1H), 4.43 (ddd, J = 1.9, 2.2, 4.3 Hz, 1H), 3.48 (dd, J = 1.9, 9.4 Hz, 
1H), 3.43 (dd, J = 1.1, 9.4 Hz, 1H), 3.39 (br s, 1H), 3.32 (br d, J = 1.7 Hz, 1H). 
 
(3R,4R,5S)-3,4-dihydroxy-5-((1R,2R)-1,2,3-trihydroxypropyl)-dihydrofuran-2(3H)-one (38) 
This compound was prepared from 41 according to literature procedures.16 The 
yield of 38 was 299 mg (70%). The diastereomeric ratio was 7:1, according to 
13C-NMR. 1H-NMR (D2O, 300 MHz): δ 4.58 (d, J = 9.2 Hz, 1H), 4.49 (d, J = 8.5 
Hz, 1H), 4.33 (dd, J = 8.5, 9.2 Hz, 1H), 3.78 (m, 1H), 3.72–3.58 (m, 3H). 13C-NMR 
(D2O, 75 MHz): δ 176.1, 79.6, 73.9, 72.6, 70.9, 67.5, 63.0. [α]25D = –71.9 (c 1.0, 
H2O). 
 
(3R,4R,5R)-5-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-3,4-dihydroxy-
dihydrofuran-2(3H)-one (42) 
To a solution of 38 (625 mg, 3.12 mmol) in acetone (50 mL) was added 2,2-
dimethoxypropane (3.5 mL, 28.5 mmol) and p-toluenesulfonic acid monohydrate 
(100 mg, 0.53 mmol). The reaction was stirred at room temperature for 2 h, after 
which the mixture was concentrated in vacuo. The product was purified by column 
chromatography (EtOAc/MeOH, 98:2). The yield was 532 mg (71%). 1H-NMR 
(D2O, 300 MHz): δ 4.67 (dd, J = 2.1, 6.9 Hz, 1H), 4.44 (m, 1H), 4.34–4.22 (m, 2H), 4.11 (dd, J = 4.6, 
8.6 Hz, 1H), 3.88 (dd, J = 0.8, 7.5 Hz, 1H), 1.49 (s, 3H), 1.43 (s, 3H). 13C-NMR (D2O, 75 MHz): δ 
175.2, 109.9, 79.4, 74.6, 73.4, 72.1, 67.6, 65.9, 25.6, 24.2. 
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Total syntheses of DAH, KDO and  
2-deoxy-β-KDO 
 
 
 
5.1 Introduction 
 
The 3-deoxy-2-ulosonic acids (e.g. 1–3, Figure 5.1) constitute a family of 
carbohydrates that are encountered in a wide variety of biological systems. For instance, 
3 deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN, 3a) was first discovered in fish 
egg membranes,1 but was later also encountered in mammalian cells and tissues, including 
human red blood cells.2,3 The well known N-acetylneuraminic acid (Neu5Ac, 3b) and its 
many derivatives are often located at the terminus of cell-surface oligosaccharides and 
therefore play an essential role in cell-to-cell communication.3,4 This important function has 
made Neu5Ac a popular starting point for the development of neuramidase inhibitors.5 For 
instance, zanamivir (4; Relenza™, GlaxoSmithKline) is currently being marketed for the 
treatment of influenza.6 
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Figure 5.1. Most common members of the family of 3-deoxy-2-ulosonic acids. 
 
Furthermore, 3-deoxy-D-arabino-2-heptulosonic acid (DAH, 1) is a key 
intermediate in the biosynthesis of aromatic metabolites in plants and micro-organisms 
(shikimate pathway). Disruption of the shikimate pathway through enzyme inhibition is 
considered to be an attractive approach in medicinal chemistry, since it represents a 
potentially new strategy toward antibacterial agents.7 In the biosynthetic pathway the 
5 
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phosphate of DAH (DAH7P) is formed through stereoselective condensation of 
phosphoenolpyruvate with D-erythrose by the enzyme DAH7P synthase and transformed in 
a series of steps to dehydroquinate by dehydroquinate synthase (Figure 5.2).8 The recent 
publication of the crystal structures of DAH7P synthase9 and dehydroquinate synthase10 
may provide new opportunities for the design and synthesis of novel enzyme inhibitors.11 
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Figure 5.2. Basic representation of the shikimate pathway. 
 
3-Deoxy-D-manno-2-octulosonic acid (KDO, 2) is an essential component of the 
cell wall lipopolysaccharides (LPS) of all gram-negative bacteria, which are generally less 
susceptible to antibacterial agents than gram-positive bacteria.12 More specifically, KDO is 
the connecting element between the lipophilic part of LPS (lipid A) and the core 
oligosaccharides. The enzyme KDO8P synthase catalyzes the formation of the 8-phosphate 
of KDO from D-arabinose-5-phosphate and phosphoenolpyruvate (Figure 5.3a). This 
conversion is remarkably similar to the role of DAH7P synthase in the shikimate pathway 
(see Figure 5.2). However, even though both enzymatic transformations appear to stem 
from a common ancestor,13 recent publications suggest distinct differences in active sites 
and catalytic mechanisms.14  
Subsequent condensation of KDO with cytidine-5'-triphosphate (CTP) is 
performed by the enzyme CMP-KDO synthetase (CKS), forming the labile cytidine 
5'-monophospho-KDO compound (CMP-KDO, Figure 5.3a). This transformation is 
believed to be the rate-determining step in the biosynthesis of LPS,15 thereby rendering it an 
interesting target in the development of antibiotics. Particularly, the elucidation of a crystal 
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structure of CKS incorporating a CMP-KDO moiety (Figure 5.3b),16 has increased the 
interest in structure-based design of new enzyme inhibitors. 
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Figure 5.3. (a) Role of KDO in LPS biosynthesis. (b) Part of the X-ray structure of CMP-KDO synthase, 
including a CMP-KDO molecule as substrate.16 
 
A good example of the potential of this approach is the 
identification of 2-deoxy-β-KDO (5a) as a potent inhibitor of CKS.17 
Despite its high inhibitory activity, 5a was found not to cross the 
cytoplasmic membrane, thereby failing to kill bacteria. However, 
coupling of an L-L-dipeptide to the 8-amino analogue of 2-deoxy-β-
KDO (5b) enabled it to be transported through the membrane by certain peptide permeases. 
Subsequent hydrolysis of the peptide tail resulted in release of the enzyme inhibitor, 
eventually leading to bacterial death.18 
The rapid increase in drug-resistant bacteria clearly emphasizes the need for 
development of new classes of antibiotics. Biosynthetic pathways that take place in micro-
organisms, but are absent in mammal physiology, such as the shikimate pathway and LPS-
biosynthesis, evidently form attractive pharmaceutical targets. Therefore, it is not surprising 
that the development of efficient synthetic routes to DAH, KDO and derivatives has been of 
broad interest over the past years.19 A number of syntheses of KDO have already been 
O
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reported, including enzymatic approaches,20 de novo syntheses21 and routes using 
carbohydrates as starting materials.22 In addition, syntheses of DAH have also been 
published, although they are somewhat less abundant in literature.23 
 
5.2 Unsuccessful approaches to functionalize the glycal 
intermediates 
 
Initial attempts to complete the synthesis of DAH (1) were based on modification 
of a glycal intermediate in earlier reported syntheses of KDO (2).24,25 These approaches 
required the preparation of the saturated counterpart of 6a (i.e. 7), which in our case could 
be generated by selective hydrogenation of the double bond of 6a with Pd/C and H2 in the 
presence of triethylamine. Conversely, carrying out this procedure in the absence of 
triethylamine resulted in quantitative hydrogenation, accompanied by removal of the benzyl 
groups, leading to compound 8 (Scheme 5.1). 
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Scheme 5.1. Double bond reduction in 6a with or without concurrent debenzylation; a Based on 1H-NMR. 
 
Next, the lithium enolate of 7 could be generated (LDA, THF, –78 °C → rt), but 
did not exhibit any reactivity toward several electrophilic reagents, including 
MoO5·Py·HMPA (MoOOPH),24,26 PhSSPh25 and PhSeCl (Scheme 5.2). Since the lithium 
enolate had clearly been formed,27 we attribute this lack of reactivity to steric hindrance. 
The large influence of steric factors may be rationalized by considering the size of the 
electrophilic reagents and the fact that a quaternary center needs to be formed. 
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Scheme 5.2. Attempted electrophilic substitution of 7 via the lithium enolate; Nu = MoOPH, PhSeCl, PhSSPh. 
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The lack of further literature precedent inspired us to actually take advantage of 
the reactivity of the double bond in 6. Initially, we attempted to hydrate 6b28 under acidic 
conditions in water, which would yield compound 9 (Table 5.1). The use of CSA or PTSA 
(entries 1 and 2) did not result in any reaction, while switching to HCl resulted in 
decomposition (entry 3). When carried out in ethanol instead of water, the reaction 
proceeded extremely slowly and produced only 25% of the desired acetal 10 after 4 days 
(entry 4). Optimization of this reaction in a microwave did not result in a significant 
improvement (entries 5–7). The optimal yield (39%) was obtained at 120 °C and under 
continuous cooling of the reaction vessel (entry 6). Finally, higher temperatures (entry 7) or 
the use of H2SO4 (entry 8) did not improve the results either. 
 
Table 5.1. Acidic hydration or acetal formation from 6b. 
H+
ROH O
OBn
OBn
H
OBnEtO2C
RO
9 (R = H)
10 (R = Et)
O
OBn
OBn
H
OBn
EtO2C
6b
 
entry acid conditions time producta yield (%) 
1 CSA THF/H2O, 60 °C 18 h 9 0b 
2 PTSA THF/H2O, 60 °C 18 h 9 0b 
3 HCl acetone/H2O, 60 °C 18 h 9 decomp. 
4 HCl EtOH, 70 °C 4 d 10 25 
5 HCl EtOH, μWc, 120 °C 50 min 10 30 
6 HCl EtOH, μWc, 120 °Cd 20 min 10 39 
7 HCl EtOH, μWc, 150 °C 30 min 10 27 
8 H2SO4 EtOH, μWc, 120 °C 20 min 10 decomp. 
a Mixture (1:1) of diastereoisomers. b No reaction. c Microwave conditions: closed vessel, 300 W. d Under 
continuous cooling of the vessel. 
 
 The remaining amount of starting material 6b was in all cases (i.e. entries 4–7) 
lower than 30%, indicating that substantial decomposition took place during all microwave 
reactions. In addition to these unsatisfactory results, hydrolysis of the resulting acetal 
appeared to be extremely problematic. Reaction of 10 with Dowex 50X2-400 or Amberlite 
IR-120 ion exchange resins in acetone/H2O at 80 °C resulted in complete hydrolysis of the 
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ester, while the ethyl acetal remained largely intact. Moreover, hydrolysis of 10 with HCl in 
acetone/H2O at 70 °C resulted in decomposition after prolonged reaction times, forcing us 
to abandon this acid-based approach. 
 
5.3 Completion of the synthesis of DAH 
 
In the end, we were pleased to find that by applying the electrophilic reagent N-
iodosuccinimide (NIS), glycal 6a could be efficiently functionalized. Upon treatment with 
NIS in acetonitrile/water at 40 °C,29 6a was converted into iodohydrin 11, which was 
isolated as a 1:1 mixture of diastereoisomers in an excellent yield of 93% (Scheme 5.3). 
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Scheme 5.3. Conversion of glycal 6a into protected DAH (12). 
 
Subsequent removal of the iodide could be carried out via two methods (Scheme 
5.3). First of all, treatment of 11 with Bu3SnH/AIBN in toluene yielded the protected form 
of DAH (12) in 66%. Alternatively, reaction of 11 under hydrogenation conditions in the 
presence of triethylamine gave 12 in a yield of 89% (83% from 6a). Omitting the 
triethylamine gave comparable results, which is rather surprising, considering the fact that 
benzyl protecting groups are generally removed under these conditions. 
As already predicted by this result, deprotection of 12 proved to be somewhat less 
trivial than expected. Despite literature precedent,22d in our hands removal of the benzyl 
protecting groups did not occur under regular hydrogenation conditions using Pd/C or 
Pd(OH)2/C, in combination with different solvents (EtOAc, EtOH, HOAc) and pressures up 
to 50 bar. Reaction of 12 with BCl3 did result in debenzylation, but the isolated yields never 
exceeded 60%. On the other hand, when carrying out the hydrogenation procedure with 
Degussa type Pd/C (H2O content 50%), complete deprotection took place within 1 h at 
room temperature under atmospheric pressure (Scheme 5.4). Saponification of the ester 
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then gave DAH (1)30 in an overall yield of 39% over 8 steps, starting from commercially 
available protected D-arabinose. 
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Scheme 5.4. Final deprotection steps for DAH (1). 
 
5.4 Investigation of the Michael acceptor ability of the 
substituted glycals 
 
 Before applying the efficient iodohydrin formation/hydrogenation sequence in a 
total synthesis of KDO (2), we decided to take a closer look at the reactivity of the glycal 
double bond. From the results in the previous section, it can be concluded that the double 
bonds in the substituted glycals are moderately nucleophilic, reacting readily with NIS, but 
significantly slower with acids. To further investigate the synthetic potential of these 
building blocks we decided to investigate if they might actually react as Michael acceptors. 
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Scheme 5.5. Attempted conjugate addition on glycal 13. 
 
 Unfortunately, treatment of 13 – the anticipated precursor for 2 – with 
MeMgBr/CuBr·SMe2 in THF at temperatures ranging from –78 °C up to 50 °C did not 
result in any conversion, nor did the reaction with PhSH/NaH (Scheme 5.5). When reacting 
13 with an excess of MeMgBr in the absence of CuBr·SMe2, selective double 1,2-addition 
occurred, leading to isolation of compound 14 in 89%. Evidently, these brief explorations 
suggest that conjugate addition to the double bond of these glycals is extremely difficult, if 
not impossible. 
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5.5 Completion of the syntheses of KDO and 2-deoxy-β-KDO 
 
 Encouraged by the efficient functionalization of the glycal double bond via the 
described iodohydrin formation/hydrogenation sequence, we decided to apply the same 
methodology in the total synthesis of KDO (2). First of all, the potential of the heterocyclic 
intermediate 13 was further demonstrated by quantitative hydrogenation of the double 
bond, selectively yielding protected 2-deoxy-α-KDO. This can then be epimerized and 
deprotected via a reported procedure24 to give 2-deoxy-β-KDO (5a) (Scheme 5.6). 
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Scheme 5.6. Completion of the synthesis of KDO (2) and 2-deoxy-β-KDO (5a). 
 
Moreover, reaction of glycal 13 with NIS appeared to proceed as anticipated at 
60 °C, giving rise to the corresponding iodohydrin, although substantial product 
decomposition was observed when the reaction was left stirring for longer than 4 h. 
Removal of the iodide also required certain optimization . Triethylamine was required in 
the hydrogenation to scavenge the liberated HI, but these mildly basic conditions led to 
partial substitution of the iodide by methanol as well. Switching to a mixture of isopropyl 
alcohol and ethyl acetate solved this problem so that protected KDO (15) could be isolated 
in a yield of 75% from 13. This NIS-based conversion now represents a significantly more 
efficient alternative to the known methods, which rely on enolate formation of the 
hydrogenated form of 13, followed by introduction of an oxygen or sulfur electrophile.24,25 
Perhaps more importantly, this mild method might even be applicable to complex 
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oligosaccharides, in which such a glycal unit is incorporated. Finally, general deprotection 
conditions converted 15 into KDO (2), which was isolated and analyzed as its ammonium 
salt.31 The overall yield of KDO (2) was 44% over 8 steps, starting from commercially 
available protected D-mannose. 
 
5.6 Conclusion 
 
In conclusion, we have shown that the highly functionalized glycals, described in 
the previous chapter, can be efficiently converted into 3-deoxy-2-ulosonic acids. This 
relatively mild sequence converts the glycals into the corresponding iodohydrins, which are 
subsequently deiodinated under hydrogenation conditions. This novel 2-step procedure now 
represents a milder and more efficient alternative to the methods used so far, making it 
potentially suitable for application in more elaborate oligosaccharides.  
The viability of the complete RCM-based synthetic pathway was proven by 
completion of the syntheses of the natural products DAH and KDO, as well as that of 
2-deoxy-β-KDO – a potent inhibitor of CMP-KDO synthetase – from natural sugars. These 
synthetic routes are now among the shortest and most efficient ones reported to date.32 
 
5.7 Experimental section 
 
General information 
For general experimental details, see Section 2.8. 
The syntheses of 6a–b and 13 are described in Chapter 4. 
 
(2R,4R,5S,6R)-Methyl 4,5-di(benzyloxy)-6-[(benzyloxy)methyl]tetrahydro-2H-pyran-2-
carboxylate (7) 
A solution of 6a (63 mg, 0.129 mmol) in EtOAc/MeOH/Et3N (50:50:1; 10 ml) 
was treated with 10% Pd/C (20 mg) and H2 (1 atm) for 1 h. The mixture was 
filtered over Celite, concentrated in vacuo and the product was purified by 
column chromatography (EtOAc/heptane, 1:4). The yield was 60 mg (95%). 
The analytical data agreed with those reported in literature.33 1H-NMR (CDCl3, 300 MHz): δ 7.36–
7.17 (m, 15H), 4.90–4.53 (m, 6H), 4.01 (dd, J = 2.0, 12.1 Hz, 1H), 3.80 (s, 3H), 3.78-3.65 (m, 3H), 
3.55–3.45 (m, 2H), 2.49 (ddd, J =  2.0, 4.9, 12.8 Hz, 1H), 1.71 (q, J = 12.2 Hz, 1H). 13C-NMR 
(CDCl3, 75 MHz): δ 170.0, 138.0, 128.2, 128.1 (2), 127.8, 127.7, 127.5 (2), 127.4, 127.3, 80.5, 79.3, 
77.8, 75.1, 74.4, 73.4, 71.5, 69.1, 52.4, 34.0. [α]22D = +10.6 (c 0.5, CH2Cl2). 
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(4R,5S,6R)-methyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-ethoxy-tetrahydro-2H-pyran-2-
carboxylate (10) 
To a solution of 6b (33 mg, 68 μmol) in EtOH (5 mL) was added concentrated 
HCl (0.1 mL). The reaction was stirred in a closed vessel at 65 °C for 4 days. 
Next, H2O was added (5 mL) and the mixture was extracted with EtOAc (3 × 5 
mL). The product was purified by column chromatography 
(EtOAc/heptane/Et3N, 10:90:0.5) and isolated as an inseparable mixture of diastereoisomers (~ 1:1). 
The yield was 9.0 mg (25%). 1H-NMR (CDCl3, 300 MHz): δ 7.37–7.18 (m, 15H), 4.88 (dd, J = 2.4, 
10.8 Hz, 1H), 4.71–4.54 (m, 5H), 4.27 (q, J = 7.1 Hz, 1H), 4.25 (q, J = 7.1 Hz, 1H), 3.80–3.52 (m, 
6H), 3.39 (dd, J = 1.8, 7.1 Hz, 0.5H), 3.36 (dd, J = 1.8, 7.0 Hz, 0.5Hz), 2.57 (dd, J = 5.1, 13.0 Hz, 
0.5H), 2.48 (dd, J = 5.1, 13.0 Hz, 0.5H), 1.73 (dd, J = 11.2, 13.0 Hz, 1H), 1.64 (dd, J = 11.2, 13.0 Hz, 
0.5H), 1.31 (t, J = 7.1 Hz, 1.5H), 1.30 (t, J = 7.1 Hz, 1.5H), 1.21 (t, J = 7.0 Hz, 1.5H), 1.18 (t, J = 7.0 
Hz, 1.5H). 
 
(4S,5S,6R)-Methyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-hydroxy-3-iodo-tetrahydro-2H-
pyran-2-carboxylate (11) 
A solution of 6a (425 mg, 0.896 mmol) and N-iodosuccinimide (301 mg, 1.34 
mmol) in MeCN (25 mL) and H2O (10 mL) was stirred for 4 h at 40 °C. Next, 
the solvent was removed in vacuo and the products were purified by column 
chromatography (EtOAc/heptane, 1:6). The product was isolated as a mixture 
(~ 1:1) of two diastereoisomers. A small portion of the mixture was separated for analytical purposes. 
The combined yield of both isomers was 514 mg (93%). First diastereomer: 1H-NMR (CDCl3, 300 
MHz): δ 7.43-7.15 (m, 15H), 4.99-4.79 (m, 3H), 4.59-4.35 (m, 4H), 4.12 (m, 1H), 4.02 (dd, J = 9.0, 
11.5 Hz, 1H), 3.89 (s, 3H), 3.73 (m, 2H), 3.62 (dd, J = 2.0, 11.3 Hz, 1H). 13C-NMR (CDCl3, 75 
MHz): δ 168.9, 138.0, 137.8 (2), 128.4 (2), 128.3, 128.0, 127.9, 127.8, 127.7 (2), 127.6, 96.1, 82.2, 
79.3, 75.5, 75.0, 74.2, 73.4, 68.2, 54.0, 30.8. [α]22D = +3.9 (c 0.9, CH2Cl2). Second diastereoisomer: 
1H-NMR (CDCl3, 300 MHz): δ 7.41-7.14 (m, 15H), 4.88-4.48 (m, 7H), 4.09 (m, 2H), 3.88-3.72 (m, 
3H), 3.84 (s, 3H), 3.46 (dd, J = 4.1, 8.7 Hz, 1H). 13C-NMR (CDCl3, 75 MHz): δ 168.9, 138.2, 138.0, 
137.5, 128.4, 128.3 (2), 128.1, 128.0, 127.9 (2), 127.7, 127.5, 96.9, 76.7, 75.7, 75.2, 74.0, 73.4, 70.8, 
68.7, 53.1, 35.0. [α]22D = –10.1 (c 0.9, CH2Cl2). Mixture: IR (CH2Cl2): ν 3030, 2981, 2870, 1725, 
1264, 1186 cm-1. HRMS (ESI+): calculated for C29H31O7INa, [M+Na]+: 641.1012, found: 641.1000. 
 
(4R,5S,6R)-Methyl 4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-hydroxy-tetrahydro-2H-pyran-2-
carboxylate (12) 
Method 1: To a solution of 11 (33.0 mg, 53.5 μmol) in toluene (10 mL) were 
added Bu3SnH (16 μL, 59.1 μmol) and AIBN (1.4 mg, 8.5 μmol) and the 
mixture was stirred at 80 °C. After 18 h, the solvent was evaporated and the 
product was purified by column chromatography (EtOAc/heptane, 1:6). The 
yield was 17.4 mg (66%). Method 2: A solution of 11 (49.5 mg, 80.0 μmol) and Et3N (35 μL, 0.25 
mmol) in MeOH (8 mL) was treated with 10% Pd/C (9 mg) and H2 (1 atm) for 18 h. After the 
reaction, the mixture was filtered over Celite, concentrated and the product was purified by column 
chromatography (EtOAc/heptane, 1:4). The yield was 35 mg (89%). 1H-NMR (CDCl3, 300 MHz): δ 
7.33–7.17 (m, 15H), 4.92–4.48 (m, 6H), 4.03 (m, 2H), 3.83 (s, 3H), 3.78–3.64 (m, 3H), 3.60 (dd, J = 
9.0, 9.8 Hz, 1H), 2.28 (dd, J = 5.0, 12.6 Hz, 1H), 2.09 (t, J = 12.2 Hz, 1H). 13C-NMR (CDCl3, 75 
MHz): δ 170.0, 138.2 (2), 138.0, 128.2, 128.1, 127.7, 127.6, 127.5, 127.4 (2), 94.9, 78.0, 77.6, 75.0, 
73.4, 73.1, 71.9, 69.0, 53.4, 36.3. IR (CH2Cl2): ν 3052, 2987, 1754 cm-1. [α]22D = +46.0 (c 0.2, 
CH2Cl2). HRMS (CI+): calculated for C29H32O7, [M+H]+: 493.2226, found: 493.2228.  
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3-Deoxy-D-arabino-2-heptulopyranosonic acid (DAH) (1) 
A solution of 12 (6.2 mg, 12.6 μmol) in MeOH (1.5 mL) was treated with 10% 
Pd/C (Degussa type E101 NE/W, H2O content 50%; 3 mg) and H2 (1 atm) for 1 
h. 1H NMR of the reaction mixture showed a quantitative conversion. The 
mixture was filtered over Celite and concentrated. The resulting DAH ester was 
dissolved in 1N NaOH (4 mL) and stirred at room temperature for 1 h. The mixture was neutralized 
with Amberlite IR-120, filtered and concentrated. The resulting solid was washed with EtOAc and 
dried, giving 1 in a yield of 2.6 mg (99%). The analytical data were in agreement with reported data.30 
1H-NMR (D2O, 400 MHz): δ 3.98–3.92 (m, 1H) 3.84–3.74 (m, 3H), 3.45 (t, J = 9.3 Hz, 1H, 5H), 2.20 
(dd, J = 5.1, 13.0 Hz, 1H, 3-H), 1.79 (t, J = 12.5 Hz, 1H, 3-H). [α]22D = +41.5 (c 0.25, D2O). 
 
2-((3aR,4R,7aR)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-4,7a-dihydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6-yl)propan-2-ol (14) 
To a solution of 13 (14.5 mg, 46.1 μmol) in THF (2 mL) was added MeMgBr 
(3M in Et2O, 1.25 equiv) and the reaction was stirred at room temperature. After 
1 h an additional 1.25 equiv of MeMgBr was added and after a total reaction 
time of 2 h TLC showed a complete conversion. The mixture was concentrated 
and the product was purified by column chromatography (EtOAc/heptane, 1:4). 
The yield was 12.9 mg (89%). 1H-NMR (CDCl3, 300 MHz): δ 4.96 (dd, J = 1.2, 
3.2 Hz, 1H), 4.40 (m, 2H), 4.11 (m, 2H), 3.76 (m, 1H), 3.47 (br, 1H), 1.42 (s, 3H), 1.39 (s, 3H), 1.38 
(s, 3H), 1.36 (s, 3H), 1.33 (s, 3H), 1.32 (s, 3H). 
 
(3aR,4R,7aR)-Methyl 4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-6-hydroxy-2,2-dimethyl-
tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-carboxylate (15) 
A solution of 13 (40 mg, 0.128 mmol) and N-iodosuccinimide (63 mg, 0.282 
mmol) in MeCN (6 mL) and H2O (1.5 mL) was stirred for 2 h at 60 °C. Next, 
the solvent was removed in vacuo and the product was purified by column 
chromatography (EtOAc/heptane, 1:6), yielding 53 mg (91%) of the 
iodohydrin. The product was a single isomer, the absolute configuration of 
which was not determined. 1H-NMR (CDCl3, 300 MHz): δ 4.56 (dd, J = 5.0, 
9.5 Hz, 1H), 4.35 (m, 2H), 4.26–4.15 (m, 3H), 4.04–3.88 (m, 2H), 3.88 (s, 3H), 1.55 (s, 3H), 1.20 (s, 
3H), 1.39 (s, 3H), 1.34 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 163.1, 109.4 (2), 95.9, 78.2, 73.8, 73.2, 
70.0, 66.8, 54.2, 30.4, 28.6, 27.1, 26.4, 25.6. HRMS (CI+): calculated for C15H24O9I [M+H]+: 
459.0516, found: 459.0501. A solution of the iodohydrin (53 mg, 0.116 mmol) and Et3N (18 μL, 
0.127 mmol) in EtOAc (5 mL) and iPrOH (5 mL) was treated with 10% Pd/C (7 mg) and H2 (1 atm) 
for 18 h. After the reaction, the mixture was filtered over Celite, concentrated and the product was 
purified by column chromatography (EtOAc/heptane, 1:4). The yield of 15 was 32 mg (75% from 
13). The analytical data agreed with those reported in literature.34 1H-NMR (CDCl3, 300 MHz): δ 
4.49 (m, 1H), 4.34 (ddd, J = 4.5, 6.2, 8.3 Hz, 1H), 4.25 (dd, J = 2.4, 6.4 Hz, 1H), 4.07 (dd, J = 6.2, 8.8 
Hz, 1H), 3.97 (dd, J = 4.5, 8.8 Hz, 1H), 3.88 (dd, J = 2.4, 8.3 Hz, 1H), 3.80 (s, 3H), 3.50 (br, 1H), 
2.49 (dd, J = 6.6, 14.5 Hz, 1H), 1.89 (dd, J = 5.0, 14.5 Hz, 1H), 1.45 (s, 3H), 1.41 (s, 3H), 1.36 (s, 
3H), 1.35 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 169.8, 109.3, 109.1, 94.4, 73.8, 71.3, 70.8, 69.8, 
67.0, 53.3, 32.6, 27.2, 27.1, 25.9, 25.5. IR (CH2Cl2): ν 3520, 3002, 2977, 1751, 1450 cm-1. [α]22D = 
+20.1 (c 0.25, CH2Cl2). HRMS (EI+): calculated for C15H24O8, [M]+: 332.1471, found: 332.1473. 
 
3-Deoxy-D-manno-2-octulosonic acid (KDO), ammonium salt (2.NH3) 
A solution of 15 (5.9 mg, 17.7 μmol) in 90% aqueous acetic acid (5 mL) was 
heated to 90 °C for 45 min. Next, the mixture was concentrated in vacuo and 
the residue was dissolved 0.1M aqueous NaOH. The reaction was stirred at 
room temperature for 1 h, followed by the addition of Amberlite IR-120. 
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After stirring for 30 min, the ion-exchange resin was filtered off and concentrated ammonia was 
added to obtain a pH of 11. The mixture was again stirred for 30 min, after which the solvent was 
evaporated, yielding the ammonium salt of 2 (4.2 mg, 99%). As expected,12,31 the 1H NMR spectrum 
in D2O showed a complicated mixture of the α- and β-furanose and -pyranose forms, as well as traces 
of lactone forms. The spectrum and the optical rotation agreed with those of a purchased sample and 
with literature data. [α]22D = +38.8 (c 0.4, H2O) [purchased sample [α]22D = +38.0 (c 0.5, H2O); lit.31a 
[α]21D = +39.5 (c 1.2, H2O)]. 
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Ring-closing metathesis of 
dehydroamino acids 
 
 
 
6.1 Introduction 
 
 Non-proteinogenic α,β-dehydroamino acids are encountered in a range of natural 
products with important biological activities.1 Their occurrence in nature, in combination 
with their interesting and diverse reactivity, has inspired many chemists to develop 
methodology to synthesize dehydroamino acids and study their behavior.2 Conceptually, a 
dehydroalanine fragment consists of a double bond substituted with both an electron-
donating and an electron-withdrawing group, similar to the α-alkoxyacrylate systems that 
were described in Chapters 3 and 4. Since the ring-closing metathesis (RCM) of these 
systems appeared to be particularly versatile and in view of the successful RCM of regular 
enamides as recently developed by our own group,3 we set out to investigate the metathesis-
behavior of dehydroamino acids.4 Initially, we focused our efforts on the generation of 
nitrogen heterocycles 1 from the corresponding precursors 2 via RCM. If successful, this 
methodology could then be applied to more complex systems, eventually resulting in 
functionalized cyclic dehydroamino acids 3 (Scheme 6.1). 
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Scheme 6.1. Ring-closing metathesis of dehydroamino acids. 
 
 Besides introduction of R substituents, building blocks of type 3 possess a double 
bond representing a useful handle for further functionalization. First of all, hydrogenation 
6 
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leads to the corresponding pipecolic acid derivatives, which are key structural elements in a 
range of natural products and pharmaceutically active compounds.5 In addition, 
dehydroamino acids are reasonably reactive in for instance Michael additions, radical 
additions and cycloadditions, opening up possibilities for functionalization at the 2- and 
3-positions.2 
 
6.2 Precursor synthesis 
 
 We envisaged that the preparation of the ring-closing metathesis precursors could 
in principle be carried out via two retrosynthetic approaches (Scheme 6.2). The first method 
is based on (protected) amines containing an olefinic bond (I). Hence, the challenge in this 
route is transformation of such an amine into a dehydroamino acid moiety. The second 
method uses a protected dehydroalanine fragment (II) as building block. Conversion into an 
RCM-precursor is then performed through N-alkylation of the dehydroalanine with for 
instance an alkyl halide. 
 
CO2RHN
PGNH NPG
CO2R
PG
I II  
Scheme 6.2. Two retrosynthetic approaches to dehydroamino acid based RCM-precursors. 
 
 Our initial efforts focused on the first method, which uses an unsaturated amine as 
building block (I). Starting from N-tosylated allylglycine methyl ester (4), we explored 
three methods for generating the dehydroamino acid fragment (Scheme 6.3). The first 
reaction (eq 1) was based on the method we previously developed for the synthesis of 
α-alkoxyacrylates from alcohols (see Section 3.5). Unfortunately, the only product that was 
isolated was the N-methylated form of 4, leading to the conclusion that substitution of 
bromide 5 did not take place, causing the unreacted nitrogen to react instead with MeI in 
the second step. Switching to K2CO3/acetone produced similar results, forcing us to 
abandon this approach. The second reaction (eq 2) was reported by Trost et al. as a method 
for facilitating nucleophilic addition to the α-position of alkynoates, as opposed to readily 
occurring conjugate addition.6 This method, which relies on the use of PPh3 and a 1:1 
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NaOAc/HOAc buffer, produced the desired product 6, albeit in poor yields (5–11%). 
Furthermore, 6 was accompanied by more or less equimolar amounts of the N-acetylated 
form of 4, which could not be separated by column chromatography. 
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Scheme 6.3. Unsuccessful approaches toward dehydroamino acids from allylglycine. 
 
Finally, the third reaction (eq 3) involved condensation of 7 with methyl pyruvate 
under Dean-Stark conditions. The resulting enamine/imine can then be directly reacted with 
acetyl chloride, forming the acetyl-protected precursor 8.7 Unfortunately, this method was 
not successful either. According to TLC, the starting material disappeared during the 
condensation, however, no clear product formation was observed upon the addition of 
acetyl chloride. At this point it was decided to shift our focus to the other approach, based 
on the alkylation of dehydroalanine fragments II (Scheme 6.2). 
Regarding the dehydroalanine building blocks, we initially focused our attention 
on sulfonamides, because of their suitability for subsequent N-alkylations. Scaffold 10 was 
prepared by reacting serine methyl ester (9) with an excess of p-toluenesulfonyl chloride 
(TsCl) in pyridine. Although TLC showed a complete conversion, 10 was isolated in a yield 
of 29%, which is comparable to that reported by others.8 This low yield can be probably 
attributed to decomposition during workup. As a side product we isolated significant 
amounts of p-toluenesulfonamide (up to 44%). This may be formed by (acid-induced) 
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enamide-imine tautomerization, followed by hydrolysis of the imine, yielding 
p-toluenesulfonamide and methyl pyruvate (Scheme 6.4).9 
 
HN
OMe
OTs
N
OMe
OTs
NH2 O
OMe
O
H2OH3O+
Ts
10  
Scheme 6.4. Possible hydrolysis mechanism for 10. 
 
Finally, using the more reactive 2- and 2,4-nitrobenzenesulfonyl chlorides did not 
yield the desired dehydroalanine either. Instead, mixtures of products were formed directly 
after the addition of one equivalent of the sulfonyl chloride. 
 
I
N
Ts
CO2Me
Br
(  )n
(  )n
11a (n = 1)
11b (n = 2)
NaH, LiI (cat.)
DMF 12a n = 1 (49%)
12b n = 2 (59%)
13
NaH, DMF 14 (22%)
HN CO2Me
Ts
10 (29%)
HCl.H2N CO2Me
9
TsCl (xs)
pyridine
OH
N
Ts
CO2Me
 
Scheme 6.5. Synthesis of RCM-precursors via alkylation of N-Ts-dehydroalanine methyl ester (10). 
 
The N-alkylations of 10 were performed in DMF, with NaH as a base. Reactions 
with K2CO3/acetone and Et3N/DMF did not show any conversion, illustrating the somewhat 
reduced nucleophilicity of the nitrogen in this dehydroamino acid, as compared to regular 
sulfonamides. Reacting 10 with 4-bromo-1-butene (11a) and 5-bromo-1-pentene (11b) 
resulted in the formation of RCM-precursors 12a and 12b in yields of 49 and 59%, 
respectively. In addition, the aromatic iodide 1310 was coupled with 10, resulting in 
precursor 14 (Scheme 6.5). 
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6.3 Ring-closing metathesis of dehydroamino acids 
 
With three precursors in hand, the stage was set for investigation of the behavior 
of these systems under metathesis conditions. The RCM-reactions were performed in 
toluene at 80 °C, with 10 mol % of the 2nd generation Grubbs catalyst (A, Scheme 6.6). 
Gratifyingly, cyclization of 12a proceeded smoothly, resulting in the formation of five-
membered heterocycle 14a in a yield of 78%. In contrast, during the reaction of 12b under 
identical conditions multiple products were formed, none of which could be separated by 
column chromatography. According to LC-MS measurements of the crude mixture the 
desired six-membered ring had not been formed. The analysis did, however, show masses 
corresponding to dimeric species of different lengths, as well as a mass, which 
corresponded to the five-membered ring analogue 15a. This suggests that olefin 
isomerization had taken place, followed by cyclization, resulting in 15a. Furthermore, 
homodimerization/cross-metathesis between 12b and its isomerized forms probably 
explains the observation of several dimers. These side-reactions are comparable to those of 
the α-alkoxyacrylates that were described in Chapter 3. 
 
NTs
N
Ts
CO2Me
A (10 mol %)
PhMe, 80 °C NTs
CO2Me
CO2Me
(  )n
n = 1: 15a (78%)
n = 2: multiple products (incl 15a)
12a n = 1
12b n = 2
14 16 (79%)
N CO2Me
Ts
MesN NMes
Ru
PhPCy3
Cl
Cl
AA (10 mol %)
PhMe, 80 °C
 
Scheme 6.6. RCM-mediated generation of five- and six membered ring heterocycles 
 
 Interestingly, ring-closing metathesis of 14 proceeded without problems in a yield 
of 79%. Apparently, the impossibility of isomerization of 14 in combination with a 
constrained geometry eliminates all side-reactions. Thus, formation of six-membered cyclic 
dehydroamino acids by RCM can indeed occur, if undesired side-reactions can be 
overcome. 
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 An additional problem we encountered during these investigations was the poor 
stability of N-Ts-protected dehydroamino acids. Not only 10 was difficult to isolate (see 
Section 6.2) and prone to decomposition, but also the alkylated forms 12a–b and 14 were 
found to readily degrade over time at –20 °C. For this reason, we decided to shift our 
attention to the Boc-protected analogues during the continuation of this research. 
 
6.4 Introduction of allylic substituents 
 
 During our work on ring-closing metathesis of carbohydrate-derived 
α-alkoxyacrylates, we found that the presence of an allylic substituent in the substrate could 
completely inhibit olefin isomerization (see Chapter 4). In view of the disappointing 
metathesis behavior of compound 12b, we decided to investigate the influence of allylic 
methyl- and phenyl-substituents on the formation of six-membered cyclic dehydroamino 
acids via RCM. 
 
Me
I
Me
CO2H
1) LiAlH4, Et2O
2) I2, PPh3, imidazole
    CH2Cl2
Ph
I
Ph
CO2Et
1) LiAlH4, Et2O
2) I2, PPh3, imidazole
    CH2Cl2
OH
MeC(OEt)3
AcOH
17 18 (74%)
19 20 21 (30%, 3 steps)  
Scheme 6.7. Synthesis of iodides with allylic substituents 
 
 The same approach to the RCM-precursors was followed as for the previously 
described compounds. This required the synthesis of substituted halides 18 and 21, which 
can then be used in the alkylation of the protected dehydroalanine derivative. Methyl-
substituted 18 was prepared from commercially available carboxylic acid 17 by reduction 
with LiAlH4 and subsequent iodination. Johnson orthoester Claisen rearrangement of 
cinnamyl alcohol (19)11 resulted in ester 20, which was transformed into the corresponding 
iodide 21 by the same reduction/iodination procedure (Scheme 6.7). 
 As mentioned earlier, we decided to continue our investigations with Boc-
protected dehydroalanine methyl ester 22. This scaffold was synthesized by Boc-protection 
of serine methyl ester (9), followed by sequential mesylation/elimination (Scheme 6.8). At 
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first, the alkylation of 22 was performed under the conditions that were used for the 
tosylated analogue 10, using DMF and NaH. The yields of these reactions were somewhat 
lower (typically ~40%), prompting the optimization of the alkylation conditions. After 
testing several leaving groups, bases and solvents, it was found that neither of these 
changes improved the yield. Interestingly, a substantial increase in yield was achieved 
when the reaction mixture in DMF was stirred at room temperature for 30 min after the 
addition of NaH, as opposed to deprotonation at –20 °C and warming to 0 °C. Making use 
of these optimized conditions, RCM-precursors 23–25 were synthesized in yields of 64–
77% (Scheme 6.8). Compound 23 was synthesized as an analogue of the tosyl-protected 
compound 12b, which gave poor results during ring-closing metathesis.  
 
CO2MeHN
Boc
R
X
CO2MeNBoc
R
A (10 mol%)
PhMe, 80 °C N
Boc
R
CO2Me
23 R = H (74%)
24 R = Me (77%)
25 R = Ph (64%)
26 R = H (multiple products)
27 R = Me (81%)
28 R = Ph (85%)
21, NaH
DMF
11b (R = H; X = Br)
18 (R = Me; X = I)
21 (R = Ph; X = I)
a
1) Boc2O, Et3N
    CH2Cl2
2) MsCl, Et3N
    CH2Cl2
CO2MeHCl.H2N
OH
22 (77%)9
 
Scheme 6.8. Synthesis of RCM-precursors via alkylation of N-Boc-dehydroalanine methyl ester (22) and 
subsequent cyclization; a a catalytic amount of LiI was added.  
 
 Ring-closing metathesis of 23 under the same conditions as its tosylated analogue 
12b gave similar results. Again multiple products were formed, none of which could be 
identified by LC-MS as the five- or six-membered ring. In addition, reaction of 23 with the 
first generation Grubbs catalyst ((PCy3)2Cl2Ru=CHPh) yielded exclusively the 
corresponding homodimer. This behavior is again analogous to that of the 
α-alkoxyacrylates that were discussed in Chapter 3. 
 In sharp contrast, the cyclization of substituted precursors 24 and 25 proceeded 
smoothly and six-membered heterocycles 27 and 28 could be isolated in yields of 81 and 
85%, respectively. No traces of side products were observed, which is surprising in both 
cases. First of all, it is striking that a single methyl substituent in 24 is apparently sufficient 
to prevent side reactions. Furthermore, 25 was expected to be prone to olefin isomerization 
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due to the position of the phenyl substituent, however, this is clearly not the case. Finally, it 
must be mentioned that compound 27 appeared fairly labile. We found its degradation to be 
caused by ruthenium residues, which remained in the product, even after careful column 
chromatography. Additional workup procedures prior to column chromatography – e.g. 
flushing over silica and stirring with activated carbon12 – solved this problem and resulted 
in the isolation of a stable product. 
 
6.5 Introduction of oxygen substituents 
 
 Since a small substituent at the allylic position is apparently sufficient to facilitate 
the ring-closing metathesis of dehydroamino acids and to prevent olefin isomerization, we 
decided to investigate whether the scope of this reaction could be extended to O-substituted 
substrates. These allylic ethers are notorious for their isomerization behavior, because they 
can easily form the corresponding enol ether, or, in case of allylic alcohols, the ketone or 
aldehyde.13 We decided to focus on substrates containing three protected alcohols as 
substituents, all possessing distinct differences in steric bulk. 
 
CO2Et
OH
CO2Et
29 31 (99%)
MeI, NaOH
DMSO
CO2Et
OTBS
OMOM
30 (97%)
CO2Et
OMe
32 (42%)
TBSCl
imidazole
CH2Cl2
MOMCl, DIPEA
TBAI, CH2Cl2
 
Scheme 6.9. Synthesis of three different building blocks for introduction in RCM-precursors. 
 
 The mutual starting point for the three RCM-precursors was hydroxy ester 29, 
which was prepared via addition of the lithium enolate of ethyl acetate to acrolein.14 Next, 
the alcohol could be transformed into three different side-groups, using standard 
procedures, resulting in the MOMO-, TBSO- and MeO-substituted esters 30–32 (Scheme 
6.9). 
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CO2MeNBoc
RO
22, NaH
DMF
36 R = MOM (76%)
37 R = TBS (66%)
38 R = Me (64%)
OR
I
OR
CO2Et
30 R = MOM
31 R = TBS
32 R = Me
33 R = MOM (62%)
34 R = TBS (48%)
35 R = Me (70%)
1) LiAlH4, Et2O
2) I2, imidazole
     PPh3, CH2Cl2
a
 
Scheme 6.10. Synthesis of RCM-precursors; a DIBALH was used instead of LiAlH4. 
 
 Conversion of the esters into the corresponding iodides was performed using the 
conditions described earlier for compounds 18 and 21, involving sequential 
reduction/iodination. The reduction of 31 with LiAlH4 was accompanied by removal of the 
TBS-group, which is a known problem for TBS-protected β-hydroxy esters.15 The use of 
DIBALH as a reducing agent left the OTBS-group intact, but resulted in a somewhat lower 
overall yield of 34 (48%), compared to those of 33 (62%) and 35 (70%, Scheme 6.10). 
Finally, the coupling of 33–35 to 22 using NaH/DMF, proceeded as expected, yielding the 
RCM-precursors 36–38 in 64–76%. 
 
A (10 mol%)
PhMe
80 °C, 18 h NBoc
OR
CO2Me
39 (27%) 
40 (59%) 
41 (43%)
CO2MeNBoc
RO
R = MOM:
R = TBS:
R = Me:
CO2MeNBoc
RO
+
42 (45%)
43 (34%)
44 (31%)
a
a
a
36
37
38  
Scheme 6.11. RCM and isomerization of allylic ether fragments in dehydroamino acids; a mixture of E/Z-isomers. 
 
 The ring-closing metathesis was again carried out in toluene at 80 °C, using 
10 mol % of catalyst A. In all cases the expected cyclic products (39–41) were formed in 
yields of 27–59%, however, together with significant amounts of non-cyclic isomerized 
starting material (42–44, Scheme 6.11). The resulting enol ethers are apparently not 
cyclized by the catalyst, judging from the absence of smaller ring products. Although the 
isolated amount of isomerized product was comparable (31–45%) for all three substrates, 
the yield of cyclized product varied considerably. The TBSO-functionalized heterocycle 40 
was isolated in an acceptable yield of 59%, whereas 39 and 41 were formed in yields of 
27% and 43%, respectively.  
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In order to gain more insight into the underlying mechanism for the observed 
isomerization of allylic ethers, we decided to monitor the conversion in time by 1H-NMR. 
A 5.0 μM solution of the MeO-substituted precursor 38 and catalyst A (10 mol %) in C6D6 
was heated to 70 °C and a sample was measured every 20 min (Figure 6.1).  
 
0%
20%
40%
60%
80%
100%
0 20 40 60 80 100 120 140
Time (min)
41 (cyclized product)
44 (isomerized product)
33 (starting material)
 
Figure 6.1. Conditions: 38 in C6D6 (5 μM), A (10 mol %), 70 °C. Values are based on 1H-NMR. 
 
 Figure 6.1 clearly shows that the formation of the intended product 41 stops at a 
certain point in time, while the formation of 44 continues until all starting material has been 
consumed. This observation clearly points to a hydride-based mechanism, suggesting that 
the metathesis catalyst decomposes quickly, resulting in a ruthenium hydride species.16 This 
compound is presumably responsible for converting the remaining starting material into the 
isomerized side-product. Furthermore, it is important to note that the isomerization is 
apparently more favored in deuterated benzene than in toluene. The final ratio between 41 
and 44 was 1:5.7 in benzene-d6, whereas it was only 1:0.7 in toluene. This is not completely 
unexpected, since it is known that the generation of a ruthenium-hydride species from 
catalyst A occurs readily in benzene.17 
The use of a number of different solvents and additives that have been reported to 
influence isomerization during olefin metathesis was not particularly successful. THF18a and 
CHCl318b as a solvent completely inhibited metathesis, as did adding Ph3P=O19a and 
(PhO)P(O)(OH)2.19b Ring-closing metathesis in the presence of Ti(i-OPr)420 did proceed, 
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but unfortunately the outcome was not influenced in a positive manner: 41 and 44 were 
formed in yields of 37% and 42%, respectively. 
Very recently, Grubbs and co-workers reported that the addition of certain metal 
hydride scavengers can prevent isomerization during olefin metathesis. For instance, 
substoichiometric amounts of benzoquinones or organic acids were found to completely 
inhibit olefin isomerization during the RCM of diallyl ether in CD2Cl2 at 40 °C.21 Despite 
the fact that the RCM of dehydroamino acids is typically carried out in toluene and at 
elevated temperatures, we decided to investigate the influence of 1,4-benzoquinone on the 
isomerization of the allylic ether moieties under these circumstances. 
 
Table 6.1. RCM in the presence of 1,4-benzoquinone. 
A (10 mol%)
1,4-benzoquinone 
(20 mol%)
PhMe
80 °C, 18 h
N
Boc
R
CO2Me
CO2MeNBoc
R CO2MeNBoc
R
+
23,36-38 26,39-41 42-44  
entry substrate R cyclized 
product  
yield 
(%)a 
isomerized 
product 
yield 
(%)a 
starting 
material (%)a 
1 36 OMOM 39 75 42b 3 22 
2 37 OTBS 40 58 43b 1 41 
3 38 OMe 41 62 44b 0 38 
4 23c H 26 98d n.a. n.a. 2 
a Yields based on 1H-NMR. b Mixture of E/Z-isomers. c Reaction time was 1 h. d Isolated yield was 94%. 
 
 Entries 1-3 in Table 6.1 clearly show that the addition of 20 mol % of 
1,4-benzoquinone almost completely inhibited isomerization of the allylic ether fragments 
of all three substrates. Cyclic products 39–41 were formed in yields of 58–75%, according 
to 1H-NMR. It should be noted, that the addition of the quinone does not necessarily 
increase the absolute yield, as is illustrated by the yield of 58% for 40, compared to 59% in 
the absence of the quinone (Scheme 6.11). This can be explained by the fact that the 
additive scavenges the decomposition product (e.g. the ruthenium hydride), but does not 
inhibit catalyst decomposition itself. Possibly, both cyclization and catalyst decomposition 
are relatively fast for the reaction of 37, meaning that a certain amount of substrate is 
rapidly cyclized anyway, before isomerization gets the upper hand. 
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 The encouraging results of these experiments prompted us to test the unsubstituted 
precursor 23 under the same conditions. Surprisingly, reaction of 23 with A in the presence 
of 1,4-benzoquinone resulted in a nearly quantitative conversion to the desired six-
membered ring 26 (entry 4), whereas without 1,4-benzoquinone no trace of this product 
was observed (Scheme 6.8). Although a complex mixture of products was formed in that 
original attempt, the current results suggest that the cause for those observations is probably 
hydride-based. 
 
6.6 Conclusion 
 
Ring-closing metathesis of dehydroamino acids was found to proceed readily and 
now presents a suitable method for the preparation of a range of five- and six-membered 
nitrogen heterocycles. Olefin isomerization of allylic ether fragments in the starting 
materials was found to be a considerable problem during the formation of 4-O-substituted 
cyclic dehydroamino acids. However, the addition of a catalytic amount of 
1,4-benzoquinone as a hydride scavenger almost completely inhibited this side-reaction. 
Even an attempted cyclization in which a complex mixture of products was formed could 
be optimized by the addition of 1,4-benzoquinone, suggesting that ruthenium hydrides are 
indeed responsible for most, if not all of the observed side-products.22 
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6.8 Experimental section 
 
General information 
For general experimental details, see Section 2.8. 
 
Methyl 2-[(4-methylphenyl)sulfonyl]amino-4-pentenoate (4) 
This compound was prepared from allylglycine, according to a literature procedure.23 
The yield was 47%. 1H NMR (MeOH, 300 MHz): δ 7.57 (d, J = 8.4 Hz, 2H), 7.23 (d, J 
= 8.4 Hz, 2H), 5.62–5.48 (m, 1H), 4.97–4.88 (m, 2H), 3.80 (t, J = 6.7 Hz, 1H), 3.31 (s, HN CO2Me
Ts
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3H), 2.31 (s, 3H), 2.27 (m, 2H). 13C NMR (CDCl3, 75 MHz): 172.4, 144.4, 138.8, 133.4, 130.2, 
127.9, 118.7, 57.1, 52.4, 38.3, 21.5. 
 
Methyl 2-(4-methylphenylsulfonamido)acrylate (10) 
To a solution of serine methyl ester hydrochloride (1.01 g, 6.49 mmol) in pyridine (20 
mL) was added p-toluenesulfonyl chloride (3.93 g, 20.6 mmol) at 0 °C. The mixture 
was stirred at 0 °C for 4 h, and overnight at room temperature. Et2O was added to the 
reaction mixture, and the organic phase was washed with 1M HCl and H2O. The organic layer was 
dried (MgSO4) and concentrated in vacuo. The product was purified by column chromatography 
(EtOAc/heptane, 1:2). The isolated yield was 472 mg (29%). 1H-NMR (CDCl3, 300 MHz): δ 7.72 (d, 
J = 8.1 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 5.65 (d, J = 1.5 Hz, 1H), 5.62 (s, 1H), 3.74 (s, 3H), 2.41 (s, 
3H). 13C-NMR (CDCl3, 75 MHz): δ 163.3, 144.1, 143.4, 138.8, 129.6, 129.5, 126.9, 126.2, 106.8, 
53.3, 21.8. 
 
1-(Iodomethyl)-2-vinylbenzene (11) 
This compound was prepared from homophthalic acid according to a reported four-step 
procedure.10 The yield was 45 mg (26% over 4 steps). 1H NMR (CDCl3, 300 MHz): δ 
7.42–7.10 (m, 4H), 7.00 (dd, J = 10.8, 18.1 Hz, 1H), 5.74 (dd, J = 1.2, 17.1 Hz), 5.45 (dd, 
J = 1.2, 10.8 Hz, 1H), 4.48 (s, 2H). 
 
General procedure A for the alkylation of N-Ts-protected dehydroalanine methyl ester 10 
A solution of 10 in DMF (~0.03M) was cooled to 0 °C and NaH (60% dispersion in mineral oil, 1.5 
equiv) was added. The resulting solution was stirred at 0 °C for 15 min. Next, the alkyl halide (2 
equiv) was added, the solution was warmed to 60 °C and stirred for 3 h. Saturated NH4Cl was added 
and the mixture was extracted with pentane. The organic layers were dried (MgSO4) and concentrated 
in vacuo. The product was purified by column chromatography (EtOAc/heptane/Et3N, 10:90:1). 
 
Methyl 2-(N-(but-3-enyl)-4-methylphenylsulfonamido)acrylate (12a) 
This compound was synthesized from 10 and bromo-1-butene, following general 
procedure A. The yield was 29.4 mg (49%). 1H-NMR (CDCl3, 300 MHz): δ 7.66 (d, 
J = 8.4 Hz, 2H), 7.26 (d, J = 8.7 Hz, 2H), 6.41 (s, 1H), 5.75 (s, 1H), 5.72–5.61 (m, 
1H), 5.02 (m, 2H), 3.64 (s, 3H), 3.43 (t, J= 7.4 Hz, 2H), 2.45 (s, 3H), 2.24 (m, 2H). 
13C NMR (CDCl3, 75 MHz): δ 163.9, 143.3, 135.8, 135.6, 134.1, 129.2, 128.5, 127.5, 117.0, 55.5, 
48.5, 32.9, 21.7. HRMS (CI+): calculated for C15H20NO4S, [M+H]+: 310.1113, found: 324.1220. 
 
Methyl 2-(4-methyl-N-(pent-4-enyl)phenylsulfonamido)acrylate (12b) 
This compound was synthesized from 10 and 5-bromo-1-pentene, following 
general procedure A. The yield was 37.5 mg (59%). 1H NMR (CDCl3, 300 
MHz): δ 7.66 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 8.3 Hz, 2H), 6.37 (s, 1H), 5.69 (s, 
1H), 5.80–5.65 (m, 1H), 4.96 (m, 2H), 3.68 (s, 3H), 3.35 (t, J = 7.2 Hz, 2H), 2.41 (s, 3H), 2.06 (m, 
2H), 1.62-1.52 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 164.0, 143.3, 137.1, 135.8, 135.7, 129.2, 
127.6, 127.5, 115.2, 52.5, 48.5, 30.6, 27.6, 21.8. HRMS (CI+): calculated for C16H22NO4S, [M+H]+: 
324.1270, found: 324.1284. 
 
Methyl 2-(4-methyl-N-(2-vinylbenzyl)phenylsulfonamido)acrylate (14) 
This compound was synthesized from 10 and 13, following general procedure 
A. The yield was 13.8 mg (22%). 1H-NMR (CDCl3, 300 MHz): δ 7.70 (d, J = 
8.1 Hz, 2H), 7.43 (d, J = 7.5 Hz, 1H), 7.29 (d, J = 8.1 Hz, 1H), 7.23–6.98 (m, 
4H), 6.16 (s, 1H), 5.58 (m, 2H), 5.29 (dd, J = 1.5, 10.8 Hz, 1H), 4.68 (s, 2H), 
3.54 (s, 3H, 2.44 (3, 3H). 13C-NMR (CDCl3, 75 MHz): δ 163.6, 143.4, 137.7, 135.6, 134.5, 133.6, 
HN CO2Me
Ts
N
Ts
CO2Me
N
Ts
CO2Me
I
N
Ts
OMe
O
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131.4, 130.3, 129.4, 129.2, 128.3, 127.7(2), 127.4, 125.8, 116.3, 52.2, 50.2, 21.8. IR (CH2Cl2): ν 
2920, 2846, 1727, 1346, 1165 cm-1. HRMS (CI+): calculated for C20H22NO4S, [M+H]+: 372.1270, 
found: 372.1281. 
 
General procedure B for ring-closing metathesis of dehydroamino acids 
A solution of the substrate in toluene (~5 μM) was stirred under an inert atmosphere. Catalyst A (10 
mol %) was added and the reaction was stirred at the specified temperature. When TLC indicated that 
the reaction was complete, the mixture was concentrated in vacuo. The product was purified by 
column chromatography (EtOAc/heptane, 1:10). 
 
Methyl 1-tosyl-4,5-dihydro-1H-pyrrole-2-carboxylate (15) 
This compound was prepared from 12a, following general procedure B, at 80 °C. The 
yield was 20.7 mg (78%). 1H-NMR (C6D6, 200 MHz): δ 7.70 (d, J = 8.3 Hz, 2H), 6.65 
(d, J = 7.9 Hz, 2H), 4.56 (d, J = 10.5 Hz, 1H), 3.59–3.45 (m, 2H), 3.30 (s, 3H), 2.24-
2.14 (m, 1H), 1.78 (s, 3H), δ 1.49–1.37 (m, 1H). 13C-NMR (C6D6, 75 MHz): δ 162.6, 161.0, 144.8, 
135.3, 129.8, 129.3, 73.4, 62.2, 52.4, 26.5, 21.5. IR (C6D6): ν 2950, 2850, 1727, 1627, 1597, 1433, 
1312 cm-1. HRMS (CI+): calculated for C13H16NO4S, [M+H]+: 282.0800, found: 282.0812. 
 
 
Methyl 2-tosyl-1,2-dihydroisoquinoline-3-carboxylate (16) 
This compound was prepared from 14, following general procedure B, at 80 °C. The 
yield was 7.3 mg (79%). 1H-NMR (CDCl3, 300 MHz): δ 7.50 (d, J = 8.4 Hz, 2H), 
7.24 (d, J = 8.4 Hz, 2H), 7.13–6.86 (m, 5H), 4.73 (s, 2H), 3.92 (s, 3H), 2.21 (3, 3H). 
13C-NMR (CDCl3, 75 MHz): δ 164.6, 143.5, 134.7, 130.9, 130.2, 129.9, 128.9, 
128.8, 128.7, 128.6, 127.4(2), 126.6, 126.0, 125.2, 52.8, 49.4, 22.9. IR (CH2Cl2): ν 
2920, 2846, 1727, 1459, 1256 cm-1. HRMS (CI+): calculated for C18H17NO4S, [M]+: 343.0878, found: 
343.0886. 
 
Methyl 2-(tert-butoxycarbonylamino)acrylate (22) 
To a solution of serine methyl ester hydrochloride (2.02g, 12.98 mmol) and Et3N (5.26 
g, 51.9 mmol) in DCM (80 mL) at 0 °C was added di-tert-butyl dicarbonate (3.12g, 
14.28 mmol). After 15 min the reaction was allowed to warm to room temperature and 
stirred overnight. The mixture was washed with saturated NaHCO3 (2 × 20 mL) and H2O (2 × 15mL) 
and the aqueous layers were extracted with DCM (2 × 10 mL). The combined organic layers were 
dried with Na2SO4 and the solvents were removed in vacuo. To the crude product were added DCM 
(140 mL) and mesylchloride (2.04g, 17.8 mmol). Next, Et3N (4.32 g, 42.7 mmol) was added drop 
wise to the stirred reaction mixture at 0 °C. After 20 min the reaction was allowed to warm to room 
temperature. and stirred for 2 h. The mixture was washed with 5% KHSO4 (2 × 20ml), dried over 
Na2SO4 and the solvents were evaporated in vacuo. The crude product was purified by column 
chromatography (Et2O/pentane, 1:20). The yield was 2.01 g (77%) of a colorless liquid. Analytical 
data agreed with those reported in literature.24 1H-NMR (CDCl3, 300 MHz): δ 7.00 (br s, 1H), 6.16 (s, 
1H), 5.73 (s, 1H), 3.85 (s, 3H), 1.51 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 164.5, 152.6, 131.4, 
105.2, 80.7, 52.9, 28.3. IR (neat): ν 3420, 2978, 1715, 1632, 1508, 1325, 1155 cm-1. 
 
5-Iodo-3-methylpent-1-ene (18) 
To a cooled (0 °C) suspension of LiAlH4 (1.00 g, 26,3 mmol) in Et2O (60 mL), was 
added a solution of methyl 3-methylpent-4-enoic acid (17) in Et2O (15 mL). After 
stirring at room temperature for 24 h, the reaction was poured over ice and the 
remaining salts were dissolved with H2SO4 (5M, 15 mL). The layers were separated and the organic 
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layer washed with H2O (15 mL). The combined aqueous layers were washed with Et2O (2 × 20 mL). 
The solvents were evaporated, yielding the corresponding alcohol (1.20 g, 90%) as a colorless liquid. 
Analytical data were agreement with reported values.25 1H-NMR (CDCl3, 300 MHz): δ 5.73 (ddd, J = 
7.8, 10.2, 17.1 Hz, 1H), 5.02 (dq, J = 0.9, 17.1 Hz, 1H), 4.96 (dq, J = 0.9, 10.2 Hz, 1H), 3.65 (t, J = 
6.6 Hz, 2H), 2.35–2.25 (m, 1H), 1.63–1.56 (m, 2H), 1.35 (br s, 1H), 1.05 (d, J = 6.6 Hz, 2H). 13C 
NMR (CDCl3, 75 MHz): δ 144.2, 113.1, 61.4, 39.6, 35.2, 20.8. The alcohol (800 mg, 7.99 mmol) was 
dissolved in CH2Cl2 (100 mL) and Ph3P (2.72 g, 9.06 mmol) and imidazole (816 g, 12.0 mmol) were 
added. Next, the reaction was cooled to 0 °C and a solution of iodine (2.64 g, 10.4 mmol) in CH2Cl2 
(60 mL) was added. The reaction mixture was stirred at room temperature for 45 min. The mixture 
was washed with a 10% Na2SO3 solution (3 × 20 mL), H2O (20 mL) and brine (20 mL). The organic 
layer was dried with Na2SO4 and the solvents were removed in vacuo. The crude product was purified 
by column chromatography (100% pentane) to give 18 (1.38 g, 82%) as a colorless liquid. Analytical 
data agreed with those reported in literature.26 1H-NMR (CDCl3, 300 MHz): δ 5.61 (ddd, J = 7.9, 
10.3, 17.3 Hz, 1H), 5.06 (m, 1H), 5.00 (m, 1H), 3.21 (m, 1H), 3.12 (m, 1H), 2.34–2.23 (m, 1H), 1.89–
1.75 (m, 2H), 1.02 (d, J = 6.7 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 142.4, 114.2, 40.3, 39.0, 20.1, 
5.4. 
 
(5-Iodopent-1-en-3-yl)benzene (21) 
This compound was synthesized from cinnamyl alcohol, according to a literature 
procedure.11 The yield was 813 mg (30% over 3 steps). Analytical data agreed with 
those reported. 1H-NMR (CDCl3, 200 MHz): δ 7.28–7.18 (m, 5H), 6.01–5.83 (ddd, J = 
7.8, 10.2, 17.4 Hz, 1H), 5.16–5.07 (m, 2H), 3.44 (q, J = 7.2 Hz, 1H), 3.19–3.03 (m, 
2H), 2.26–2.15 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 142.7, 140.5, 128.8, 127.8, 126.8, 115.4, 
50.2, 38.9, 4.9. 
 
General procedure C for the alkylation of N-Boc-protected dehydroalanine methyl ester 22 
A solution of 22 in DMF (~0.1M) was cooled to 0 °C and NaH (60% dispersion in mineral oil, 1.3 
equiv) was added. The resulting solution was stirred at 0 °C for 15 min and at room temperature for 
30 min. Next, the reaction was cooled to 0 °C, followed by addition of the alkyl halide (2 equiv).The 
solution was allowed to warm to room temperature and stirred for 2 h. Saturated NH4Cl was added 
and the mixture was extracted with pentane. The organic layers were dried (Na2SO4) and concentrated 
in vacuo. The crude product was purified by column chromatography (EtOAc/heptane). 
 
Methyl 2-(tert-butoxycarbonyl(pent-4-enyl)amino)acrylate (23) 
This compound was synthesized from 22 and 5-bromo-1-pentene, following 
general procedure C. A catalytic amount of LiI (5mg, 0.037mmol) was used as 
an additive. The yield was 122 mg (74%) of a pale yellow oil. 1H-NMR (CDCl3, 
300 MHz): δ 5.91 (s, 1H), 5.80 (ddt, J = 6.6, 10.1, 17.0 Hz, 1H), 5.40 (s, 1H), 5.06–4.95 (m, 2H) 3.79 
(s, 3H), 3.50 (m, 2H), 2.14–2.06 (m, 2H), 1.74–1.64 (m, 2H) 1.43 (s, 9H). 13C NMR (CDCl3, 75 
MHz): δ 165.4, 153.7, 117.1, 115.0, 81.0, 52.4, 49.2, 31.2, 28.5, 27.8. IR (CH2Cl2): ν 2976, 2930, 
2857, 1736, 1710, 1631 cm-1. HRMS (CI+): calculated for C14H24NO4, [M+H]+: 270.1705, found: 
270.1714. 
 
Methyl 2-(tert-butoxycarbonyl(3-methylpent-4-enyl)amino)acrylate (24) 
This compound was synthesized from 22 and 18, following general procedure C. 
The yield was 553 mg (77%) of a colorless oil. 1H-NMR (CDCl3, 400 MHz): δ 
5.89 (s, 1H), 5.72–5.64 (m, 1H), 5.38 (s, 1H), 4.96 (m, 1H), 3.77 (s, 3H), 3.47 
(m, 2H), 2.21–2.11 (m, 1H), 1.57 (m, 1H), 1.41 (s, 9H), 1.01 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 75 MHz): δ 165.7, 153.9, 143.8, 140.3, 117.1, 113.3, 81.0, 
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52.3, 48.0, 35.7, 34.8, 28.3, 20.3. IR (CH2Cl2): ν 2974, 2932, 1736, 1706, 1633, 1366, 1153 cm-1. 
HRMS (CI+): calculated for C15H26NO4, [M+H]+: 284.1862, found: 284.1850. 
 
Methyl 2-(tert-butoxycarbonyl(3-phenylpent-4-enyl)amino)acrylate (25) 
This compound was synthesized from 22 and 21, following general procedure C. 
The yield was 281 mg (64%) of a colorless oil: 1H-NMR (CDCl3, 300 MHz): δ 
7.32–7.27 (m, 2H), 7.20 (m, 3H), 6.00–5.88 (m, 1H), 5.86 (s, 1H), 5.31 (s, 1H), 
5.08 (m, 1H), 5.02 (m, 1H) 3.77 (s, 3H), 3.58–3.48 (m, 1H), 3.42–3.26 (m, 2H), 
2.05–1.97 (m, 2H), 1.40 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 165.7, 153.8, 
143.7, 141.5, 140.3, 128.7, 127.6, 126.5, 117.0, 114.8, 81.1, 52.4, 48.1, 47.5, 33.5, 28.3. IR (CDCl3): 
ν 2976, 1734, 1707, 1633, 1156 cm-1. HRMS (CI+): calculated for C20H28NO4, [M+H]+: 346.2018, 
found: 346.20187. 
 
1-tert-Butyl 2-methyl 4-methyl-5,6-dihydropyridine-1,2(4H)-dicarboxylate (27) 
This compound was prepared from 24, following general procedure B, at 60 °C. The 
yield was 22.2 mg (81%). Additional workup was required in order to prevent 
degradation of the product over time. The product was stirred overnight with activated 
carbon to remove any ruthenium residues, after which the solvent was evaporated and 
the product purified by column chromatography (EtOAc/heptane, 1:40) to give 26 (18.4 mg, 67%). 
1H-NMR (CDCl3, 300 MHz): δ 5.82 (d, J = 3.3 Hz, 1H), 3.76 (s, 3H), 3.56 (m, 2H), 2.40 (m, 1H), 
1.88 (m, 1H), 1.46 (m, 1H), 1.42 (s, 9H), 1.06 (d, J = 7.2 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 
165.9, 153.2, 131.9, 126.9, 81.5, 52.0, 42.0, 31.0, 28.6, 28.2, 20.6. IR (CH2Cl2): ν 2954, 2930, 2854, 
1735, 1709, 1640, 1367 cm-1. HRMS (CI+): calculated for C13H21NO4, [M]+: 255.1471, found: 
255.1483 and 255.1477 (duplo). 
 
1-tert-Butyl 2-methyl 4-phenyl-5,6-dihydropyridine-1,2(4H)-dicarboxylate (28) 
This compound was prepared from 25, following general procedure B, at 80 °C. The 
yield was 11.3 mg (85%) of a colorless oil. 1H-NMR (CDCl3, 300 MHz): δ 7.35–717 
(m, 5H), 5.99 (d, J = 3.6 Hz, 1H), 3.81 (s, 3H), 3.68 (m, 2H), 3.63–3.56 (m, 1H), 2.22–
2.12 (m, 1H), 1.88–1.77 (m, 1H), 1.47 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 165.4, 
152.8, 143.3, 133.3, 128.7, 127.6, 126.8, 122.8, 81.8, 52.3, 42.2, 39.8, 32.4, 28.4. IR 
(CDCl3): ν 2977, 2949, 2927, 1734, 1706, 1638, 1365 cm-1. HRMS (CI+): calculated for C18H23NO4 
[M]+: 317.1627, found: 317.1614. 
 
Ethyl 3-(methoxymethoxy)pent-4-enoate (30) 
DIPEA (4.8 mL, 27.6 mmol) was added to a solution of 2914 (0.197 g, 1.37 mmol), 
chloromethyl methyl ether (1.06 mL, 13.96 mmol) and TBAI (51 mg, 0.14 mmol) in 
CH2Cl2 (35 mL) at 0 °C. The reaction was protected from light and allowed to warm to room 
temperature. After stirring for 18 h, saturated NaHCO3 (10 mL) and Et2O (5 mL) were added. The 
organic layer was washed with brine (10 mL) and the aqueous layers were washed with CH2Cl2 (2 × 
10 mL). The combined organic layers were dried with NaSO4 and the solvents were evaporated in 
vacuo. Column chromatography (EtOAc/heptane, 1:10) afforded 30 (249 mg, 97%) as a pale yellow 
liquid. 1H NMR (CDCl3, 300 MHz): δ 5.74 (ddd, J = 7.5, 10.2, 17.1 Hz, 1H), 5.30 (ddd, J = 0.9, 1.5, 
17.1, 1H), 5.23 (ddd, J = 0.9, 1.5, 10.2, 1H), 4.69 (d, J = 6.6 Hz, 1H), 4.56 (d, J = 6.6 Hz, 1H), 4.50 
(m, 1H), 4.15 (dq, J = 1.4, 7.2 Hz, 2H), 3.36 (s, 3H), 2.64 (dd, J = 8.4, 15.0 Hz, 1H), 2.49 (dd, J = 5.1, 
15.0 Hz, 1H) 1.27 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 170,5, 136.7, 118.1, 94.1, 74.0, 
60.8, 55.8, 41.3, 14.6. 
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Ethyl 3-(tert-butyldimethylsilyloxy)pent-4-enoate (31) 
To a stirred solution of 2914 (1.00 g, 3.87 mmol) and imidazole (527 mg, 7.74 mmol) 
in CH2Cl2 (20 mL) at 0 °C was added TBSCl (1.17 g, 7.74 mmol). After 15min the 
reaction was warmed to room temperature and stirred overnight. Saturated NaHCO3 
(5 mL) was added and the organic layer was extracted with H2O (10 mL) and brine (10 mL). After 
removing the solvent in vacuo, the crude product was purified by Kugelrohr distillation to afford 31 
(1.79 g, 99%) as a colorless liquid. Analytical data agreed with those reported in literature.27 1H-NMR 
(CDCl3, 300 MHz): δ 5.86–5.77 (m, 1H), 5.20 (dt, J = 1.5, 17.1 Hz, 1H), 5.05 (dt, J = 1.4, 10.2 Hz, 
1H), 4.57 (m, 1H), 4.20–4.03 (m, 2H), 2.52 (dd, J = 7.7, 14.4 Hz, 1H), 2.42 (dd, J =  5.4, 14.4 Hz), 
1.26 (t, J = 7.2 Hz, 3H), 0.86 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H). 13C-NMR (CDCl3, 75 MHz): δ 170.9, 
140.2, 114.6, 71.1, 60.6, 44.0, 26.0, 18.5, 14.6, –3.9,   –4.7. 
 
Ethyl 3-methoxypent-4-enoate (32) 
Powdered NaOH (0.613 g, 15.3 mmol) was added to a solution of 2914 (1.49 g, 10.4 
mmol) and MeI (1.3 mL, 20.9 mmol) in DMSO (5 mL) at 0 °C. After stirring for 2 h 
an additional amount of NaOH (0.330 g, 8.45 mmol) and MeI (1.3 mL, 20.9 mmol) 
was added an the reaction was allowed to warm to room temperature. After 2 h the reaction mixture 
was diluted with H2O (20 mL), and extracted with pentane (4 × 10 mL). The organic layer was dried 
(Na2SO4) and the solvents removed in vacuo. The crude product was purified by column 
chromatography (100% pentane → Et2O/pentane, 1:20) to give 32 (692 mg, 42%) as a colorless 
liquid. 1H-NMR (CDCl3, 300 MHz): δ 5.77–5.65 (m, 1H), 5.32–5.22 (m, 2H), 4.15 (q, J = 7.0 Hz, 
2H), 4.07–3.99 (m, 1H), 3.29 (s, 3H), 2.60 (dd, J = 8.1, 15.3 Hz, 1H), 2.45 (dd, J = 5.4, 15.0 Hz, 1H), 
1.26 (t, J = 7.0 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 171.0, 137.1, 118.0, 79.3, 60.6, 56.6, 41.2, 
14.3. 
 
General procedure D for the transformation of ethyl esters into iodides 
To a suspension of LiAlH4 (1.3 equiv) in Et2O at 0 °C was added a solution of the ethyl ester in Et2O. 
The reaction was warmed to room temperature and stirred for 15 min, after which it was cooled to 0 
°C and H2O was added. To dissolve the remaining salts H2SO4 (1M) was added and the mixture was 
stirred for 30 min. The organic layer was separated and the water layer exhaustively extracted with 
Et2O. The organic layer was dried with MgSO4 and concentrated in vacuo. The resulting alcohol was 
purified by column chromatography (Et2O/pentane). The alcohol was dissolved in CH2Cl2 and PPh3 
(1.3 equiv) and imidazole (1.5 equiv) were added. The reaction was cooled to 0 °C and a solution of 
iodine (1.3 equiv) in CH2Cl2 was added. After 30 min the reaction was warmed to room temperature 
and stirred for 1.5 h. Next, the mixture was extracted with a 10% Na2SO3 solution (3 x), H2O and 
brine. The organic layer was dried with Na2SO4 and the solvents were evaporated in vacuo. The crude 
product was purified by column chromatography (Et2O/pentane). 
 
5-Iodo-3-(methoxymethoxy)pent-1-ene (33) 
This compound was prepared from 30, following general procedure D. The yield was 
469 mg (62% over 2 steps) of a colorless liquid. 1H-NMR (CDCl3, 300 MHz): δ 5.72–
5.62 (m, 1H), 5.34–5.24 (m, 1H), 4.74 (d, J = 7.2 Hz, 1H), 4.56 (d, J = 6.9 Hz, 1H), 
4.14 (m, 2H), 3.41 (s, 3H), 3.33–3.20 (m, 2H), 2.21–1.98 (m, 2H). 13C-NMR (CDCl3, 75 MHz): δ 
136.9, 118.3, 94.0, 77.2, 56.0, 39.5, 2.1. 
 
tert-Butyl(5-iodopent-1-en-3-yloxy)dimethylsilane (34) 
This compound was prepared from 31, following general procedure D. DIBALH was 
used instead of LiAlH4 in the reduction step. Workup after this step was carried out by 
pouring the mixture into a cold HCl solution, separating the organic phase, extracting 
the aqueous phase with Et2O and concentrating the combined organic phases. The yield of 33 was 205 
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mg (48% over 2 steps) of a colorless liquid. 1H-NMR (CDCl3, 300 MHz): δ 5.88 (ddd, J = 6.3, 10.2, 
17.1 Hz, 1H), 5.21 (dt, J = 1.2, 17.1 Hz, 1H), 5.09 (m, 1H), 4.22-4.15 (m, 1H), 3.20 (m, 2H), 2.06–
1.94, (m, 2H), 0.90 (s, 9H), 0.10 (s, 3H), 0.05 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 140.6, 115.0, 
73.9, 41.9, 26.0, 18.3, 2.7, –4.1, –4.6. HRMS (CI+): calculated for C11H24OSiI, [M+H]+: 327.0642, 
found: 327.06446. 
 
5-Iodo-3-methoxypent-1-ene (35) 
This compound was prepared from 32, following general procedure D. The yield was 
586 mg (70% over 2 steps) of a colorless liquid. 1H-NMR (CDCl3, 400 MHz): δ 5.66 
(m, 1H), 5.27 (m, 2H), 3.66 (m, 1H), 3.30 (s, 3H), 3.28 (m, 1H), 3.20 (m, 1H), 2.11–
2.02 (m, 1H), 2.00–1.91 (m, 1H). 13C NMR (CDCl3, 75 MHz): 137.5, 118.2, 82.5, 56.6, 39.1, 2.4.  
 
Methyl 2-(tert-butoxycarbonyl(3-(methoxymethoxy)pent-4-enyl)amino)acrylate (36) 
This compound was synthesized from 22 and 33, following general 
procedure C. The yield was 157 mg (76%) of a colorless oil. 1H-NMR 
(CDCl3, 300 MHz): δ 5.93 (s, 1H), 5.76–5.64 (m, 1H), 5.43 (s, 1H), 5.24 (m, 
1H), 5.20 (ddd, J = 0.9, 1.5, 4.2 Hz, 1H), 4.69 (d, J = 6.6 Hz, 1H), 4.54 (d, J 
= 6.6 Hz, 1H), 4.07 (m, 1H), 3.79 (s, 3H), 3.61 (m, 2H), 3.37 (s, 3H), 1.98–
1.79 (m, 2H), 1.44 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 165.3, 153.5, 140.0, 137.7, 117.5, 117.3 
94.0, 81.2, 75.4, 55.8, 52.5, 46.4, 34.1, 28.5. IR (CH2Cl2): ν 2979, 2950, 2889, 1736, 1710, 1632 
cm-1. HRMS (CI+): calculated for C16H28NO6, [M+H]+: 330.1917, found: 330.1905. 
 
Methyl 2-(tert-butoxycarbonyl(3-(tert-butyldimethylsilyloxy)pent-4-enyl)amino)acrylate (37) 
This compound was synthesized from 22 and 34, following general procedure 
C. The yield was 131 mg (66%) of a colorless oil. 1H-NMR (CDCl3, 300 
MHz): δ 5.87 (s, 1H), 5.80 (ddd, J = 6.0, 10.2, 17.1 Hz, 1H), 5.38 (s, 1H), 5.16 
(dt, J = 1.5, 17.1 Hz, 1H), 5.05 (m, 1H), 4.18 (m, 1H), 3.77 (s, 3H), 3.54 (m, 
2H), 1.81 (m, 2H), 1.41 (s, 9H), 0.88 (s, 9H), 0.04 (s, 3H), 0.02 (s, 3H). 13C-NMR (CDCl3, 75 MHz): 
δ 165.7, 153.8, 141.0, 140.4, 116.6, 114.3, 81.0, 71.9, 52.3, 46.4, 36.2, 28.3, 26.0, 18.3, –4.2, –4.8. IR 
(CH2Cl2): ν 2951, 2928, 2855, 1737, 1712, 1631, 1251 cm-1. HRMS (CI+): calculated for 
C20H38NO5Si, [M+H]+: 400.2519, found: 400.2513. 
 
Methyl 2-(tert-butoxycarbonyl(3-methoxypent-4-enyl)amino)acrylate (38) 
This compound was synthesized from 22 and 35, following general procedure 
C. The yield was 394 mg (64%) of a colorless oil: 1H-NMR (CDCl3, 300 MHz): 
δ 5.90 (s, 1H), 5.72–5.60 (m, 1H), 5.41 (s, 1H), 5.23 (m, 1H), 5.18 (m, 1H), 
3.77 (s, 3H), 3.68–3.56 (m, 2H), 3.57–3.25 (m, 1H), 1.81 (m, 2H), 1.41 (s, 9H). 
13C-NMR (CDCl3, 75 MHz): δ 165.7, 153.9, 140.3, 138.3, 117.4, 117.2, 81.1, 80.5, 56.3, 52.3, 46.2, 
34.0, 28.3. IR (CH2Cl2): ν 2977, 2933, 2821, 1736, 1710, 1632, 1366 cm-1. HRMS (CI+): calculated 
for C15H26NO5, [M+H]+: 300.1811, found: 300.1809. 
 
General procedure E for ring-closing metathesis of allylic ether functionalized dehydroamino 
acids 
A solution of the substrate in toluene (~3 μM) was stirred under an inert atmosphere at 80 °C. 
Catalyst A (5 mol %) was added and the reaction was stirred at 80 °C for 1 h. Next, a second portion 
of A (5 mol %) was added and the reaction was stirred overnight at 80 °C. The solvent was 
evaporated and the crude product purified by column chromatography (EtOAc/heptane, 1:20). 
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1-tert-Butyl 2-methyl 4-(methoxymethoxy)-5,6-dihydropyridine-1,2(4H)-dicarboxylate (39) 
This compound was prepared from 36, following general procedure E. Product 39 
(24.4 mg, 27%) was isolated as a colorless oil. Compound 42 (1.4:1) was isolated as a 
side product (44.5 mg, 45%). 39: 1H-NMR (CDCl3, 300 MHz): δ 5.89 (m, 1H), 4.69 
(dd, J = 4.8, 6.9 Hz, 2H) 4.16 (m, 1H), 4.03 (m, 1H), 3.79 (s, 3H), 3.26–3.17 (m, 1H), 
2.00 (m, 1H) 1.91–1.80 (m, 1H), 1.45 (s, 9H). 13C-NMR (CDCl3, 75 MHz): δ 165.2, 152.3, 134.3, 
118.2, 94.9, 82.1, 66.2, 55.7, 52.3, 40.3, 30.3, 28.3. IR (CH2Cl2): ν 2979, 2951, 2890, 1737, 1710, 
1634 cm-1. HRMS (EI+): calculated for C14H23NO6, [M]+: 301.1525, found: 301.1525. 42: 1H-NMR 
(CDCl3, 300 MHz): δ 5.89 and 5.88 (2 × s, 1H), 5.45 and 5.43 (2 × s, 1H), 4.86 and 4.85 (2 × s, 2H), 
4.77 (q, J = 6.9 Hz, 0.6H), 4.72 (q, J = 6.7 Hz, 0.4H), 3.77 and 3.76 (2 × s, 3H), 3.57 (m, 2H), 3.44 
and 3.37 (2 × s, 3H), 2.46 (m, 2H), 1.59 (d, J = 6.9 Hz, 3H), 1.42 (br s, 9H). LRMS: m/z 230 [M+H-
Boc]+. 
 
1-tert-Butyl 2-methyl 4-(tert-butyldimethylsilyloxy)-5,6-dihydropyridine-1,2(4H)-dicarboxylate 
(40) 
This compound was prepared from 37, following general procedure E. Product 40 (6.9 
mg, 59%) was isolated as a colorless oil. Compound 43 (2.1:1) was isolated as a side 
product (4.3 mg, 34%). 40: 1H-NMR (CDCl3, 300 MHz): δ 5.79 (d, J = 3.91 Hz, 1H) 
4.23 (m, 1H), 3.96 (m, 1H) 3.79 (s, 3H), 3.29–3.20 (m, 1H), 1.83 (m, 2H) 1.43 (s, 9H) 
0.88 (s, 9H), 0.08 (s, 6H). 13C-NMR (CDCl3, 75 MHz): δ 165.9, 152.8, 133.1, 121.7, 81.9, 62.3, 52.3, 
40.1, 33.3, 28.2, 25.9, 18.3, –4.4, –4.6. IR (CH2Cl2): ν 2952, 2929, 2856, 1738, 1713, 1636, 1247 
cm-1. HRMS (CI+): calculated for C18H34NO5Si, [M+H]+: 372.2206, found: 372.2207. 43: 1H-NMR 
(CDCl3, 300 MHz): δ 5.90 and 5.85 (2 × s, 1H), 5.46 and 5.43 (2 × s, 1H), 4.67 (q, J = 6.9 Hz, 0.3H), 
4.53 (q, J = 6.7 Hz, 0.7H), 3.76 (2 × s, 3H), 3.57 (m, 2H), 2.39 and 2.29 (2 × m, 2H), 1.51 (d, J = 6.9 
Hz, 0.3H), 1.48 (d, J = 6.7 Hz, 0.7H), 1.41 (br s, 9H), 0.93 and 0.88 (2 × s, 9H), 0.10 (2 × s, 6H). 
LRMS: m/z 271 [M+H-Boc]+. 
 
1-tert-Butyl 2-methyl 4-methoxy-5,6-dihydropyridine-1,2(4H)-dicarboxylate (41) 
This compound was prepared from 38, following general procedure E. Product 41 
(13.1 mg, 43%) was isolated as a colorless oil. Compound 44 (3.1:1) was isolated as a 
side product (10.4 mg, 31%). 41: 1H-NMR (CDCl3, 400 MHz): δ 5.97 (m, 1H) 4.00 
(dt, J = 4.3, 12.9 Hz), 3.79 (s, 3H), 3.77 (m, 2H), 1.99 (m, 1H), 1.80 (m, 1H), 1.43 (s, 
9H). 13C-NMR (CDCl3, 75 MHz): δ 165.6, 152.7, 134.4, 117.9, 82.1, 70.2, 56.2, 52.3, 40.2, 29.1, 
28.1. IR (CH2Cl2): ν 2977, 2932, 1735, 1709, 1637, 1367 cm-1. HRMS (CI+): calculated for 
C13H21NO5, [M]+: 271.1420, found: 271.1425. 44: 1H-NMR (CDCl3, 300 MHz): δ 5.90 and 5.86 (2 × 
s, 1H), 5.43 and 5.41 (2 × s, 1H), 4.60 (q, J = 6.7 Hz, 0.8H), 4.44 (q, J = 6.8 Hz, 0.2H), 3.76 (2 × s, 
3H), 3.63–3.52 (m, 2H), 3.49 and 3.42 (2 × s, 3H), 2.47 and 2.39 (2 × m, 2H), 1.59 (d, J = 6.8 Hz, 
2.3H), 1.54 (d, J = 6.7 Hz, 0.7H), 1.41 (br s, 9H). LRMS: m/z 171 [M+H-Boc]+. 
 
1-tert-Butyl 2-methyl 5,6-dihydropyridine-1,2(4H)-dicarboxylate (26) 
To a solution of 23 (10.1 mg, 37.5 μmol) in toluene (8 mL) and 1,4-benzoquinone (0.8 
mg, 20 mol %) was added A (3.2 mg, 10 mol %). The reaction was stirred at 80 °C for 
1 h, after which TLC showed a complete conversion. The solvent was evaporated and 
the product was purified by column chromatography (EtOAc/heptane, 1:10). The yield was 8.5 mg 
(94%) of a colorless oil. 1H-NMR (CDCl3, 400 MHz): δ 5.98 (t, J = 3.9 Hz, 1H), 3.77 (s, 3H), 3.57 
(m, 2H), 2.21 (m, 2H), 1.79 (m, 2H), 1.42 (s, 9H). 13C-NMR (CDCl3, 75 MHz): δ 165.7, 153.1, 132.8, 
121.9, 81.4, 51.9, 43.1, 28.1, 23.0, 22.7. IR (CH2Cl2): ν 2955, 2930, 2864, 1732, 1710, 1640 cm-1. 
HRMS (CI+): calculated for C12H19NO4, [M]+: 241.1314, found: 214.1311. 
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Synthesis of optically active 4-
substituted cyclic dehydroamino acids 
 
 
 
7.1 Introduction 
 
 Pipecolic acid (piperidine-2-carboxylic acid) is a non-proteinogenic amino acid, 
which is commonly found in nature, mainly in plants, fruits and fungi.1–6 It plays an 
important role in several metabolic processes and is a constituent of a number of natural 
products with remarkable biological activities, such as the immunosuppressants rapamycin1 
and FK5062 and the antitumor antibiotic sandramycin.3 In addition, it is often used in 
peptide chemistry as a proline analogue in order to induce β-turns.4 Naturally occurring 
pipecolic acid moieties are generally biosynthesized from lysine by lysine cyclodeaminases 
(Figure 7.1).5 
 
N
H
CO2H
L-pipecolid 
acid
lysine cyclodeaminase
CO2HH2N
NH2
L-lysine
NH3
 
Figure 7.1. Biosynthesis of L-pipecolic acid from L-lysine. 
 
As a result of this broad range of important biological functions, the synthesis of 
derivatives of pipecolic acids and pharmaceutical applications thereof has been a 
widespread subject of research over the past decades.6 One of the most studied classes is 
the family of 4-substituted pipecolic acids, which constitute key structural elements in a 
number of pharmaceutically relevant compounds (Figure 7.2). For instance, 4-methyl 
substituted pipecolic acid is a constituent of argatroban, a potent inhibitor of the enzyme 
thrombin, which has been on the market for many years.7 More recently, introduction of a 
7 
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phenyl instead of a methyl substituent, along with additional modifications, has led to the 
development of the selective trypsin inhibitor MNAPPA.8 
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Figure 7.2. Therapeutically relevant agents incorporating a 4-substituted pipecolic acid moiety. 
 
 Furthermore, 4-O-substituted pipecolic acids have been applied in a number of 
biologically active compounds. For instance, palinavir – developed by Boehringer 
Ingelheim – is a highly potent peptidomimetic-based inhibitor of HIV-1 protease9 and more 
recently synthesized Palinavir analogues were found to be among the most potent anti-HIV 
agents reported so far.10 Finally, several free 4-substituted pipecolic acids appeared to have 
considerable potential for the treatment of a variety of neurodegenerative diseases by acting 
as NMDA receptor antagonists. The most potent examples, developed in the labs of Eli 
Lilly, include LY23306311 and selfotel.12 
 We realized that the cyclic dehydroamino acids substituted at the allylic position, 
prepared by ring-closing metathesis in Chapter 6, may represent valuable intermediates en 
route to 4-substituted pipecolic acid derivatives. Whereas the heterocyclic products in 
Chapter 6 are racemic, enantiomerically pure analogues would have to be prepared in order 
to obtain biologically relevant building blocks. If a similar RCM-based retrosynthetic 
approach is to be followed – i.e. alkylation of protected dehydroalanine (3) and subsequent 
cyclization by RCM – a general synthetic procedure for enantiomerically pure iodides 4 is 
required (Scheme 7.1).  
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HO2C CO2Me
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N CO2Me N CO2Me
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hydrogenation
1 2
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Scheme 7.1. Retrosynthetic approach to enantiomerically pure 4-substituted cyclic dehydroamino acids. 
 
We envisioned that carboxylic acids 5 are useful precursors for these iodides, 
particularly since they can possibly be generated via asymmetric hydrogenation of 
functionalized itaconic acid mono esters 6. Because carboxylic acids can be selectively 
reduced in the presence of esters, it should be possible to convert the carboxylic acid 
function of 5 into a double bond prior to transforming the methyl ester into the 
corresponding iodide. Nonetheless, the asymmetric hydrogenation of mono-acids 6 poses a 
reasonable challenge. Although dimethyl itaconate (R = H) is commonly used as a model 
substrate in the development of new catalyst systems for asymmetric hydrogenation,13 the 
use of itaconic mono- or diacids, in particular substituted variants, has remained largely 
unexplored. 
 
7.2 Synthesis of itaconic acid mono-esters 
 
 We decided to focus our attention on four different itaconic acid derivatives. 
Besides the unsubstituted mono-ester 6a, an ethyl-substituted analogue (6b) and two aryl-
substituted substrates (6c–d) were selected as starting points. The preparation of the 
itaconic acid mono-esters 6 was carried out via several methods. The unsubstituted mono-
ester 6a could be readily synthesized from itaconic acid (7) itself. Reaction of 7 in the 
presence of Amberlyst 15 in methanol under reflux conditions yielded pure 6a in 94%, 
accompanied by only trace amounts of the corresponding diester (Scheme 7.2). The 
synthesis of substituted itaconates required a somewhat larger effort. First of all, ethyl-
substituted mono-ester 6b was readily synthesized via a reported procedure.14 Hence, 
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dimethyl maleate (8) was reacted with 1-nitropropane in the presence of one equivalent of 
DBU, resulting in sequential conjugate addition and elimination of HNO2. The formed 
(E)-diester 9 was then hydrolyzed with aqueous NaOH, followed by mono-esterification 
with Amberlyst 15 in methanol, resulting in the formation of 6b in 53% from 8 (Scheme 
7.2). 
 
MeO2C
MeO2C
NO2
DBU (1 equiv)
MeCN, rt MeO2C
CO2Me HO2C
CO2Me
1) 2M NaOH
    EtOH, reflux
2) Amberlyst 15
    MeOH, reflux 6b (53%, 3 steps)
HO2C
CO2H HO2C
CO2Me
Amberlyst 15
 MeOH, reflux
6a (94%)7
8 9  
Scheme 7.2. Synthesis of unsubstituted and ethyl-substituted itaconates. 
 
 Synthesis of aryl-substituted itaconic acid mono-esters via the previously 
described route is more laborious, because it would require the preparation of the 
corresponding nitroalkane reagents, which are not commercially available. Therefore, we 
chose to prepare 6c and 6d through a Stobbe condensation15 of dimethyl succinate (10) with 
aldehydes 11a–b (Scheme 7.3). 
 
MeO2C
MeO2C
+
KOtBu
tBuOH
reflux
O
MeO2C
CO2H HO2C
CO2Me
1) 2 M NaOH
    EtOH, reflux
2) Amberlyst 15
    MeOH, reflux 6c R = H (41%, 3 steps)
6d R = OMe (52%, 3 steps)
R
R
R
11a (R = H)
11b (R = OMe)
10 12a (R = H)
12b (R = OMe)  
Scheme 7.3. Synthesis of aryl-substituted itaconates via a Stobbe condensation. 
 
 Condensation of dimethyl succinate with benzaldehyde and 4-methoxy-
benzaldehyde in refluxing tert-butyl alcohol resulted in the formation of mono-esters 12a–b 
as single (E)-geometrical isomers. Next, the mono-esters were hydrolyzed with 2 M NaOH 
and the resulting diacids were subsequently mono-esterified with Amberlyst 15 in 
methanol, leading to the desired hydrogenation precursors 6c–d. 
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7.3 Asymmetric hydrogenation: initial tests 
 
 The asymmetric hydrogenations of the four itaconates were performed using the 
phosphoramidite ligand library (e.g. MonoPhos, Figure 7.3), developed by Feringa, 
Minnaard, de Vries et al. in collaboration with DSM Pharmaceutical Products.16,17 Over the 
past years, these monodentate ligands have proven to be useful in the asymmetric 
hydrogenation of a range of prochiral olefins, including α- and β-dehydroamino acids and 
esters,18 itaconic acid derivatives,18b-e enol acetates and enol carbamates,19 enamides20 
acrylic acids21 and imines.22 Besides asymmetric hydrogenation, this class of ligands has 
also been successfully applied, for example, in the enantioselective copper-catalyzed 
conjugate addition of dialkylzinc reagents,23 in allylic substitution,24 in the asymmetric 
Heck reaction25 and in asymmetric arylations with arylboronic acids.26 
Their good accessibility and modular nature makes these ligands particularly 
suitable for combinatorial applications.27 Phosphoramidites are essentially built up from 
two fragments, both of which can be varied to a large extent. In a common synthetic 
procedure, a (non-)chiral diol is converted into the corresponding chlorophosphite by 
refluxing in an excess of PCl3. This chlorophosphite is then reacted with the appropriate 
(non-)chiral amine in the presence of triethylamine, resulting in the phosphoramidite ligand, 
which can often be purified by crystallization (Figure 7.3). 
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Figure 7.3. Structure of MonoPhos and a general synthetic route for phosphoramidite ligands. 
 
 Although MonoPhos was the first phosphoramidite ligand that was discovered to 
induce high enantioselectivities in olefin hydrogenation,18e follow-up research has shown 
other, analogous ligands to be better suited for numerous substrates. For instance, piperidyl-
substituted phosphoramidite L1 (PipPhos) was identified as an excellent ligand for the 
asymmetric hydrogenations of a range of compounds, including dehydroamino acid and 
itaconic acid derivatives18b and enol acetates/carbamates.19 For this reason we decided to 
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start our investigations into the hydrogenation of 6a–d with L1 (Table 7.1). The 
hydrogenations were carried out in an Endeavor apparatus,28 which is essentially an 
autoclave with eight parallel reaction vessels capable of accommodating 5 mL of solvent. 
In addition, it allows the continuous monitoring of hydrogen uptake, thereby enabling the 
reactions to be followed in time. The hydrogenations in Table 7.1 were carried out at a 
pressure of 5 bar with 0.5 mmol of substrate, using 2 mol % of [Rh(COD)2]BF4 and 4 
mol % of ligand. 
 
Table 7.1. Asymmetric hydrogenation in Endeavor apparatus. 
HO2C
CO2Me
R
6a-d
HO2C
CO2Me
R
5a-d
O
O
P N
(S)-L1
O
O
P N
(S)-L2
O
O
P N
(S)-L3
[Rh(COD)2]BF4 (2 mol %), L (4 mol %)
solvent (0.1 M), H2 (5 bar), rt, 18 h
 
entry substrate R ligand solvent product conv. (%)a 
ee 
(%)a,b 
1 6a H (S)-L1 CH2Cl2 5a >99 97 
2 6b Et (S)-L1 CH2Cl2 5b 98 94 
 3c 6c Ph (S)-L1 CH2Cl2 5c 91 52 
4 6d p-MeOC6H4 (S)-L1 CH2Cl2 5d 60 46 
5 6a H (S)-L1 MeOH 5a >99 –7 
6 6b Et (S)-L1 MeOH 5b n.d.d n.d. 
7 6c Ph (S)-L1 MeOH 5c n.d.d n.d. 
8 6d p-MeOC6H4 (S)-L1 MeOH 5d n.d.d n.d. 
9 6d p-MeOC6H4 (S)-L2 CH2Cl2 5d 86 62 
10 6d p-MeOC6H4 (S)-L3 CH2Cl2 5d 78 –51 
a Determined by HPLC. b (S)-configuration. c Pressure slowly raised to 25 bar due to leakage. d No significant H2-
consumption was observed. 
 
We were pleased to find that the hydrogenation of 6a and 6b in dichloromethane 
proceeded nearly quantitatively and with excellent ee’s of 97% and 94% (entries 1 and 2), 
thereby eliminating the need for extensive optimization for these substrates. On the other 
hand, the reactions of 6c and 6d under the same conditions resulted in lower conversions29 
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and ee’s of 52% and 46% (entries 3 and 4). A striking difference in reactivity was observed 
when carrying out the hydrogenations of 6a–d in methanol instead of dichloromethane. No 
significant hydrogen uptake was observed for 6b–d, indicating that no reaction had taken 
place (entries 6–8). The reaction of 6a was found to proceed quantitatively, however, 
hardly any enantiomeric excess was observed (entry 5). This extreme solvent dependency 
has been observed before with these catalyst systems and in many cases the use of non-
protic solvents is found to give the best results.17 
 Additionally, we investigated if different ligand backbones had an influence on the 
enantioselectivity in the hydrogenation of the aryl-substituted substrate 6d (entries 9 and 
10). We employed an octahydro-analogue of L1 (i.e. L2) and a ligand with a 
3,3'-dimethylbinol moiety (L3). Unfortunately, these two ligands offered only a slight 
improvement in terms of enantioselectivity. The result from entry 10 is remarkable, since 
the opposite enantiomer is apparently formed, possibly due to a different coordination mode 
of substrate and/or ligands to the rhodium. 
 Furthermore, we decided to study the influence of lower catalyst loadings on the 
conversion and enantioselectivity of the hydrogenations of 6a and 6b (Table 7.2). Lowering 
the amount of catalyst from 2 mol % to 0.5 mol % actually improved the ee of 5a somewhat 
(99.7%, entry 1). On the other hand, the ee of 5b appeared to be surprisingly low (58%, 
entry 2), indicating that for this substrate at least 2 mol % of catalyst is required to obtain an 
acceptable ee. This latter result can probably be ascribed to the presence of minor 
impurities in the starting material.  
 
Table 7.2. Influence of lower catalyst loadings.a 
entry substrate R cat. (mol %) ligand 
conc. 
(M) product 
conv. 
(%)b 
ee 
(%)b,c 
1 6a H 0.5 (S)-L1 0.2 5a >99 99.7 
2 6b Et 0.5 (S)-L1 0.2 5b >99 58 
3 6a H 1 (S)-L2 0.1 5a >99 98 
4 6b Et 1 (S)-L2 0.1 5b >99 91 
a Conditions: [Rh(COD)2]BF4/ligand (1:2), CH2Cl2, H2 (5 bar), rt, 18 h. b Determined by HPLC. c (S)-
configuration. 
 
The use of ligand L2, which was already found to slightly improve the 
enantioselectivity for 6c (see Table 7.1), resulted in comparable ee’s for 6a and 6b (entries 
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3 and 4). It should be noted that these two experiments were performed with 1 mol % of 
catalyst, making comparison in the case of 6b more complicated, in view of the influence of 
catalyst loading discussed earlier (see above). 
 
7.4 Asymmetric hydrogenation: library experiment 
 
 Because the hydrogenation experiments conducted so far with 6c and d did not 
result in satisfactory enantioselectivities, we decided to carry out a high-throughput 
experiment with a solution-phase library of 48 ligands. Figure 7.4 shows a schematic 
representation of the parallel ligand synthesis and subsequent hydrogenation. 
 
P Cl
O
O
Et3N
R1R2NH
or
R1OH
Parallel
synthesizer
Parallel
filtration
-Et3N.HCl
Parallel
reactor
Substrate (6d)
[Rh(COD)2]BF4 ResultsLigand
library  
Figure 7.4. Schematic representation of the automated ligand synthesis and subsequent hydrogenation. 
 
The ligands were prepared in a fully automated fashion by a liquid handling robot, 
which was placed inside a glove box. Stock solutions of the chlorophosphite, triethylamine 
and the amine or the alcohol (for the preparation of phosphites rather then 
phosphoramidites) were dispensed into a microplate, which was shaken for 2 h followed by 
parallel filtration, resulting in the different ligand solutions. Next, fractions of these 
solutions were transferred to 48 vials, alongside solutions of [Rh(COD)2]BF4 and substrate 
6d.30 The 48 parallel hydrogenations were performed in dichloromethane in a Premex 96-
Multi Reactor,31 using 4 mol % of catalyst and 25 bar of H2 at room temperature for 6 h. 
Afterwards, conversions and ee’s were determined by chiral HPLC. 
The 48 ligands that were selected for the parallel hydrogenation experiment are 
depicted in Figure 7.5a. Besides eight secondary amines, we decided to include five 
primary amines, because we envisaged that the steric hindrance of 6c–d can possibly be 
compensated for by using less hindered ligands. Phosphoramidite ligands derived from 
primary amines are generally known to be somewhat unstable, specially towards column 
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chromatography purification used in traditional synthesis. The mild purification used in the 
automated synthesis and the immediate coordination of the ligand to the metal makes these 
ligands easily available. 
 
1 9
2 10
3 11
A B C
4 12
5 13
6 14
7 15
8 16
O
O
P R O
O
P R
O
O
P R
HO2C
CO2Me
6d
HO2C
CO2Me
5d
[Rh(COD)2]BF4 (4 mol %)
L (8 mol %)
CH2Cl2, H2 (25 bar)
rt, 6 h
OMe OMe
HN H2N
HN H2N
HN
Ph
H2N
Ph
HN H2N
Ph
HN
Ph H2N
HO
HN
HO
HOHN
HN
 
1 10 100 48 86 20 100 9 1 9
2 17 90 7 51 14 90 10 2 10
3 8 38 10 1 29 7 11 3 11
conversion 4 1 100 1 4 2 27 12 4 12 100-90
5 26 100 30 0 34 7 13 5 13 90-80
6 31 95 17 8 18 100 14 6 14 80-70
7 13 75 21 3 14 84 15 7 15 70-60
8 14 18 11 8 17 48 16 8 16 60-50
50-40
1 1 96 14 12 6 94 9 1 9 40-30
2 21 95 41 58 6 91 10 2 10 30-20
3 23 82 55 9 74 65 11 3 11 20-10
ee 4 83 98 67 95 44 62 12 4 12 10-0
5 99 68 99 0 100 97 13 5 13
6 21 94 80 11 26 87 14 6 14
7 21 87 76 27 44 45 15 7 15
8 4 59 68 61 20 32 16 8 16
A B C
BA B C C
A B C
A
 
Figure 7.5. Asymmetric hydrogenation of 6d; (a) List of amines/alcohols and backbones used in ligand library. (b) 
Conversions and (absolute) ee values. 
(a) 
(b) 
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In addition, we used three different alcohols instead of amines, resulting in the 
corresponding phosphite ligands, reported by Reetz and co-workers, which are also known 
to be excellent ligands for asymmetric hydrogenation.32 Moreover, we chose to study three 
different BINOL-type ligand backbones (i.e. A–C), which in combination with the 16 
amine/alcohol fragments eventually resulted in a library of 48 different ligands. 
 Figure 7.5b shows the results obtained in the asymmetric hydrogenation of 6d. To 
our delight, several entries resulted in both a conversion and an ee of ≥90%. In general, the 
ligands based on the normal BINOL-backbone (A) appeared to be the most suitable. Entries 
A9, A10, A12 and A14 showed the best results, with conversions of 90–100% and ee’s of 
94–98%. The ligands that were based on the octahydro-BINOL-backbone (C) were found 
to give lower conversions and ee’s, with the exception of those used in entries C9 and C10, 
which produced data comparable to those from the analogous ligands in entries A9 and 
A10. 
 Clearly, the use of phosphoramidite ligands based on primary amines is the key to 
success for the hydrogenation of 6d. Whereas these ligands were in a number of cases 
found to give excellent ee’s and conversions, the ligands based on secondary amines give 
poor conversions and in most cases low ee’s. A noteworthy exception is presented by the 
ligands based on N-benzylaniline (entries A5, B5 and C5). Although the conversions 
obtained with these ligands are poor (26–34%), the observed ee’s are surprisingly high (99–
100%). In addition, the isopropyl-substituted phosphite ligand in entry A14 also gave a 
high conversion (95%) and ee (94%), suggesting that monodentate phosphite ligands are 
also suitable for the hydrogenation of these substrates. 
Finally, the more hindered 3,3'-dimethyl-BINOL-based ligands (B) were found to 
be less suitable for this specific substrate, generally exhibiting poor conversions and at best 
only moderate ee’s. This is again in agreement with the observation that less hindered 
ligands are required for the hydrogenation of more hindered substrates. 
In the end, two ligands were selected from the library to be scaled up to 0.5 mmol 
scale and to test if similar results could be obtained with substrate 6c. First of all, 
phosphoramidite ligand L4 was selected based on the results in Figure 7.5 (entry A9). In 
addition, we chose to use the analogous phosphite ligand L5 in view of possible stability 
issues with L4 (Figure 7.6). 
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Figure 7.6. Isopropyl-substituted phosphoramidite (L4) and phosphite (L5) ligands. 
 
 Table 7.3 shows the application of L4 and L5 in the hydrogenation of 6c-d on 
0.5 mmol scale in the Endeavor reactor. The ligands were prepared in a similar fashion as 
in the library experiment, namely in a glove box and using the same stock solutions as used 
by the parallel synthesizer. First of all, we were pleased to see that the behavior of 6c in 
terms of reactivity and enantioselectivity was almost identical to that of 6d. The use of 
phosphite ligand L5 resulted in quantitative conversions and ee’s of 96 and 97% (entries 3 
and 4), which is slightly better than the results obtained in the library experiment. However, 
phosphoramidite ligand L4 was found to give somewhat lower ee’s than those observed in 
the library experiment (91–92% compared to 96%, entries 1 and 2)).  
 
Table 7.3. Translation of library results to 0.5 mmol Endeavor-experiments.a 
entry substrate R ligandb product conv (%)c ee (%)c,d 
1 6c Ph (S)-L4 5c >99 91 
2 6d p-MeOC6H4 (S)-L4 5d >99 92 
3 6c Ph (S)-L5 5c >99 97 
4 6d p-MeOC6H4 (S)-L5 5d >99 96 
a Conditions: [Rh(COD)2]BF4 (1 mol %), ligand (2 mol %), solvent (0.1 M), H2 (25 bar), rt, 2 h. b Ligands were 
prepared in a glove box and not further purified. c Determined by HPLC. d (S)-configuration. 
 
 Preforming the catalyst complex [(L)2Rh(COD)]BF4 prior to the hydrogenation 
did not improve the results for both substrates and ligands. Therefore, it was decided to 
select L5 as the ligand for the gram-scale hydrogenation of 6c–d and to prepare a stock 
solution of this ligand in the glove box, as was done with the experiments in Table 7.3. 
 
7.5 Asymmetric hydrogenation: autoclave experiments 
 
 Since the mono-acids 5a–d are intended as building blocks for cyclic 
dehydroamino acids 1, the asymmetric hydrogenations of 6a–d evidently need to be carried 
 
Chapter 7 
 114
out on a preparative scale. Thus, gram-scale hydrogenations of 6a–d were performed in an 
autoclave vessel, using ligand L1 for substrates 6a–b and ligand L5 for substrates 6c–d 
(Table 7.4).  
 The hydrogenations of 6a–b (entries 1 and 2) were carried out under 10 bar of H2 
pressure using a relatively low amount of catalyst (0.5 mol %) for 6a, since lower catalyst 
loadings were found not to diminish the conversion and ee for this substrate (see Table 7.2). 
Gratifyingly, both reactions resulted in complete conversion of the starting material within 
3 h and a product with an ee of 99%. 
 
Table 7.4. Autoclave hydrogenations at gram-scale. 
HO2C
CO2Me
R
6a-d
HO2C
CO2Me
R
5a-d
[Rh(COD)2]BF4/L (1:2) 
CH2Cl2 , H2, rt
 
entry substr. R cat. (%) ligand 
conc. 
(M) 
press. 
(bar) prod. 
conv. 
(%)a 
ee 
(%)b 
1 6a H 0.5 (S)-L1 0.28 10 5a >99 99 (S) 
2 6b Et 2 (S)-L1 0.11 10 5b >99 99 (S) 
3 6c Ph 2 (R)-L5c 0.10 25 5c >99 94 (R) 
4 6d p-MeO-C6H4 
2 (R)-L5c 0.12 25 5d >99 89 (R) 
a Determined by 1H-NMR. b Determined by HPLC. c Ligand synthesized by hand in a glove-box; (R)-isomer was 
prepared. 
 
 For the hydrogenation of 6c–d, a solution of ligand L5 was synthesized in a glove 
box under identical conditions as employed in the library experiment. Next, the appropriate 
amount of this solution, the [Rh(COD)2]BF4 and the dichloromethane were transferred into 
the high-pressure vessel and the hydrogenation was performed under 25 bar of H2 (entries 3 
and 4). The conversions of the starting materials were again quantitative, however, the ee’s 
were somewhat lower than those observed in the library and Endeavor-experiments. In the 
end, compounds 5c and 5d were isolated with ee’s of 94% and 89%, respectively. 
 
7.6 Conversion to iodide scaffolds 
 
 The selected route from the mono-acids 5 to the corresponding olefinic iodides 4 
involved selective reduction of the carboxylic acids with BH3·SMe2 followed by oxidation 
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to the aldehyde with trichloroisocyanuric acid (TCCA) and TEMPO.33 Subsequent Wittig 
reaction of the crude aldehydes resulted in the olefinic esters 13, which were purified by 
column chromatography. Generation of the phosphonium ylide in the Wittig reaction was 
initially carried out with n-BuLi, however, due to low yields and poor reproducibility we 
decided to switch to NaHMDS as a base. Next, the ester groups were converted into the 
corresponding iodides by subsequent reduction with LiAlH4 and iodination of the crude 
alcohol with I2/PPh3/imidazole. 
 The syntheses of 13a–b via this route proceeded well, resulting in isolation of the 
two products in 56% and 60% over three steps (Scheme 7.4). However, a setback was that 
the ee dropped to 75% and 85% for 13a and b, respectively. This partial racemization might 
occur during the Wittig reaction, possibly due to remaining NaHMDS or due to the basicity 
of the phosphonium ylide. Finally, 13a and b were reduced with LiAlH4 in THF followed 
by iodination with I2/PPh3, resulting in iodides 4a and b in yields of 86% and 78% over two 
steps. 
 
HO2C
CO2Me
5a (R = H; ee 99%)
5b (R = Et; ee 99%)
CO2Me
13a (R = H): 56%, ee 75%
13b (R = Et): 60%, ee 85%
1) BH3·SMe2, THF
2) TCCA, TEMPO
    DCM
3) Ph3PMeBr
    NaHMDS, THF
I
4a (R = H): 86%
4b (R = Et): 78%
1) LiAlH4, Et2O
2) I2, PPh3
    imidazole, DCM
R R R
 
Scheme 7.4. Transformation of hydrogenation products into unsaturated iodides. 
 
 The synthesis of 13c proceeded in a similar yield as observed for 13a and 13b 
(61% over 3 steps), however, application of this synthetic route to 5d proved to be 
problematic (Scheme 7.5). After reduction of the carboxylic acid function of 5d, oxidation 
of the alcohol to the corresponding aldehyde with TCCA/TEMPO resulted in multiple 
products, presumably due to overoxidation at for instance the benzylic position. Purification 
of the alcohol before the oxidation or the use of lower amounts of TCCA did not improve 
the outcome of this reaction, forcing us to apply a different oxidation method. Thus, 
oxidation of the alcohol with TPAP/NMO in acetone produced a single aldehyde and 
subsequent Wittig olefination resulted in 13d in an overall yield of 58%. Moreover, a small 
amount of racemization was again observed for both 13c and d and the compounds were 
isolated with ee’s of 84% and 83%, respectively. 
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HO2C
CO2Me
1) BH3·SMe2, THF
2) TCCA, TEMPO
    DCM
3) Ph3PMeBr
    NaHMDS, THF
5c
ee 94%
CO2Me
13c  61%
 ee 84%
4c  80%
1) LiAlH4, THF
2) I2, PPh3
    imidazole, DCM
I
HO2C
CO2Me
OMe
5d
ee 89%
BH3·SMe2
THF CO2Me
OMe
HO
TCCA
TEMPO
DCM
multiple
products
1) TPAP, NMO
    acetone
2) Ph3PMeBr
    NaHMDS, THF
CO2Me
OMe
13d  58% (3 steps)
ee 83%
OMe
1) LiAlH4, THF
2) I2, PPh3
    imidazole, DCM I
4d  88%
 
Scheme 7.5. Synthesis of aryl-substituted iodides. 
 
 Finally, transformation of 13c and 13d into the corresponding olefinic iodides 
proceeded as expected, resulting in the isolation of 4c and 4d in 80% and 88% over two 
steps. 
 
7.7 Alkylation of protected dehydroalanine and subsequent 
RCM 
 
 With the four desired unsaturated iodides in hand, the stage was set for the 
synthesis of the corresponding RCM-precursors. Similar to the synthesis of the racemic 
precursors described in Chapter 6, 2a–d were prepared by alkylation of protected 
dehydroalanine 334 (Scheme 7.6). The alkylations were performed using the optimized 
conditions described in Section 6.4. Deprotonation of 3 at room temperature in DMF using 
NaH as a base and subsequent addition of the appropriate iodide resulted in the formation 
of RCM-precursors 2a–d in yields of 58–77%. 
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N
Boc
CO2Me
4a-d CO2MeHN
Boc
NaH
DMF, 0 °C → rt
+
3
N
Boc
CO2Me
N
Boc
CO2Me N
Boc
CO2Me
OMe
2a (58%) 2b (67%)
2c (61%) 2d (77%)  
Scheme 7.6. Preparation of RCM precursors. 
 
 Finally, we were pleased to find that ring-closing metathesis of olefins 2a–d 
proceeded readily. Reaction of these compounds with the second generation Grubbs 
catalyst (A) in toluene at 80 °C for 4 h resulted in the formation of functionalized cyclic 
dehydroamino acids 1a–d in excellent yields of 81–90% (Scheme 7.7). Determination of 
the ee’s of the products by chiral HPLC, led to the conclusion that no significant 
racemization had taken place during the four-step conversions of 13a–d to 1a–d. 
 
A (10 mol %)
PhMe
80 °C, 4 h
N
Boc
CO2Me
1a 81%
ee 73%
N
Boc
CO2Me
1b 82%
ee 83%
N
Boc
CO2Me
1c 89%
ee 82%
2a-d
N
Boc
CO2Me
1d 90%
ee 81%
OMe
MesN NMes
Ru
PhPCy3
Cl
Cl
 
Scheme 7.7. Ring-closing metathesis of dehydroamino acids. 
 
 
7.8 Conclusions and future prospects 
 
 We have demonstrated that enantiomerically enriched 4-substituted cyclic 
dehydroamino acids can be prepared via a novel combined asymmetric hydrogenation/ring-
closing metathesis approach, starting from itaconic acid mono-esters. Application of the 
monodentate phosphoramidite/phosphite ligand library proved to be a useful method for 
achieving high enantioselectivities in the hydrogenation of substituted itaconic acid 
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derivatives. Unfortunately, a slight drop in ee was observed during conversion of the 
hydrogenation products to the corresponding metathesis-precursors, presumably due to 
partial racemization under the basic conditions of the Wittig reaction step. Finally, RCM of 
the dehydroamino acid double bonds with the allylically substituted olefinic bonds 
proceeded efficiently, thereby yielding the desired 4-substituted cyclic dehydroamino acids 
in excellent yields.35 
These substituted heterocycles present a useful class of synthetic building blocks. 
First of all, the dehydroamino acid double bonds may be further functionalized through for 
instance Michael additions, radical additions and cycloadditions.36 In addition, asymmetric 
hydrogenation of cyclic dehydroamino acids could in principle lead to both the D- and L-
pipecolic acid derivatives. These specific hydrogenations have only been scarcely 
investigated in the past37 and recent achievements in catalyst development – e.g. application 
of monodentate phosphorus ligands – would validate further research into this area. 
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7.10 Experimental section 
 
General information 
For general experimental details, see Section 2.8. 
Ligands L2 and L3 were available in the lab at the time of need. In addition, they can be synthesized 
through the same procedure that was employed for L1. 
 
4-Methoxy-2-methylene-4-oxobutanoic acid (6a) 
Amberlyst-15H+ (2.4 g) was washed to neutral with MeOH and added to a solution 
of itaconic acid 7 (2.03 g, 15.6 mmol) in MeOH (40 mL). After gentle stirring for 6 
d at room temperature, the suspension was filtered over Celite and the solvent 
evaporated. The resulting light brown solid was dissolved in CH2Cl2 and filtered over Celite after 
HO2C
CO2Me
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which the solvent was evaporated yielding a white solid. The crude product was recrystallized 
(heptane/toluene, 3:2) yielding pure 6a (2.11 g, 94%) as white crystals. The analytical data agreed 
with those reported in literature.38 1H-NMR (CDCl3, 300 MHz): δ 6.48 (m, 1H), 5.84 (m, 1H), 3.71 (s, 
3H), 3.35 (s, 2H). 13C-NMR (CDCl3, 75 MHz): δ 171.2, 171.1, 133.3, 131.1, 52.3, 37.2. 
 
(E)-2-(2-Methoxy-2-oxoethyl)pent-2-enoic acid (6b) 
To a solution of dimethyl maleate (5.03 g, 33.5 mmol) in MeCN (100 mL) were 
added 1-nitropropane (3.05 mL, 33.5 mmol) and DBU (5.05 mL, 33.6 mmol). The 
mixture was stirred at room temperature for 20 h, after which the volatiles were 
removed in vacuo. The crude product was purified by column chromatography 
(EtOAc/heptane, 1:6). The resulting diester was dissolved in EtOH (30 mL) and aqueous NaOH 
(0.5M, 150 mL) was added. The reaction was stirred at reflux temperature for 1 h, followed by 
evaporation of most of the EtOH under reduced pressure. Extra H2O (100 mL) was added and the 
mixture was washed with EtOAc (3 × 100 mL). Next, the aqueous layer was acidified (pH ~ 1) with 
2M HCl, extracted with EtOAc (2 × 150 mL) and the organic layers were dried (MgSO4) and 
concentrated. The resulting di-acid was dissolved in MeOH (150 mL), Amberlyst-15H+ (3.5 g) was 
added and the reaction was refluxed for 7 h. The mixture was filtered over Celite and concentrated in 
vacuo, resulting in crude 6b. The product was recrystallized from toluene/heptane, yielding 6b as a 
white crystalline solid. The overall yield was 3.06 g (53%). The analytical data agreed with those 
reported in literature.14a 1H-NMR (CDCl3, 300 MHz): δ 7.09 (t, J = 7.6 Hz, 1H), 3.68 (s, 3H), 3.34 (s, 
2H), 2.22 (m, 2H), 1.07 (t, J = 7.6 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 172.3, 171.1, 150.0, 124.3, 
52.1, 31.7, 22.5, 12.8. 
 
(E)-2-Benzylidene-4-methoxy-4-oxobutanoic acid (6c) 
To a refluxing suspension of KOtBu (16.5 g, 140.5 mmol) in tBuOH (100 mL) was 
carefully added a solution of dimethyl succinate (23.3 g, 159 mmol) and 
benzaldehyde (13.6 g, 127 mmol) in tBuOH (100 mL). The reaction was stirred at 
reflux temperature for 18 h, after which the solvent was removed in vacuo. The 
residue was dissolved in 1M HCl (100 mL) and this solution was extracted with EtOAc (3 × 100 mL). 
The organic layers were dried (Na2SO4) and concentrated. The resulting mono-acid was dissolved 
EtOH (50 mL) and aqueous NaOH (2M, 100 mL) was added. The reaction was stirred at reflux 
temperature for 1 h, followed by evaporation of most of the EtOH under reduced pressure. Extra H2O 
(100 mL) was added and the mixture was washed with EtOAc (3 × 100 mL). Next, the aqueous layer 
was acidified (pH ~ 1) with 2M HCl, extracted with EtOAc (2 × 100 mL) and the organic layers were 
dried (Na2SO4) and concentrated. The resulting di-acid was dissolved in MeOH (170 mL), 
Amberlyst-15H+ (5.8 g) was added and the reaction was refluxed for 16 h. The mixture was filtered 
over Celite and concentrated in vacuo, resulting in crude 6c. The product was recrystallized from 
toluene/heptane, yielding 6c as a white solid. The overall yield was 11.5 g (41%). The analytical data 
agreed with those reported in literature.39 1H-NMR (CDCl3, 300 MHz): δ 8.03 (s, 1H), 7.38 (m, 5H), 
3.75 (s, 3H), 3.56 (s, 2H). 13C-NMR (CDCl3, 75 MHz): δ 172.7, 171.4, 144.3, 134.6, 129.3, 129.2, 
128.7, 125.2, 52.3, 33.2. 
 
(E)-4-Methoxy-2-(4-methoxybenzylidene)-4-oxobutanoic acid (6d) 
To a refluxing suspension of KOtBu (16.8 g, 150 mmol) in tBuOH (60 mL) was 
carefully added a solution of dimethyl succinate (17.5 g, 120 mmol) and 
4-methoxybenzaldehyde (13.6 g, 100 mmol) in tBuOH (60 mL). The reaction 
was stirred at reflux temperature for 18 h, after which the solvent was removed 
in vacuo. The residue was dissolved in 1M HCl (80 mL) and this solution was extracted with EtOAc 
(3 × 75 mL). The organic layers were dried (Na2SO4) and concentrated. The resulting mono-acid was 
dissolved EtOH (40 mL) and aqueous NaOH (2M, 100 mL) was added. The reaction was stirred at 
HO2C
CO2Me
HO2C
CO2Me
HO2C
CO2Me
OMe
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reflux temperature for 2 h, followed by evaporation of most of the EtOH under reduced pressure. 
Extra H2O (100 mL) was added and the mixture was washed with EtOAc (3 × 100 mL). Next, the 
aqueous layer was acidified (pH ~ 1) with 2M HCl, extracted with EtOAc (3 × 150 mL) and the 
organic layers were dried (Na2SO4) and concentrated. The resulting di-acid was dissolved in MeOH 
(200 mL), Amberlyst-15H+ (8.5 g) was added and the reaction was refluxed for 18 h. The mixture 
was filtered over Celite and concentrated in vacuo, resulting in crude 6d. The product was 
recrystallized from toluene/heptane, yielding 6d as an off-white crystalline solid. The overall yield 
was 13.1 g (52%). 1H-NMR (CDCl3, 300 MHz): δ 7.96 (s, 1H), 7.35 (d, J = 8.8 Hz, 2H), 6.93 (d, J = 
8.8 Hz, 2H), 3.83 (s, 3H), 3.74 (s, 3H), 3.59 (s, 2H). 13C-NMR (CDCl3, 75 MHz): δ 172.6, 171.6, 
160.6, 144.0, 131.2, 127.1, 122.8, 114.2, 55.4, 52.3, 33.3. HRMS (CI+): calculated for C13H14O5, 
[M]+: 250.0841, found: 250.0835. 
 
O,O'-(S)-(1,1'-2,2'-Diyl)-N-(1-piperidinyl)phosphoramidite (L1) 
A suspension of (S)-binol (17.5 g, 61.2 mmol) in PCl3 (60 mL) was refluxed 
under an inert atmosphere for 4 h. The PCl3 was evaporated in vacuo, toluene 
(50 mL) was added and again evaporated in vacuo. Next, the residue was 
dissolved in dry toluene (120 mL) and piperidine (13.3 mL, 2.2 equiv) was 
added. The mixture was stirred for 16 h, after which Et2O (50 mL) was added 
and the solids were filtered off. The filtrate was concentrated, yielding an off-white solid, which could 
be recrystallized from toluene/heptane. The product was isolated as a white crystalline solid in an 
overall yield of 13.7 g (56%). Analytical data agreed with those reported in literature.40 1H-NMR 
(CDCl3, 300 MHz): δ 7.54–7.19 (m, 8H), 3.10–2.89 (m, 4H), 1.60–1.38 (m, 6H). 13C-NMR (CDCl3, 
75 MHz): δ 149.8, 149.2, 132.6, 131.3, 130.6, 130.1, 129.8, 128.2, 127.0, 125.9, 124.7, 124.4, 124.0, 
123.9, 122.7, 122.1, 122.0, 45.4, 45.1, 27.0, 26.8, 24.6. 
 
Endeavor experiments 
Into the glass reaction vessels the substrate, Rh(COD)2BF4 and the ligand were weighed in. The 
vessels were placed in the reactors and 5 mL of solvent was added. The reactors were then purged for 
30 minutes with N2 before applying a hydrogen atmosphere. The pressure was kept constant during 
the reaction and the hydrogen uptake was monitored. After completion of the reaction, the reactors 
were opened and samples were taken, which were filtered over a short silica column and subjected to 
ee determination by GC or HPLC. Conversions were determined by 1H-NMR. 
 
Library synthesis and hydrogenation 
General: The library was synthesized using a Zinsser Lissy liquid handling robot equipped with 4 
probes and placed inside a glove box. Whatman PKP 2mL 96-well filter plates in combination with 
the UniVac 3 vacuum manifold were used to perform the parallel filtration of the ligand library. The 
hydrogenation reaction is carried out in a Premex 96-Multi Reactor31 that can accommodate 96 
reactions vessels at the same temperature and hydrogen pressure. 
Conditions: Into 48 wells of the filter plate were transferred a solution of the desired chlorophosphite 
(0.15 M; 333 μL, 0.05 mmol), a triethylamine solution (0.50 M; 100 μL, 0.05 mmol) and solutions of 
the selected amines and alcohols (0.15 M; 333 μL, 0.05 mmol). The microplate was shaken for 2 
hours, after which parallel filtration was performed to remove the precipitated salts, yielding 48 
solutions of the different ligands (0.065 M). The appropriate amounts of the ligand solutions (93 μL, 
8 mol %) were transferred into 48 vials, equipped with stirring bars and the toluene was allowed to 
evaporate overnight. Next, a stock solution of Rh(COD)2BF4 in CH2Cl2 (0.020 M; 150 μL, 4 mol %) 
was added to each of the vials, allowing the formation the different catalysts. A solution of 6d in 
CH2Cl2 (0.03 M; 2.5 mL, 75 μmol) was then added to each vial and the resulting mixtures were 
transferred under a N2 atmosphere to the parallel hydrogenation apparatus. The mixtures were 
hydrogenated under 25 bar of H2 for 6 h and the conversions and ee’s were determined by chiral 
O
O
P N
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HPLC (Chiralcel OD column; heptane/iso-propanol/TFA, 95:5:0.05). The conversions and (absolute) 
ee’s are depicted in Figure 7.5. 
 
General procedure A for the hydrogenation of 6a–d in an autoclave vessel 
To a Schlenk tube were added Rh(COD)2BF4, the ligand and dry CH2Cl2 (5 mL) under a N2 
atmosphere. The resulting solution was stirred at room temperature for 10 min. In a Parr Hastelloy C 
autoclave were sequentially added 6, CH2Cl2 (45 mL) and the catalyst solution. Next, the vessel was 
closed and the reaction mixture was stirred by an overhead turbine stirrer at room temperature and 
under N2. Next, H2 pressure was applied and the mixture was stirred for the specified time. The 
conversion was measured by 1H-NMR and the ee was determined by chiral HPLC. The solvent was 
evaporated and the product was purified by column chromatography (EtOAc/heptane, 1:2). 
 
(S)-4-Methoxy-2-methyl-4-oxobutanoic acid (5a) 
This compound was prepared from 6a (2.01 g, 13.9 mmol) following general 
procedure A (0.5 mol % Rh(COD)2BF4, 1.0 mol % L1, 10 bar H2, 3 h). The 
conversion was >99%, the isolated yield was 1.88 g (92%). The ee was determined by HPLC to be 
98.6% (Chiralpak AD column; heptane/n-butanol/TFA, 95:5:0.05). Analytical data agreed with those 
reported in literature.41 1H-NMR (CDCl3, 300 MHz): δ 3.69 (s, 3H), 3.02-2.91 (m, 1H), 2.75 (dd, J = 
8.1, 16.7 Hz, 1H), 2.43 (dd, J =  6.0, 16.7 Hz, 1H), 1.26 (d, J = 7.2 Hz, 3H). 13C-NMR (CDCl3, 75 
MHz): δ 181.5, 172.3, 51.8, 37.1, 35.7, 16.8. [α]22D = –10.6 (c 0.8, CHCl3). 
 
(S)-2-(2-Methoxy-2-oxoethyl)pentanoic acid (5b) 
This compound was prepared from 6b (0.94 g, 5.45 mmol) following general 
procedure A (2.0 mol % Rh(COD)2BF4, 4.0 mol % L1, 10 bar H2, 3 h). The 
conversion was >99%, the isolated yield was 0.88 g (93%). The ee was determined 
by HPLC to be 98.5% (Chiralpak AD column; heptane/ethanol/ TFA, 95:5:0.05). 
Analytical data agreed with those reported in literature.14a A small amount was converted into the di-
acid42 in order to compare the sign of the optical rotation and thereby determine the absolute 
stereochemistry. 1H-NMR (CDCl3, 300 MHz): δ 3.68 (s, 3H), 2.87 (m, 1H), 2.70 (m, 1H), 2.44(dd, J 
= 5.1, 16.6 Hz, 1H), 1.73–1.46 (m, 2H), 1.43–1.21 (m, 2H), 0.92 (t, J = 7.2 Hz, 3H). 13C-NMR 
(CDCl3, 75 MHz): δ 180.7, 172.4, 51.9, 40.8, 35.4, 33.8, 20.1, 13.8. [α]22D = –15.2 (c 0.6, CHCl3). 
 
(R)-2-Benzyl-4-methoxy-4-oxobutanoic acid (5c) 
This compound was prepared from 6c (1.11 g, 5.04 mmol) following general 
procedure A (2.0 mol % Rh(COD)2BF4, 4.0 mol % L5, 25 bar H2, 16 h). The 
conversion was >99%, the isolated yield was 1.05 g (94%). The ee was determined 
by HPLC to be 93.7% (Chiralpak AD column; heptane/ethanol/ TFA, 95:5:0.05). 
Analytical data agreed with those reported in literature.43 A small amount was converted into the di-
acid,44 in order to compare the sign of the optical rotation and thereby determine the absolute 
stereochemistry. 1H-NMR (CDCl3, 300 MHz): δ 7.33–7.16 (m, 5H), 3.64 (s, 3H), 3.21–3.10 (m, 2H), 
2.79 (m, 1H), 2.65 (dd, J = 8.8, 16.9 Hz, 1H), 2.41 (dd, J = 4.7, 16.9 Hz, 1H). 13C-NMR (CDCl3, 75 
MHz): δ 179.5, 172.2, 137.9, 129.0, 128.6, 126.8, 51.8, 42.7, 37.3, 34.4. [α]22D = +11.1 (c 0.5, 
CH2Cl2).  
 
(R)-4-Methoxy-2-(4-methoxybenzyl)-4-oxobutanoic acid (5d) 
This compound was prepared from 6d (1.49 g, 5.95 mmol) following general 
procedure A (2.0 mol % Rh(COD)2BF4, 4.0 mol % L5, 25 bar H2, 2 h). The 
conversion was >99%, the isolated yield was 1.41 g (94%). The ee was 
determined by HPLC to be 89.0% (Chiralcel OD column; 
heptane/iso-propanol/TFA, 95:5:0.05). 1H-NMR (CDCl3, 300 MHz): δ 7.09 (d, J = 8.7 Hz, 2H), 6.83 
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(d, J = 8.7 Hz, 2H), 3.78 (s, 3H), 3.64 (s, 3H), 3.17–3.03 (m, 2H), 2.76–2.60 (m, 2H), 2.40 (dd, J = 
4.8, 16.9 Hz, 1H). 13C-NMR (CDCl3, 75 MHz): δ 178.6, 172.3, 158.4, 130.0, 129.8, 114.0, 55.2, 51.8, 
42.8, 36.6, 34.4. [α]22D = +17.4 (c 0.4, CHCl3). HRMS (CI+): calculated for C13H16O5, [M]+: 
252.0998, found: 252.0988. 
 
General procedure B for the preparation of olefins 13a-d 
To a cooled (–20 °C) solution of carboxylic acid 5 in THF was added BH3.Me2S (2 equiv). The 
mixture was stirred at room temperature for 3 h and MeOH was added. The solvents were remove in 
vacuo and this procedure was repeated twice. The resulting crude alcohol was dissolved in CH2Cl2 
and cooled to 0 °C. Next, trichloroisocyanuric acid (1 equiv) and TEMPO (0.01 equiv) were added 
and the reaction was stirred upon warming to room temperature. After 30 min the mixture was filtered 
over Celite and washed with H2O and 1 N HCl. The organic layer was concentrated, yielding the 
crude aldehyde. Next, Ph3PCH3Br (1.1 equiv) was suspended in THF and cooled to –78 °C. 
NaHMDS (2 M solution, 1.0 equiv) was added and the mixture was stirred upon gradually warming 
to room temperature. After 1 h the solution was cooled to –78 °C and a solution of the aldehyde was 
added. The reaction was stirred at room temperature for 18 h, after which saturated NH4Cl was added. 
The aqueous layer was extracted with pentane and the organic layer was dried with Na2SO4 and 
concentrated. The resulting olefin 13 was purified by column chromatography (Et2O/pentane, 1:20). 
 
(S)-Methyl 3-methylpent-4-enoate (13a) 
This compound was prepared from 5a according to general procedure B. The yield 
was 270 mg (56%). The ee was determined by GC to be 75% (Supelco GammaDEX 
120 column; 50 °C isothermal). The analytical data agreed with those reported in literature.45 1H-
NMR (CDCl3, 300 MHz): δ 5.76 (ddd, J = 6.9, 10.2, 17.2 Hz, 1H), 5.02 (m, 2H), 3.65 (s, 3H), 2.67 
(m, 1H), 2.31 (m, 2H), 1.04 (d, J = 6.9 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 172.9, 142.4, 113.3, 
51.4, 41.1, 34.4, 19.7. [α]22D = +2.5 (c 0.2, CHCl3). 
 
(S)-Methyl 3-vinylhexanoate (13b) 
This compound was prepared from 5b according to general procedure B. The yield 
was 101 mg (60%). The ee was determined by GC to be 85% (Chiraldex G-TA 
column; 65 °C isothermal) 1H-NMR (CDCl3, 300 MHz): δ 5.61 (ddd, J = 8.3, 10.2, 
17.2 Hz, 1H), 4.99 (m, 2H), 3.64 (s, 3H), 2.51 (m, 1H), 2.39–2.23 (m, 2H), 1.39–
1.23 (m, 4H), 0.87 (m, 3H). 13C-NMR (CDCl3, 75 MHz): δ 173.0, 141.1, 114.9, 51.4, 40.2, 40.0, 36.7, 
20.1, 14.0. [α]22D = –3.5 (c 0.2, CHCl3). 
 
(R)-Methyl 3-benzylpent-4-enoate (13c) 
This compound was prepared from 5c according to general procedure B. The yield 
was 76 mg (61%). The ee was determined by HPLC to be 84% (Chiralcel OD-H 
column; hexane/iso-propanol, 97:3). The analytical data agreed with those reported 
in literature.46 1H-NMR (CDCl3, 300 MHz): δ 7.30–7.14 (m, 5H), 5.72 (ddd, J = 7.8, 
10.0, 17.6 Hz, 1H), 4.97 (m, 2H), 3.62 (s, 3H), 2.87 (m, 1H), 2.68 (m, 2H), 2.39 (dd, J = 5.9, 15.0 Hz, 
1H), 2.29 (dd, J = 8.3, 5.0 Hz, 1H). 13C-NMR (CDCl3, 75 MHz): δ 175.9, 140.3, 139.4, 129.3, 128.2, 
126.2, 115.2, 51.4, 41.6, 41.0, 38.7. [α]22D = +7.0 (c 0.1, CH2Cl2). 
 
(R)-Methyl 3-(4-methoxybenzyl)pent-4-enoate (13d) 
This compound was prepared from 5d according to general procedure B, using 
modified oxidation conditions. The crude alcohol was dissolved in acetone and 
NMO (1.1 equiv) and TPAP (1 mol %) were added. The reaction was stirred at 
room temperature for 2 h, after which the mixture was filtered over Celite and 
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flushed over a short silica column. The solvent was evaporated, yielding the crude aldehyde, which 
was used in the next step. The overall yield of 13d was 62 mg (58%). The ee was determined by 
HPLC to be 83% (Chiralcel OD-H column; hexane/iso-propanol, 99.6:0.4). 1H-NMR (CDCl3, 300 
MHz): δ 7.06 (d, J = 8.8 Hz, 2H), 6.81 (d, J = 8.8 Hz, 2H), 5.71 (ddd, J = 7.9, 9.7, 17.6 Hz, 1H), 4.97 
(m, 2H), 3.77 (s, 3H), 3.62 (s, 3H), 2.83 (m, 1H), 2.62 (m, 2H), 2.32 (m, 2H). 13C-NMR (CDCl3, 75 
MHz): δ 172.9, 158.0, 140.4, 131.4, 130.2, 115.1, 113.6, 55.2, 51.4, 41.8, 40.1, 38.6. IR (CHCl3): ν 
3055, 2910, 1736, 1640, 1610 cm-1. [α]22D = +7.8 (c 1.9, CHCl3). 
 
General procedure C for the preparation of iodides 4a-d 
To a solution of 13 in Et2O at –78 °C was added LiAlH4 (1.1 equiv). The reaction was gradually 
warmed to room temperature and stirred for 1 h, after which H2O was added. To dissolve the 
remaining salts HCl (1M) was added and the mixture was extracted with Et2O. The organic layers 
were dried (Na2SO4) and concentrated in vacuo. The crude alcohol was dissolved in CH2Cl2 and PPh3 
(1.3 equiv) and imidazole (1.5 equiv) were added. The reaction was cooled to 0 °C and a solution of 
iodine (1.3 equiv) in CH2Cl2 was added. After 30 min the reaction was warmed to room temperature 
and stirred for 2 h. Next, the mixture was extracted with H2O and brine. The organic layer was dried 
(Na2SO4) and the solvents were evaporated in vacuo. The product was purified by column 
chromatography (100% pentane). 
 
(S)-5-Iodo-3-methylpent-1-ene (4a) 
This compound was prepared from 13a according to general procedure C. The yield 
was 74 mg (86%) The analytical data agreed with those reported in literature.47 1H-
NMR (CDCl3, 400MHz): δ 5.61 (ddd, J = 7.9, 10.3, 17.3, 1H), 5.06 (m, 1H), 4.99 (m, 1H), 3.21 (m, 
1H), 3.12 (m, 1H), 2.34–2.23 (m, 1H), 1.89–1.75 (m, 2H), 1.02 (d, J= 6.7 Hz, 3H). 13C NMR (CDCl3, 
75 MHz): δ 142.4, 114.2, 40.3, 39.0, 20.1, 5.4. [α]22D = +20.6 (c 0.2, CHCl3). 
 
(S)-3-(2-Iodoethyl)hex-1-ene (4b) 
This compound was prepared from 13b according to general procedure C. The yield 
was 91 mg (78%) 1H-NMR (CDCl3, 300 MHz): δ 5.44 (m, 1H), 5.04 (m, 2H), 3.23 (m, 
1H), 3.03 (m, 1H), 2.10 (m, 1H), 1.91 (m, 1H), 1.74 (m, 1H), 1.36–1.19 (m, 4H), 0.87 
(m, 3H). 13C-NMR (CDCl3, 75 MHz): δ 141.1, 115.8, 44.6, 38.5, 36.8, 20.1, 14.0, 5.3. 
IR (CHCl3): ν 3076, 2957, 1641 cm-1. [α]22D = +21.3 (c 0.5, CHCl3). HRMS (EI+): calculated for 
C8H15I, [M]+: 238.0219, found: 238.0215. 
 
(R)-(2-(2-Iodoethyl)but-3-enyl)benzene (4c) 
This compound was prepared from 14c according to general procedure C. The yield 
was 37 mg (80%). 1H-NMR (CDCl3, 300 MHz): δ 7.31–7.13 (m, 5H), 5.53 (ddd, J = 
8.5, 10.5, 19.0 Hz, 1H), 5.02 (m, 2H), 3.24 (m, 1H), 3.04 (m, 1H), 2.66 (m, 2H), 2.47 
(m, 1H), 1.96 (m, 1H), 1.74 (m, 1H). 13C-NMR (CDCl3, 75 MHz): δ 140.2, 139.6, 
129.2, 128.2, 126.1, 116.3, 46.3, 41.3, 37.5, 4.8. IR (CHCl3): ν 3068, 2920, 2861, 1640, 1452 cm-1. 
[α]22D = –43.4 (c 1.6, CHCl3). HRMS (CI+): calculated for C12H15I, [M]+: 286.0219, found: 286.0227. 
 
(R)-1-(2-(2-Iodoethyl)but-3-enyl)-4-methoxybenzene (4d) 
This compound was prepared from 13d according to general procedure C. The 
yield was 45 mg (88%). 1H-NMR (CDCl3, 300 MHz): δ 7.05 (d, J = 8.8 Hz, 2H), 
6.81 (d, J = 8.8 Hz, 2H), 5.52 (ddd, J = 8.7, 10.3, 19.0 Hz, 1H), 5.01 (m, 2H), 3.78 
(s, 3H), 3.23 (ddd, J = 5.0, 8.1, 13.1 Hz, 1H), 3.03 (m, 1H), 2.60 (m, 2H), 2.41 (m, 
1H), 1.95 (m, 1H), 1.72 (m, 1H). 13C-NMR (CDCl3, 75 MHz): δ 157.9, 140.3, 
131.6, 130.1, 116.2, 113.6, 55.2, 46.5, 40.4, 37.5, 4.9. IR (CHCl3): ν 3071, 2859, 1638, 1449 cm-1. 
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[α]22D = –34.5 (c 2.2, CHCl3). HRMS (CI+): calculated for C13H17OI, [M]+: 316.0324, found: 
316.0317. 
 
General procedure D for the alkylation of 3 with iodides 4a-d 
A solution of 334 in DMF (~0.1M) was cooled to 0 °C and NaH (60% dispersion in mineral oil, 1.2 
equiv) was added. The resulting solution was stirred at 0 °C for 15 min and at room temperature for 
30 min. Next, the reaction was cooled to 0 °C, followed by addition of 4 (1.5 equiv).The solution was 
allowed to warm to room temperature and stirred for 2 h. Saturated NH4Cl was added and the mixture 
was extracted with pentane. The organic layers were dried (Na2SO4) and concentrated in vacuo. The 
crude product was purified by column chromatography (EtOAc/heptane). 
 
(S)-Methyl 2-(tert-butoxycarbonyl(3-methylpent-4-enyl)amino)acrylate (2a) 
This compound was prepared from 4a and 3 following general procedure D. 
The yield was 23 mg (58%). 1H-NMR (CDCl3, 400 MHz): δ 5.89 (s, 1H), 
5.72–5.64 (m, 1H), 5.38 (s, 1H), 4.96 (m, 1H), 3.77 (s, 3H), 3.47 (m, 2H), 
2.21–2.11 (m, 1H), 1.57 (m, 1H), 1.41 (s, 9H), 1.01 (d, J = 6.7 Hz, 3H). 13C NMR (CDCl3, 75 MHz): 
δ 165.7, 153.9, 143.8, 140.3, 117.1, 113.3, 81.0, 52.3, 48.0, 35.7, 34.8, 28.3, 20.3. IR (CH2Cl2): ν 
2974, 2932, 1736, 1706, 1633, 1366, 1153 cm-1. [α]22D = +1.0 (c 0.4, CHCl3). HRMS (CI+): 
calculated for C15H26NO4, [M+H]+: 284.1862, found: 284.1850. 
 
(S)-Methyl 2-(tert-butoxycarbonyl(3-vinylhexyl)amino)acrylate (2b) 
This compound was prepared from 4b and 3 following general procedure D. 
The yield was 18 mg (67%). 1H-NMR (CDCl3, 300 MHz): δ 5.88 (s, 1H), 5.52 
(ddd, J = 8.8, 10.4, 19.2 Hz, 1H), 5.36, (s, 1H), 4.96 (m, 2H), 3.77 (s, 3H), 
3.44 (m, 2H), 1.98 (m, 1H), 1.71-1.57 (m, 2H), 1.54 (s, 9H), 1.52-1.24 (m, 
4H), 0.86 (m, 3H). 13C-NMR (CDCl3, 75 MHz): δ 165.3, 152.5, 142.3, 140.2, 116.7, 114.8, 80.8, 
52.2, 41.5, 38.1, 37.1, 31.2, 28.1, 20.1, 14.0. IR (CHCl3): ν 2973, 2932, 1735, 1706, 1633, 1154 cm-1. 
[α]22D = –3.6 (c 0.3, CHCl3). HRMS (ESI+): calculated for C17H29NO4Na, [M+Na]+: 334.1994, found: 
334.1973. 
 
(R)-Methyl 2-((3-benzylpent-4-enyl)(tert-butoxycarbonyl)amino)acrylate (2c) 
This compound was prepared from 4c and 3 following general procedure D. 
The yield was 16 mg (61%). 1H-NMR (CDCl3, 300 MHz): δ 7.27-7.10 (m, 
5H), 5.84 (s, 1H), 5.59 (ddd, J = 8.4, 10.2, 18.8 Hz, 1H), 5.27, (s, 1H), 4.90 
(m, 2H), 3.75 (s, 3H), 3.46 (m, 2H), 2.64 (m, 2H), 2.32 (m, 1H), 1.75 (m, 1H), 
1.55 (m, 1H), 1.39 (s, 9H). 13C-NMR (CDCl3, 75 MHz): δ 165.9, 155.9, 141.2, 
141.1, 140.1, 129.3, 128.1, 125.9, 117.0, 115.4, 80.9, 52.2, 47.7, 43.3, 41.7, 32.4, 28.1. IR (CHCl3): ν 
2976, 2955, 1734, 1707, 1633, 1356 cm-1. [α]22D = –5.3 (c 0.4, CHCl3). HRMS (ESI+): calculated for 
C21H29NO4Na, [M+Na]+: 382.1994, found: 382.1977. 
 
(R)-Methyl 2-((3-benzylpent-4-enyl)(tert-butoxycarbonyl)amino)acrylate (2d) 
This compound was prepared from 4d and 3 following general procedure D. 
The yield was 24 mg (77%). 1H-NMR (CDCl3, 300 MHz): δ 7.03 (d, J = 8.8 
Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 5.84 (s, 1H), 5.58 (ddd, J = 8.6, 10.2, 18.8 
Hz, 1H), 5.28 (s, 1H), 4.90 (m, 2H), 3.76 (s, 3H), 3.75 (s, 3H), 3.45 (m, 2H), 
2.57 (m, 2H), 2.28 (m, 1H), 1.73 (m, 1H), 1.50 (m, 1H), 1.39 (s, 9H). 13C-
NMR (CDCl3, 75 MHz): δ 167.8, 157.9, 157.8, 142.0, 141.4, 132.2, 130.1, 117.0, 115.3, 113.4, 80.9, 
55.2, 52.2, 43.4, 40.8, 38.1, 32.3, 28.1. IR (CHCl3): ν 2974, 1734, 1705, 1633 cm-1. [α]22D = –3.7 (c 
1.0, CHCl3). HRMS (ESI+): calculated for C22H31NO5Na, [M+Na]+: 412.2100, found: 412.2112. 
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General procedure E for ring-closing metathesis of dehydroamino acids 2a-d 
A solution of 2 in toluene (~2 μM) was stirred under an inert atmosphere at 80 °C. Catalyst A (5 
mol %) was added and the reaction was stirred at 80 °C for 1 h. Next, a second portion of A (5 
mol %) was added and the reaction was stirred for an additional 3 h. The mixture was cooled to room 
temperature and silica gel was added. The solvent was removed and the crude product, adsorbed to 
silica, was purified by column chromatography (EtOAc/heptane, 1:20). The ee of the product was 
determined by chiral HPLC. 
 
(S)-1-tert-Butyl 2-methyl 4-methyl-5,6-dihydropyridine-1,2(4H)-dicarboxylate (1a) 
This compound was prepared from 2a following general procedure E. The yield was 
6.0 mg (81%). The ee was determined by HPLC to be 73% (Chiralcel AD-H column; 
hexane/iso-propanol, 98:2). 1H-NMR (CDCl3, 300 MHz): δ 5.82 (d, J = 3.3 Hz, 1H), 
3.76 (s, 3H), 3.56 (m, 2H), 2.40 (m, 1H), 1.88 (m, 1H), 1.46 (m, 1H), 1.42 (s, 9H), 1.06 
(d, J = 7.2 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 165.9, 153.2, 131.9, 126.9, 81.5, 52.0, 42.0, 31.0, 
28.6, 28.2, 20.6. IR (CH2Cl2): ν 2954, 2930, 2854, 1735, 1709, 1640, 1367 cm-1. [α]22D = –9.6 (c 0.3, 
CHCl3). HRMS (CI+): calculated for C13H21NO4, [M]+: 255.1471, found: 255.1477. 
 
(S)-1-tert-Butyl 2-methyl 4-propyl-5,6-dihydropyridine-1,2(4H)-dicarboxylate (1b) 
This compound was prepared from 2b following general procedure E. The yield was 
3.0 mg (82%). The ee was determined by HPLC to be 83% (Chiralcel AD-H column; 
hexane/iso-propanol, 98:2). 1H-NMR (CDCl3, 300 MHz): δ 5.88 (d, J = 3.4 Hz, 1H), 
3.76 (s, 3H), 3.67 (ddd, J = 3.4, 6.7, 12.9 Hz, 1H), 3.45 (ddd, J = 3.2, 8.9, 12.9 Hz, 
1H), 2.26 (m, 1H), 1.88 (m, 1H), 1.47 (m, 1H), 1.43 (s, 9H), 1.42–1.33 (m, 4H), 0.91 
(t, J = 6.8 Hz, 3H). 13C-NMR (CDCl3, 75 MHz): δ 165.6, 153.1, 132.0, 126.7, 81.5, 52.0, 41.7, 31.1, 
29.0, 28.1, 20.2, 14.1. IR (CHCl3): ν 2961, 2930, 2844, 1735, 1709, 1638, 1368 cm-1. [α]22D = –13.3 
(c 0.15, CHCl3). HRMS (EI+): calculated for C15H26NO4, [M+H]+: 284.1862, found: 284.1859. 
 
(R)-1-tert-Butyl 2-methyl 4-benzyl-5,6-dihydropyridine-1,2(4H)-dicarboxylate (1c) 
This compound was prepared from 2c following general procedure E. The yield was 
6.5 mg (89%). The ee was determined by HPLC to be 82% (Chiralcel AD-H column; 
hexane/iso-propanol, 98:2). 1H-NMR (CDCl3, 300 MHz): δ 7.32–7.15 (m, 5H), 5.84 
(d, J = 2.6 Hz, 1H), 3.76 (s, 3H), 3.66 (ddd, J = 3.3, 6.7, 13.1 Hz, 1H), 3.46 (ddd, J = 
3.3, 8.8, 13.1 Hz, 1H), 2.74 (m, 1H), 2.59 (m, 2H), 1.80 (m, 1H), 1.55 (m, 1H), 1.43 (s, 
9H). 13C-NMR (CDCl3, 75 MHz): δ 165.7, 152.9, 139.2, 132.4, 129.0, 128.5, 126.4, 124.3, 81.5, 52.0, 
41.7. 41.2, 35.5, 28.7, 28.0. IR (CHCl3): ν 2976, 2925, 1734, 1705, 1637, 1362 cm-1. [α]22D = +21.7 
(c 0.3, CHCl3). HRMS (ESI+): calculated for C19H25NO4Na, [M+Na]+: 354.1681, found: 354.1667. 
 
(R)-1-tert-Butyl 2-methyl 4-(4-methoxybenzyl)-5,6-dihydropyridine-1,2(4H)-dicarboxylate (1d) 
This compound was prepared from 2d and following general procedure E. The yield 
was 17.5 mg (90%). The ee was determined by HPLC to be 81% (Chiralcel AD-H 
column; hexane/iso-propanol, 98:2). 1H-NMR (CDCl3, 300 MHz): δ 7.07 (d, J = 8.7 
Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 5.83 (d, J = 2.9 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 
3H), 3.64 (ddd, J = 3.5, 6.8, 13.0 Hz, 1H), 3.46 (m, 1H), 2.67 (m, 1H), 2.54 (m, 2H), 
1.79 (m, 1H), 1.54 (m, 1H), 1.42 (s, 9H). 13C-NMR (CDCl3, 75 MHz): δ 165.7, 
158.2, 153.0, 132.3, 131.2, 129.9, 124.5, 113.9, 81.5, 55.2, 51.9, 40.3, 38.0, 35.7, 28.7, 28.0. IR 
(CHCl3): ν 2978, 2921, 1732, 1706, 1637 cm-1. [α]22D = +27.5 (c 0.8, CHCl3). HRMS (ESI+): 
calculated for C20H27NO5Na, [M+Na]+: 384.1787, found: 384.1785. 
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Summary 
 
Over the past decade olefin metathesis has rapidly emerged as one of the most 
important and widely utilized techniques in synthetic organic chemistry. In particular, its 
ability to efficiently generate heterocyclic molecules has turned it into a versatile tool for 
the preparation of naturally occurring molecules and pharmaceutically active compounds. 
In 2005, the major influence of olefin metathesis was recognized by the Royal Swedish 
Academy of Sciences, awarding the Nobel Prize in Chemistry to the developers of this 
process. Ruthenium-containing catalysts, such as 1 and 2, have played a major role in 
recent metathesis research. With these powerful catalysts the scope of olefin metathesis has 
increased over the past years, starting from regular terminal olefins to more substituted 
ones. 
 
MesN NMes
Ru
PCy3
Cl
Cl Ph
catalyst Ru
PCy3
PCy3
Cl
Cl Ph
1 2Ring-closing metathesis (RCM)  
 
 This thesis deals with the application of ring-closing metathesis (RCM) to several 
types of, thus far unexplored, highly functionalized olefinic fragments. In addition to the 
investigation of model systems, the relevance of this methodology is demonstrated by 
preparing more elaborate systems, including heterocyclic natural products. 
Chapter 1 provides a brief historical overview of the discovery of olefin 
metathesis and the development of synthetically useful catalysts for different types of 
metathetic transformations. In addition, the scope of ring-closing metathesis (RCM) in 
terms of directly functionalized double bonds is discussed as well as some illustrative 
examples of applications of RCM in natural product synthesis. 
 Chapter 2 describes a comprehensive study of the scope of a combined 
oxypalladation/ring-closing metathesis route to oxygen heterocycles 6, which may serve as 
versatile building blocks for different classes of natural products. 
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OHR1
+
OR1 OR2 OR1 OR2
3
(  )n(  )n (  )n
4 6
R2O •
5
Pd/ligand
Et3N, MeCN
RCM
 
 
The work discussed in this chapter mainly focuses on the mechanism and scope of the 
palladium-catalyzed formation of allylic O,O-acetals 5. This mild procedure was shown to 
be a suitable method for coupling alcohols, phenols and carboxylic acids to the 
alkoxyallenes 4, thereby resulting in a range of allylic acetals and esters. 
Considering the examples of ring-closing metathesis of both electron-rich and 
electron-poor olefins reported in literature, we set out to investigate the metathesis behavior 
of olefins that are substituted with both an electron-withdrawing and -donating group. 
Chapter 3 of this thesis describes the investigation of RCM of such compounds – α-
alkoxyacrylates such as 7 – leading to a range of oxygen heterocyclic compounds. 
 
O CO2EtO
CO2Et
10 (21%)9 (30%)8 (20%)
2 (10 mol %)
PhMe
 70 °C, 16 h
7
OBnO2C
(  )3 OBnO2C OOBnO2C
BnO2C
+ +
11 (89%) 12 (92%)
 
 
Although RCM of the α-alkoxyacrylate systems by itself was successful, an initial setback 
was the observation of isomerization of the unhindered terminal olefin as a side-reaction 
prior to cyclization. For instance, RCM of 7 resulted in the formation of smaller rings 9 and 
10 besides the desired seven-membered ring product 8. In contrast, the preparation of 
benzofuran and benzopyran derivatives via RCM did not suffer from olefin isomerization 
and 11 and 12 could be isolated in high yields. 
The application of this methodology to highly functionalized carbohydrate-derived 
substrates is discussed in Chapter 4. The development of a novel, efficient method for 
preparing the α-alkoxyacrylate precursors (e.g. 15) followed by RCM, resulted in the 
formation of a variety of heterocyclic products, such as 16. These functionalized glycals 
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present a class of useful building blocks for a number of natural products and derivatives 
thereof. 
 
O
O
HO
O
O
O
O
O
O
O
MeO2C
13 15
1) 
2) MeI
    Na2CO3
    70%
N
CO2MeBr
2 (10 mol %)
PhMe
85 °C, 1 h
91%
OMeO2C
O
O
O
OH
16
14, NaH
 
 
During the investigations described in Chapter 4, the first example of a one-carbon 
homologation in a ring-closing metathesis process was observed. This novel side-reaction 
may provide important new insights into catalyst decomposition and might open up new 
possibilities for versatile tandem reaction sequences. 
Further functionalization of two of the described glycals resulted in short and 
efficient total syntheses of the natural products DAH (23) and KDO (25) and the known 
enzyme inhibitor 2-deoxy-β-KDO (24). These transformations, which proceed via 
iodohydrin intermediates such as 21 are discussed in Chapter 5. 
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 Inspired by the RCM results of α-alkoxyacrylate precursors, it was decided to 
extend this research to the nitrogen analogues, i.e. α,β-dehydroamino acids. The synthesis 
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and subsequent cyclization of a range of unsubstituted model systems are described in 
Chapter 6, as well as the investigation of several allylically substituted variants (27a–f). 
 
2 (10 mol%)
PhMe, 80 °C NBoc
R
CO2MeCO2MeNBoc
R
27a (R = H):
27b (R = Me):
27c (R = Ph):
27d (R = OMOM):
27e (R = OTBS):
27f (R = OMe):
a in the presence of 
  1,4 benzoquinone (20 mol %)
98%a
81%
85%
75%a
58%a
62%a
26a-f 27a-f
 
 
As an extension to the latter systems, Chapter 7 describes a novel combined 
asymmetric hydrogenation/ring-closing metathesis approach to optically active 
4-substituted cyclic dehydroamino acids. Mono-acids 29a–d were employed as chiral 
building blocks for these heterocycles. These scaffolds were synthesized on a preparative 
scale in collaboration with DSM, via asymmetric hydrogenation of the itaconic acid mono-
esters 28a–d, using a monodentate phosphoramidite/phosphite ligand library. 
 
HO2C
CO2Me
R
28a-d
HO2C
CO2Me
Rh(COD)2BF4/L
H2, CH2Cl2
>99% conversion
HO2C
CO2Me
HO2C
CO2Me HO2C
CO2Me
OMe
29a (ee 99%) 29b (ee 99%)
29c (ee 94%) 29d (ee 89%)
O
O
P RL =
 
 
The mono-ester building blocks were converted into the corresponding olefinic iodides 
30a–d through a straightforward five-step procedure. Coupling of the iodides with 
protected dehydroalanine 31 resulted in the RCM-precursors (32a–d). 
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Finally, cyclization of the dehydroamino acid double bonds with the allylically substituted 
olefinic bonds proceeded efficiently, thereby yielding the desired 4-substituted cyclic 
dehydroamino acids (33a–d) in excellent yields. 
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Samenvatting 
 
Gedurende het laatste decennium heeft olefinemetathese zich ontwikkeld tot één 
van de belangrijkste en meest toegepaste technieken binnen de synthetisch organische 
chemie. Vooral door de mogelijkheid om op efficiente wijze heterocyclische moleculen te 
genereren, is het een breed toepasbare methode gebleken voor het synthetiseren van 
natuurstoffen en farmaceutisch actieve verbindingen. In 2005 is de grote invloed van 
olefinemetathese erkend door de Koninklijke Zweedse Academie voor Wetenschappen 
middels het toekennen van de Nobelprijs voor de Chemie aan de ontwikkelaars van dit 
proces. Ruthenium-bevattende katalysatoren zoals 1 en 2 hebben een belangrijke rol 
gespeeld in het meest recente onderzoek naar olefinemetathese. Met behulp van deze 
krachtige en tolerante katalysatoren is het toepassingsgebied van dit process de laatste jaren 
vergroot van eenvoudige, eindstandige dubbele bindingen naar meer gesubstitueerde 
olefines. 
 
MesN NMes
Ru
PCy3
Cl
Cl Ph
katalysator Ru
PCy3
PCy3
Cl
Cl Ph
1 2Ringsluitingsmetathese (RCM)  
 
 Dit proefschrift behandelt de toepassing van ringsluitingsmetathese (RCM) op 
verschillende, niet eerder onderzochte, sterk gesubstitueerde dubbele bindingen. Naast het 
onderzoek naar meer basale modelsystemen, wordt de relevantie van deze methodologie 
aangetoond door de synthese van meer ingewikkelde systemen, waaronder enkele 
heterocyclische natuurstoffen. 
 In Hoofdstuk 1 wordt een beknopt historisch overzicht gegeven van de 
ontdekking van olefinemetathese en de ontwikkeling van praktisch toepasbare katalysatoren 
voor verschillende metathese-gebaseerde omzettingen. De omvang van het 
toepassingsgebied van ringsluitingsmetathese wordt beschreven met de nadruk op 
gefunctionaliseerde dubbele bindingen. Daarnaast wordt een aantal illustratieve 
voorbeelden beschreven van het gebruik van RCM in de synthese van natuurstoffen. 
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 Hoofdstuk 2 beschrijft een brede studie naar de toepasbaarheid van een 
gecombineerd oxypalladering/ringsluitingsmetathese proces voor de bereiding van de 
zuurstof heterocycli 6. Deze veelzijdige verbindingen kunnen dienen als bouwstenen voor 
verschillende klassen van natuurstoffen. 
 
OHR1
+
OR1 OR2 OR1 OR2
3
(  )n(  )n (  )n
4 6
R2O •
5
Pd/ligand
Et3N, MeCN
RCM
 
 
Het werk in dit hoofdstuk richt zich met name op het mechanisme en de toepasbaarheid van 
de palladium-gekatalyseerde vorming van allylische O,O-acetalen 5. Er wordt aangetoond, 
dat deze milde procedure een geschikte methode vormt voor het koppelen van alcoholen, 
phenolen en carbonzuren met alkoxyallenen 4, wat heeft geresulteerd in een serie allylische 
acetalen en esters. 
 Inspelend op voorbeelden uit de literatuur van RCM van elektronenrijke en 
elektronenarme dubbele bindingen, werd besloten het metathesegedrag van olefines met 
zowel een elektronenstuwende als een -zuigende substituent te bestuderen. Hoofdstuk 3 
beschrijft het onderzoek naar de RCM van dit soort verbindingen – α-alkoxyacrylaten zoals 
7 – resulterend in een serie van zuurstof heterocycli. 
 
O CO2EtO
CO2Et
10 (21%)9 (30%)8 (20%)
2 (10 mol %)
PhMe
 70 °C, 16 u
7
OBnO2C
(  )3 OBnO2C OOBnO2C
BnO2C
+ +
11 (89%) 12 (92%)
 
 
Hoewel ringsluiting van de α-alkoxyacrylaten succesvol was, werd als ongewenste 
nevenreactie olefineisomerisatie voorafgaand aan cyclisatie waargenomen. Tijdens de RCM 
van 7 resulteerde dit bijvoorbeeld in de vorming van de kleinere ringsystemen 9 en 10 naast 
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de gewenste zevenring 8. De synthese van benzofuran- en benzopyranderivaten leed echter 
niet onder deze nevenreactie, zodat 11 en 12 in hoge opbrengst konden worden geïsoleerd. 
 De toepassing van deze methodologie op sterk gefunctionaliseerde 
koolhydraatderivaten wordt beschreven in Hoofdstuk 4. De ontwikkeling van een nieuwe, 
efficiente methode voor het maken van de α-alkoxyacrylaat-precursors (zoals 15), gevolgd 
door RCM, heeft geresulteerd in de syntheses van een reeks heterocyclische producten, 
waaronder 16. Deze gefunctionaliseerde glycalen vormen een klasse van nuttige 
bouwstenen voor verschillende natuurstoffen en derivaten daarvan. 
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In de loop van dit deel van het onderzoek, werd het eerste voorbeeld van een één-koolstof 
homologatie tijdens ringsluitingsmetathese waargenomen. Deze nevenreactie kan leiden tot 
belangrijk nieuw inzicht in de afbraak van katalysatoren en mogelijkerwijs tot de 
ontwikkeling van nieuwe tandem-reacties. 
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Verdere functionalisering van twee beschreven glycalen heeft geleid tot korte en 
efficiente totaalsyntheses van de natuurstofen DAH (23), KDO (25) en de bekende 
enzymremmer 2-deoxy-β-KDO (24). Deze transformaties, die verlopen via joodhydrin-
intermediairen zoals 21, worden in Hoofdstuk 5 behandeld. 
 Geïnspireerd door de resultaten met de RCM van α-alkoxyacrylaten, werd 
besloten om dit onderzoek uit te breiden naar de stikstof-analoga, dat wil zeggen naar α,β-
dehydroaminozuren. De synthese en daaropvolgende cyclisatie van een reeks 
ongesubstitueerde modelsystemen zijn beschreven in Hoofdstuk 6, alsmede het onderzoek 
van verschillende allylisch gesubstitueerde varianten (27a–f). 
 
2 (10 mol%)
PhMe, 80 °C NBoc
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R
27a (R = H):
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62%a
26a-f 27a-f
 
 
 Als aanvulling op de laatstgenoemde systemen, behandelt Hoofdstuk 7 een 
nieuwe gecombineerde asymmetrische hydrogenering/ringsluitingsmetathese benadering 
voor de synthese van optisch actieve 4-gesubstitueerde cyclische dehydroaminozuren.  
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Als chirale bouwstenen voor deze heterocycli zijn de monozuren 29a–d gebruikt. Deze 
verbindingen zijn op preparatieve schaal bereid in samenwerking met DSM, door middel 
van asymmetrische hydrogenering van de itaconzure monoesters 28a–d, gebruik makend 
van een monodentaat fosforamidiet/fosfiet bibliotheek van liganden. Vervolgens zijn de 
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monoester-bouwblokken 28a–d in vijf stappen omgezet in de overeenkomstige jodides 
30a–d door middel van standaardmethoden. Koppeling van deze jodides met beschermd 
dehydroalanine 31 resulteerde in RCM-precursors 32a–d. 
 
HO2C
CO2Me
29a-d
R
1) BH3·SMe2
2) oxidatie
3) Ph3PMeBr, NaHMDS
4) LiAlH4
5) I2, PPh3, imidazool
      56−61%
30a-d 32a-d
R
I
R
N
Boc
CO2Me
CO2MeHN
N
Boc
CO2Me
33a  81%
ee 73%
N
Boc
CO2Me
33b  82%
ee 83%
N
Boc
CO2Me
33c  89%
ee 82%
N
Boc
CO2Me
33d  90%
ee 81%
OMe
NaH 
58−77%
2 (10 mol%)
PhMe, 80 °C
31Boc
 
 
De cyclisaties van de dehydroaminozuur-bindingen met de allylisch gesubstitueerde 
olefines veriepen uiteindelijk succesvol. Dit resulteerde in de gewenste 4-gesubstitueerde 
cyclische dehydroaminozuren (33a–d) in goede opbrengsten. 
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Dankwoord 
 
Er schuilt een vreemd soort ironie in het feit, dat het meest gelezen deel van het proefschrift 
vaak pas als laatste, met de meeste haast en met de minste nauwkeurigheid wordt 
geschreven. Ondanks het niet-wetenschappelijk karakter van een dankwoord, kan bepaalde 
ontbrekende informatie echter toch leiden tot onherstelbare schade. Bij voorbaat dus mijn 
excuses aan de mensen die ik ga vergeten. 
Na een leuke en leerzame hoofdvakstage anorganische chemie besloot ik in 2001 dat het 
misschien handig zou zijn om eens wat meer synthetische ervaring op te doen. Niks meer, 
niks minder, gewoon handig. Zo'n negen maanden later had ik een bijvakstage in de groep 
van Floris Rutjes erop zitten en keek ik toch heel anders tegen de organische chemie aan. 
Floris, toen je me het aanbod deed om in jouw nieuwe, dynamische groep als promovendus 
aan interessante, actuele chemie te gaan werken, was dit te aantrekkelijk om nee tegen te 
zeggen. Het is altijd erg fijn geweest om goed met mijn eigen promotor overweg te kunnen 
en er is al die jaren nooit een drempel geweest om eens bij je binnen te lopen, ook als was 
het maar voor een hele simpele vraag. Bedankt voor de goede begeleiding en voor al die 
goede ideeën die altijd precies op het juiste moment leken te komen. 
Mijn copromotor Floris van Delft wil ik bedanken voor zijn enthousiasme en continue 
stortvloed aan plannen. Jouw idee om eens te gaan kijken naar een op metathese gebaseerde 
synthese van KDO, heeft mijn onderzoek eigenlijk een vliegende start gegeven. Dit 
"nevenprojectje" heeft zich in 4 jaar zelfs doorontwikkeld tot het uiteindelijke hoofdthema 
van dit boekje, een neiging die nevenprojecten trouwens wel vaker lijken te hebben. Verder 
wil ik Richard Blaauw bedanken voor zijn scherpe en heldere kijk op de chemie en zijn 
hulp bij vele lastige vraagstukken.  
Bij DSM Pharmaceutical Products (Geleen) wil ik André de Vries, Laurent Lefort, Hans de 
Vries en Hans Schoemaker bedanken voor hun enorme gastvrijheid en behulpzaamheid 
tijdens de asymmetrische hydrogeneringen aldaar. Het blijft verbazingwekkend hoeveel ik 
bij jullie heb kunnen bereiken in zo'n korte tijd. De vier bouwstenen die bij deze 
experimenten zijn gemaakt hebben de belangrijke basis gelegd voor de eindverbindingen 
van hoofdstuk 7. Hans de Vries wil ik tevens bedanken voor het plaatsnemen in mijn 
manuscriptcommissie. Dit laatste geldt natuurlijk ook voor Jeroen Cornelissen en Alan 
Rowan. 
Iedere promovendus weet, dat studenten vaak de sleutel zijn tot een goed gevuld 
proefschrift (sommige studenten tenminste…). Met bloed, zweet en tranen proberen ze een 
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hoofdstuk en een publicatie bij elkaar te werken (sommige studenten tenminste...), zonder 
daar zelf erg veel voor terug te krijgen, behalve misschien een eigen promotieplaats 
(sommige studenten tenminste...). Ik ben gezegend geweest met twee fantastische 
hoofdvakstudenten, die op dit moment allebei zelf het plezier en de stress van een 
promotieproject aan het ervaren zijn. Marcel, met je tomeloze enthousiasme voor je eigen 
en andermans werk (en voor het slagersvak en voor tweewielige snelheidsmonsters en voor 
weet ik wat nog meer) had je een constante positieve invloed op het algehele lab-humeur. 
Hoofdstukken 4 en 6 zijn mede door jouw harde werken tot stand gekomen, waarvoor mijn 
dank. Dennis, de vele reacties in hoofdstuk 6 zijn voor een groot deel jouw werk geweest. 
Met een buitenkant van correctheid en vriendelijkheid heb je snel vrienden gemaakt, maar 
wat de meesten niet weten is, dat je dat beeld juist gebruikt om bepaalde akties uit te halen, 
zonder dat mensen het van jou zien aankomen. Ik kan me in ieder geval nog een bepaald 
telefoontje herinneren over nieuwe remschijven (of waren het nu remblokken?). Tenslotte 
nog bedankt dat je mijn paranimf wilt zijn, zie het maar als een goed opstapje naar je eigen 
ceremonie over een paar jaar (als je dat molecuul tenminste een keer afkrijgt). 
Zoals al vaak gezegd, kwam het grootste plezier misschien wel uit het werken met een 
leuke groep mensen, waarmee zowel gezelligheid als frustratie gedeeld kon worden. In 
eerste instantie vond dit alles nog plaats in een haastig opgeknapt oud-Tanzaniaans lab en 
kantoor in het UL (Lee, Joost, Marjolijn, Mark) en de laatste jaren in een flitsend nieuw lab 
(Valeria, Jasper Ka., Stan, Brian, Sander). Aan de laatstgenoemden heb ik in ieder geval 
één trauma overgehouden: ik kan geen bekerglas meer laten vallen, zonder direct angstig 
om te kijken of iemand het gemerkt heeft. Nou ja, in de zuurkast met de meeste scherven 
wordt het hardst gewerkt, zullen we maar zeggen… 
Uiteraard wil ik ook de overige collega's bedanken voor de sfeervolle tijd: Hester, Bart, 
Sjef, Christien, Roy, Jan, Leon, Henri, Roel, Maarten, Bas G., Guuske, Daniel, Dani, Pjotr, 
Kasia, Claudia, Martijn, Kaspar, Pieter, Jorge, Marloes, Rutger, Bas v.d. B., Bas R., Peter 
B., Jasper Kl., Denis. Ook de vele studenten, die in die tijd zijn gekomen en gegaan, hebben 
vaak op hun eigen manier een onuitwisbare indruk achtergelaten en verdienen het om als 
groep even genoemd te worden, ik ga echt niet alle namen opschrijven. 
Op organisatorisch en administratief vlak wil ik Jacky en Desiree bedanken voor het 
regelen van zo'n beetje alles wat niet in het lab gebeurt. Het blijft ongelooflijk hoe jullie 
zo'n grote groep academici net voldoende weten te stroomlijnen, zodat net niet alles in de 
soep loopt. Ad Swolfs, Peter van Galen en Helene Amatdjais-Groenen wil ik bedanken 
voor de vele noodzakelijke analyses. Pieter van der Meer, Chris Kroon en uiteraard de 
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altijd-vriendelijke-en-niet-chagrijnig-te-krijgen Peter van Dijk wil ik bedanken voor alle 
technische ondersteuning. 
Zonder leven buiten het lab loopt een mens al gauw het risico een beetje vreemd (of een 
briljant wetenschapper) te worden. Een aantal mensen wil ik dan ook bedanken voor de 
(soms hoognodige) afleiding buiten werktijden, of het nu in de vorm van een gezamelijke 
weekendtrip, een rik- of klaverjas-festijn, of gewoon een gezellig samenzijn was. Volleerd 
paranimf Jaap wil ik natuurlijk ook bedanken dat hij dat karwei ook voor mij opknapt. 
Misschien dat het eens tijd wordt om zelf in dat pakje op de voorgrond te staan, ik heb er in 
ieder geval vertrouwen in dat dat binnen (min of meer) afzienbare tijd ook echt zal 
gebeuren. En Paul: hopelijk blijf je niet al te lang down under, ten eerste omdat we geen 
klaverjaspartner meer hebben, ten tweede omdat je wederhelft zonder jouw invloed zijn 
ongeorganiseerde zelf weer is geworden. Ook Ruud en José (met uitbreiding), Agnes en 
Harold (nog zonder uitbreiding), Nicole en Roel (met uitbreiding) horen uiteraard in dit 
rijtje thuis. Allemaal bedankt voor de leuke momenten, die me hebben geholpen om af en 
toe eens aan de andere aspecten van het leven te kunnen denken. 
Mijn schoonouders hebben altijd meegeleefd met het wel en wee van het promotietraject 
alsof ik hun eigen zoon was, waarvoor ik ze erg dankbaar ben. Het is alleen verschrikkelijk 
jammer, dat jullie net niet allebei het voltooien van dit boekje hebben kunnen meemaken. 
Mijn ouders wil ik ontzettend bedanken voor al hun steun en interesse door de jaren heen. 
Vanaf het begin van mijn studie zijn jullie trots op mij geweest, zonder dat je ook maar enig 
idee had wat ik nu eigenlijk deed en in wat voor diepe put jullie die berg collegegeld ieder 
jaar stortte. Nu, na ook nog eens een promotietijd van vier jaar, is “moeilijke moleculen 
maken” toch een goede, begijpelijke omschrijving voor mijn bezigheden geworden. Ik ben 
ervan overtuigd dat dit boekje bij jullie nog jarenlang trots midden op tafel ligt, net zoals ik 
daar, jaren na mijn afstuderen, nog een oud stageverslag terugvond. 
Laatste woorden worden normaal gesproken gewijd aan de belangijkste persoon en dit 
dankwoord is hierop geen uitzondering. Lieve Regina, een simpel dankjewel zou niet 
voldoende zijn, dus ga ik daar ook niet aan beginnen. Jouw onvoorwaardelijke opoffering 
tijdens de afgelopen jaren is eigenlijk niet in woorden uit de drukken en ik ben van plan om 
je daar vanaf nu veel voor terug te gaan geven. Nou vooruit dan, op de valreep toch nog 
even: dank je wel! 
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Curriculum Vitea 
 
De auteur van dit proefschrift werd geboren op 22 november 1976 te Roosendaal. In juni 
1995 behaalde hij zijn VWO diploma aan het Gertrudislyceum in Roosendaal, waarna in 
september van dat jaar werd begonnen met de studie scheikunde aan de Radboud 
Universiteit Nijmegen (voorheen Katholieke Universiteit Nijmegen). De hoofd- en 
bijvakstages werden uitgevoerd in respectievelijk de vakgroep Anorganische Chemie onder 
prof. A. W. Gal en dr. P. H. M. Budzelaar en de vakgroep Synthetisch Organische Chemie 
onder prof. F. P. J. T. Rutjes. Het doctoraal examen werd behaald in 2002. 
Vanaf maart 2002 tot en met februari 2006 was hij werkzaam als promovendus in de 
vakgroep Synthetisch Organische Chemie aan de Radboud Universiteit Nijmegen. In deze 
periode werd onder leiding van prof. F. P. J. T. Rutjes het, in dit proefschrift beschreven, 
onderzoek uitgevoerd, dat mede gefinancierd werd door NWO-CW. 
Vanaf 1 augustus 2006 is Koen Hekking werkzaam als research scientist bij MercaChem 
B.V. in Nijmegen. 
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